NO | NAME OF PRODUCT | COMPOSITION | GRADE | STRENGTH | MARKET |
1 | ACECLOFENAC TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
ACECLOFENAC | I.P. | 100 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
2 | ACECLOFENAC, DROTAVERINE HYDROCHLORIDE TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
ACECLOFENAC | I.P. | 100 MG | |||
DROTAVERINE HYDROCHLORIDE | I.P. | 80 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
3 | ACECLOFENAC, PARACETAMOL TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
ACECLOFENAC | I.P. | 100 MG | |||
PARACETAMOL | I.P. | 325 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
4 | ACECLOFENAC, PARACETAMOL TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
ACECLOFENAC | I.P. | 100 MG | |||
PARACETAMOL | I.P. | 325 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
5 | ACECLOFENAC, PARACETAMOL TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
ACECLOFENAC | B.P. | 100 MG | |||
PARACETAMOL | B.P. | 500 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
6 | ACECLOFENAC, THIOCOLCHICOSIDE TABLETS | EACH FILM COATED TABLETS CONTAINS: | DOMESTIC | ||
ACECLOFENAC | I.P. | 100 MG | |||
THIOCOLCHICOSIDE | I.P. | 4 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
7 | ACECLOFENAC, THIOCOLCHICOSIDE TABLETS | EACH FILMCOATED TABLET CONTAINS: | DOMESTIC | ||
ACECLOFENAC | I.P. | 100 MG | |||
THIOCOLCHICOSIDE | I.P. | 8 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOURED USED | |||||
8 | ACECLOFENAC, PARACETAMOL, CHLORZOXAZONE TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
ACECLOFENAC | I.P. | 100 MG | |||
PARACETAMOL | I.P. | 325 MG | |||
CHLORZOXAZONE | U.S.P. | 250 MG | |||
EXCIPIENTS | Q.S | ||||
9 | ACECLOFENAC, PARACETAMOL, SERRATIOPEPTIDASE TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
ACECLOFENAC | I.P. | 100 MG | |||
PARACETAMOL | I.P. | 325 MG | |||
SERRATIOPEPTIDASE | I.P. | 10 MG | |||
(EQ.TO 20000 ENZYME ACTIVITY UNITS OF SERRATIOPEPTIDASE) | |||||
(AS ENTERIC COATED GRANULES) | |||||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
10 | ACECLOFENAC, PARACETAMOL, SERRATIOPEPTIDASE TABLETS | EACH FILM COATED TABLET CONTAINS | DOMESTIC | ||
ACECLOFENAC | I.P. | 100 MG | |||
PARACETAMOL | I.P. | 325 MG | |||
SERRATIOPEPTIDASE | I.P. | 15 MG | |||
(EQ.TO 30000 ENZYME ACTIVITY UNITS OF SERRATIOPEPTIDASE) | |||||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
11 | ACETAZOLAMIDE TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
ACETAZOLAMIDE | B.P. | 250 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
12 | ACETYLSALICYLIC ACID TABLETS | EACH UNCOATED TABLET CONTAINS: | EXPORT | ||
ACETYLSALICYLIC ACID | B.P. | 500 MG | |||
EXCIPIENTS | Q.S | ||||
13 | ACICLOVIR TABLETS | EACH UNCOATED TABLET CONTAINS: | EXPORT | ||
ACICLOVIR | B.P. | 200 MG | |||
EXCIPIENTS | Q.S | ||||
14 | ACICLOVIR TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
ACICLOVIR | I.P. | 400 MG | |||
EXCIPIENTS | Q.S | ||||
15 | ACICLOVIR TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
ACICLOVIR | I.P. | 800 MG | |||
EXCIPIENTS | Q.S | ||||
16 | ACICLOVIR DISPERSIBLE TABLETS | EACH UNCOATED DISPERSIBLE TABLET CONTAINS: | EXPORT | ||
ACICLOVIR | B.P. | 400 MG | |||
EXCIPIENTS | Q.S | ||||
17 | ACICLOVIR DISPERSIBLE TABLETS | EACH UNCOATED DISPERSIBLE TABLET CONTAINS: | EXPORT | ||
ACICLOVIR | B.P. | 800 MG | |||
EXCIPIENTS | Q.S | ||||
18 | ALBENDAZOLE CHEWABLE TABLETS | EACH UNCOATED CHEWABLE TABLET CONTAINS: | EXPORT | ||
ALBENDAZOLE | U.S.P. | 200 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
19 | ALBENDAZOLE CHEWABLE TABLETS | EACH UNCOATED CHEWABLE TABLET CONTAINS: | EXPORT | ||
ALBENDAZOLE | U.S.P. | 400 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
20 | ALBENDAZOLE CHEWABLE TABLETS | EACH UNCOATED CHEWABLE TABLET CONTAINS: | DOMESTIC | ||
ALBENDAZOLE | I.P. | 400 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
21 | ALBENDAZOLE TABLETS | EACH UNCOATED TABLET CONTAINS: | EXPORT | ||
ALBENDAZOLE | U.S.P. | 400 MG | |||
EXCIPIENTS | Q.S | ||||
22 | ALBENDAZOLE TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
ALBENDAZOLE | I.P. | 400 MG | |||
EXCIPIENTS Q.S | Q.S | ||||
23 | ALBENDAZOLE, IVERMECTIN TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
ALBENDAZOLE | I.P. | 400 MG | |||
IVERMECTIN | I.P. | 6 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
24 | ALBENDAZOLE, IVERMECTIN TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
ALBENDAZOLE | I.P. | 400 MG | |||
IVERMECTIN | I.P. | 12 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
25 | ALPRAZOLAM DISPERSIBLE TABLETS | EACH UNCOATED DISPERSIBLE TABLETCONTAINS: | DOMESTIC | ||
ALPRAZOLAM | I.P. | 0.25 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
26 | ALPRAZOLAM TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
ALPRAZOLAM | I.P. | 0.25 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
27 | ALPRAZOLAM TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
ALPRAZOLAM | I.P. | 0.5 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
28 | ALPRAZOLAM TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
ALPRAZOLAM | I.P. | 1 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
29 | ALPRAZOLAM, FLUOXETINE HYDROCHLORIDE TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
ALPRAZOLAM | I.P. | 0.25 MG | |||
FLUOXETINE HYDROCHLORIDE | I.P. | ||||
EQ TO FLUOXETINE | 20 MG | ||||
EXCIPIENTS | Q.S | ||||
30 | AMBROXOL HYDROCHLORIDE TABLETS | EACH UNCOATED TABLET CONTAINS: | EXPORT | ||
AMBROXOL HYDROCHLORIDE | B.P. | 30 MG | |||
EXCIPIENTS | Q.S | ||||
31 | AMBROXOL HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE TABLETS | EACH UNCOATED TABLET CONTAINS: | EXPORT | ||
AMBROXOL HYDROCHLORIDE | B.P. | 30 MG | |||
CETIRIZINE HYDROCHLORIDE | B.P. | 5 MG | |||
EXCIPIENTS | Q.S | ||||
32 | AMBROXOL HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE TABLETS | EACH UNCOATED TABLET CONTAINS: | EXPORT | ||
AMBROXOL HYDROCHLORIDE | B.P. | 60 MG | |||
CETIRIZINE HYDROCHLORIDE | B.P. | 5 MG | |||
EXCIPIENTS | Q.S | ||||
33 | AMBROXOL HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
AMBROXOL HYDROCHLORIDE | I.P. | 60 MG | |||
CETIRIZINE HYDROCHLORIDE | I.P. | 5 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
34 | AMISULPRIDE TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
AMISULPRIDE | I.P. | 50 MG | |||
EXCIPIENTS | Q.S | ||||
35 | AMISULPRIDE TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
AMISULPRIDE | I.P. | 100 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
36 | AMITRIPTYLINE HYDROCHLORIDE TABLETS | EACH FILM COTAED TABLET CONTAINS: | DOMESTIC | ||
AMITRIPTYLINE HYDROCHLORIDE | I.P. | ||||
EQ.TO AMITRIPTYLINE | 10 MG | ||||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
37 | AMITRIPTYLINE HYDROCHLORIDE TABLETS | EACH FILM COTAED TABLET CONTAINS: | DOMESTIC | ||
AMITRIPTYLINE HYDROCHLORIDE | I.P. | ||||
EQ.TO AMITRIPTYLINE | 25 MG | ||||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
38 | AMITRIPTYLINE HYDROCHLORIDE, CHLORDIAZEPOXIDE TABLETS | EACH FILM COTAED TABLET CONTAINS: | DOMESTIC | ||
CHLORDIAZEPOXIDE | I.P. | 5 MG | |||
AMITRIPTYLINE HYDROCHLORIDE | I.P. | ||||
EQ.TO AMITRIPTYLINE | 12.5 MG | ||||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
39 | AMITRIPTYLINE HYDROCHLORIDE, CLONAZEPAM TABLETS | EACH FILM COTAED TABLET CONTAINS: | DOMESTIC | ||
AMITRIPTYLINE HYDROCHLORIDE | I.P. | ||||
EQ.TO AMITRIPTYLINE | 10 MG | ||||
CLONAZEPAM | I.P. | 0.5 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
40 | AMLODIPINE TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
AMLODIPINE BESYLATE | I.P. | ||||
EQ. TO AMLODIPINE | 2.5 MG | ||||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
41 | AMLODIPINE TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
AMLODIPINE BESYLATE | I.P. | ||||
EQ. TO AMLODIPINE | 5 MG | ||||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
42 | AMLODIPINE TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
AMLODIPINE BESYLATE | B.P. | ||||
EQ.TO AMLODIPINE | 5 MG | ||||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
43 | AMLODIPINE TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
AMLODIPINE BESYLATE | B.P. | ||||
EQ.TO AMLODIPINE | 10 MG | ||||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
44 | AMLODIPINE, LISINOPRIL TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
LISINOPRIL DIHYDRATE | B.P. | ||||
EQ. TO ANHYDROUS LISINOPRIL | 5 MG | ||||
AMLODIPINE BESYLATE | B.P. | ||||
EQ. TO AMLODIPINE | 5MG | ||||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
45 | AMLODIPINE, ATENOLOL TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
AMLODIPINE BESYLAT | I.P. | ||||
EQ. TO AMLODIPINE | 5 MG | ||||
ATENOLOL | I.P. | 50 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
46 | AMLODIPINE, ATENOLOL TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
S-AMLODIPINE BESYLATE | I.P. | ||||
EQ TO S-AMLODIPINE | 2.5 MG | ||||
ATENOLOL | I.P. | 50 MG | |||
EXCIPIENTS | Q.S | ||||
47 | AMLODIPINE, LOSARTAN POTASSIUM TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
AMLODIPINE BESYLATE | I.P. | ||||
EQ TO AMLODIPINE | 5 MG | ||||
LOSARTAN POTASSIUM | I.P. | 50 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
48 | AMLODIPINE, LOSARTAN POTASSIUM TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
S-AMLODIPINE BESYLATE | I.P. | ||||
EQ TO S-AMLODIPINE | 2.5 MG | ||||
LOSARTAN POTASSIUM | I.P. | 50 MG | |||
EXCIPIENTS | Q.S | ||||
49 | AMLODIPINE, TELMISARTAN TABLETS | EACH UNCOATED TABLET CONTAINS : | DOMESTIC | ||
TELMISARTAN | I.P. | 40 MG | |||
AMLODIPINE BESYLATE | I.P. | ||||
EQ TO AMLODIPINE | 5 MG | ||||
EXCIPIENTS | Q.S | ||||
50 | ARIPIPRAZOLE TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
ARIPIPRAZOLE | I.P. | 5 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
51 | ARIPIPRAZOLE TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
ARIPIPRAZOLE | I.P. | 10 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
52 | ARIPIPRAZOLE TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
ARIPIPRAZOLE | I.P. | 15 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
53 | ARIPIPRAZOLE TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
ARIPIPRAZOLE | I.P. | 30 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
54 | ARTEMETHER, LUMEFENTRINE TABLETS | EACH UNCOATED TABLET CONTAINS: | EXPORT | ||
ARTEMETHER | B.P. | 80 MG | |||
LUMEFANTRINE | U.S.P. | 480 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
55 | ARTEMETHER, LUMEFENTRINE TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
ARTEMETHER | I.P. | 80 MG | |||
LUMEFANTRINE | I.P. | 480 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
56 | ARTEMETHER, LUMEFENTRINE TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
ARTEMETHER | I.P. | 40 MG | |||
LUMEFANTRINE | I.P. | 240 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
57 | ATENOLOL TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
ATENOLOL | B.P. | 50 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
58 | ATORVASTATIN TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
ATORVASTATIN CALCIUM | U.S.P. | ||||
EQ. TO ATORVASTATIN | 10 MG | ||||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
59 | ATORVASTATIN TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
ATORVASTATIN CALCIUM | U.S.P. | ||||
EQ. TO ATORVASTATIN | 20 MG | ||||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
60 | ATORVASTATIN TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
ATORVASTATIN CALCIUM | U.S.P. | ||||
EQ. TO ATORVASTATIN | 40 MG | ||||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
61 | ATORVASTATIN TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
ATORVASTATIN CALCIUM | I.P. | ||||
EQ TO ATORVASTATIN | 10 MG | ||||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
62 | ATORVASTATIN TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
ATORVASTATIN CALCIUM | I.P. | ||||
EQ TO ATORVASTATIN | 20 MG | ||||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
63 | AZITHROMYCIN TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
AZITHROMYCIN DIHYDRATE | U.S.P. | ||||
EQ.TO AZITHROMYCIN | 250 MG | ||||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
64 | AZITHROMYCIN TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
AZITHROMYCIN DIHYDRATE | U.S.P. | ||||
EQ.TO ANHYDROUS AZITHROMYCIN | 500 MG | ||||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
65 | AZITHROMYCIN TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
AZITHROMYCIN DIHYDRATE | I.P. | ||||
EQ.TO AZITHROMYCIN | 250 MG | ||||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
66 | AZITHROMYCIN TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
AZITHROMYCIN DIHYDRATE | I.P. | ||||
EQ.TO ANHYDROUS AZITHROMYCIN | 500 MG | ||||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
67 | BENDAZOLE TABLET | EACH UNCOATED TABLET CONTAINS: | EXPORT | ||
BENDAZOLE | B.P. | 20 MG | |||
EXCIPIENTS | Q.S | ||||
68 | BETAMETHASONE TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
BETAMETHASONE | I.P. | 0.5 MG | |||
EXCIPIENTS | Q.S | ||||
69 | BETAMETHASONE TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
BETAMETHASONE | I.P. | 1 MG | |||
EXCIPIENTS | Q.S | ||||
70 | BISACODYL DELAY RELEASE TABLETS | EACH ENTERIC COATED TABLET CONTAINS: | EXPORT | ||
BISACODYL | U.S.P. | 5 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
71 | BISACODYL TABLETS | EACH ENTERIC COATED TABLET CONTAINS: | DOMESTIC | ||
BISACODYL | I.P. | 5 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
72 | BISOPROLOL FUMARATE TABLETS | EACH UNCOATED TABLET CONATINS: | EXPORT | ||
BISOPROLOL FUMARATE | B.P. | 2.5 MG | |||
EXCIPIENTS | Q.S | ||||
73 | BISOPROLOL FUMARATE TABLETS | EACH UNCOATED TABLET CONATINS: | EXPORT | ||
BISOPROLOL FUMARATE | U.S.P. | 5 MG | |||
EXCIPIENTS | Q.S | ||||
74 | BISOPROLOL FUMARATE TABLETS | EACH UNCOATED TABLET CONTAINS: | EXPORT | ||
BISOPROLOL FUMARATE | U.S.P. | 10 MG | |||
EXCIPIENTS | Q.S | ||||
75 | BROMHEXINE HYDROCHLORIDE, TERBUTALINE SULPHATE, GUAIPHENESIN TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
BROMHEXINE HYDROCHLORIDE | I.P. | 4 MG | |||
TERBUTALINE SULPHATE | I.P. | 2.5 MG | |||
GUAIPHENESIN | I.P. | 100 MG | |||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
76 | BROMHEXINE HYDROCHLORIDE, TERBUTALINE SULPHATE, GUAIPHENESIN TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
BROMHEXINE HYDROCHLORIDE | I.P. | 8 MG | |||
TERBUTALINE SULPHATE | I.P. | 2.5 MG | |||
GUAIPHENESIN | I.P. | 100 MG | |||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
77 | CALCIUM GLUCONATE TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
CALCIUM GLUCONATE | B.P. | 500 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
78 | CALCIUM WITH CHOLECALCIFEROL TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
CALCIUM CARBONATE (FROM ORGANIC SOURCE OYSTER SHELL) | B.P. | 250 MG | |||
CHOLECALCIFEROL | B.P. | 125 I.U | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
79 | CALCIUM WITH VITAMIN D3 TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
CALCIUM CARBONATE | 1250 MG | ||||
(FROM AN ORGANIC SOURCE OYSTER SHELL) | |||||
EQ. TO 500 MG ELEMENTAL CALCIUM | |||||
VITAMIN D3 | I.P. | 250 I.U | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
80 | CALCIUM WITH VITAMIN D3 TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
CALCIUM CARBONATE (FROM ORGANIC SOURCE OYSTER SHELL) | B.P. | 1250 MG | |||
EQ. TO ELEMENTAL CALCIUM | 500 MG | ||||
VITAMIN D3 | B.P. | 250 I.U | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
81 | CALCIUM WITH MAGNESIUM, ZINC AND VITAMIN D3 TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
CALCIUM CITRATE | U.S.P. | 1000 MG | |||
MAGNESIUM HYDROXIDE | I.P. | ||||
EQ. TO ELEMENTAL MAGNESIUM | 100 MG | ||||
ZINC SULFATE MONOHYDRATE | I.P. | ||||
EQ TO ELEMENTAL ZINC | 4 MG | ||||
VITAMIN D3 | I.P. | 200 I.U | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
82 | CAPTOPRIL TABLETS | EACH UNCOATED TABLET CONTAINS: | EXPORT | ||
CAPTOPRIL | B.P. | 25 MG | |||
EXCIPIENTS | Q.S | ||||
83 | CARBAMAZEPINE TABLETS | EACH UNCOATED TABLET. CONTAINS: | EXPORT | ||
CARBAMAZEPINE | B.P. | 200 MG | |||
EXCIPIENTS | Q.S | ||||
84 | CARISOPRODOL TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
CARISOPRODOL | I.P. | 350 MG | |||
EXCIPIENTS | Q.S | ||||
85 | CETIRIZINE DI-HYDROCHLORIDE TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
CETIRIZINE DIHYDROCHLORIDE | U.S.P. | 10 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOURS USED | |||||
86 | CETIRIZINE HYDROCHLORIDE TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
CETIRIZINE HYDROCHLORIDE | I.P. | 10 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
87 | CETIRIZINE HYDROCHLORIDE TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
CETIRIZINE HYDROCHLORIDE | I.P. | 5 MG | |||
EXCIPIENTS | Q.S | ||||
88 | CETIRIZINE HYDROCHLORIDE TABLETS | EACH UNCOATED TABLET CONTAIN | DOMESTIC | ||
CETIRIZINE HYDROCHLORIDE | I.P. | 10 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
89 | CETIRIZINE HYDROCHLORIDE TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
CETIRIZINE HYDROCHLORIDE | B.P. | 10 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
90 | CETIRIZINE HYDROCHLORIDE TABLETS | EACH UNCOATED TABLET CONTAINS: | EXPORT | ||
EACH UNCOATED TABLET CONTAIN | U.S.P. | 10 MG | |||
EXCIPIENTS | |||||
APPROVED COLOUR USED | |||||
91 | CHLORAMPHENICOL TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
CHLORAMPHENICOL | U.S.P. | 500 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
92 | CHLORDIAZEPOXIDE TABLET | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
CHLORDIAZEPOXIDE | I.P. | 10 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
93 | CHLORDIAZEPOXIDE TABLET | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
CHLORDIAZEPOXIDE | I.P. | 25 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
94 | CHLORDIAZEPOXIDE, TRIFLUOPERAZINE TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
CHLORDIAZEPOXIDE | I.P. | 10MG | |||
TRIFLUOPERAZINE HYDROCHLORIDE | I.P. | ||||
EQ TO TRIFLUOPERAZINE | 1 MG | ||||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
95 | CHLORPHENIRAMINE MALEATE TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
CHLORPHENIRAMINE MALEATE | I.P. | 4 MG | |||
EXCIPIENTS | Q.S | ||||
96 | CHLORPHENIRAMINE MALEATE TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
CHLORPHENIRAMINE MALEATE | U.S.P. | 4 MG | |||
EXCIPIENTS | Q.S | ||||
97 | CHLORPROMAZINE HDROCHLORIDE TABLETS | EACH FILM COATED TABLET CONATINS: | EXPORT | ||
CHLORPROMAZINE HYDROCHLORIDE | U.S.P. | 100 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
98 | CINNARIZINE TABLETS | EACH UNCOATED TABLET CONTAINS: | EXPORT | ||
CINNARIZINE | B.P. | 25 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
99 | CINNARIZINE TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
CINNARIZINE | I.P. | 25 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
100 | CINNARIZINE TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
CINNARIZINE | I.P. | 75 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
101 | CINNARIZINE, PIRACETAM TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
CINNARIZINE | B.P. | 25 MG | |||
PIRACETAM | B.P. | 400 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
102 | CINNARIZINE, DOMPERIDONE TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
CINNARIZINE | I.P. | 20 MG | |||
DOMPERIDONE | I.P. | 15 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
103 | CINNARIZINE, DOMPERIDONE TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
CINNARIZINE | I.P. | 75 MG | |||
DOMPERIDONE | I.P. | 15 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
104 | CIPROFLOXACIN HYDROCHLORIDE TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
CIPROFLOXACIN HYDROCHLORIDE | I.P. | ||||
EQ TO CIPROFLOXACIN | 250 MG | ||||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
105 | CIPROFLOXACIN HYDROCHLORIDE TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
CIPROFLOXACIN HYDROCHLORIDE | I.P. | ||||
EQ TO CIPROFLOXACIN | 500 MG | ||||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
106 | CIPROFLOXACIN HYDROCHLORIDE TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
CIPROFLOXACIN HYDROCHLORIDE | U.S.P. | ||||
EQ TO CIPROFLOXACIN | 250 MG | ||||
EXCIPIENTS | Q.S | ||||
107 | CIPROFLOXACIN HYDROCHLORIDE TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
CIPROFLOXACIN HYDROCHLORIDE | U.S.P. | ||||
EQ TO CIPROFLOXACIN | 500 MG | ||||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
108 | CIPROFLOXACIN HYDROCHLORIDE, TINIDAZOLE TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
CIPROFLOXACIN HYDROCHLORIDE | B.P. | ||||
EQ.TO CIPROFLOXACIN | 500 MG | ||||
TINIDAZOLE | B.P. | 600 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
109 | CIPROFLOXACIN HYDROCHLORIDE, TINIDAZOLE TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
CIPROFLOXACIN HYDROCHLORIDE | I.P. | ||||
EQ TO CIPROFLOXACIN | 500 MG | ||||
TINIDAZOLE | I.P. | 600 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
110 | CIPROFLOXACIN HYDROCHLORIDE, ORNIDAZOLE TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
CIPROFLOXACIN HYDROCHLORIDE | I.P. | ||||
EQ TO CIPROFLOXACIN | 500 MG | ||||
ORNIDAZOLE | I.P. | 500 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
111 | CLARITHROMYCIN TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
CLARITHROMYCIN | U.S.P. | 250 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
112 | CLARITHROMYCIN TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
CLARITHROMYCIN | U.S.P. | 500 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
113 | CLOBAZAM TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
CLOBAZAM | I.P. | 5 MG | |||
EXCIPIENTS | Q.S | ||||
114 | CLOBAZAM TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
CLOBAZAM | I.P. | 10 MG | |||
EXCIPIENTS | Q.S | ||||
115 | CLOMIPHENE CITRATE TABLETS | EACH UNCOATED TABLET CONTAINS: | EXPORT | ||
CLOMIPHENE CITRATE | U.S.P. | 50 MG | |||
EXCIPIENTS | Q.S | ||||
116 | CLOMIPRAMINE HYDROCHLORIDE TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
CLOMIPRAMINE HYDROCHLORIDE I.P. | I.P. | 25 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
117 | CLOMIPRAMINE HYDROCHLORIDE TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
CLOMIPRAMINE HYDROCHLORIDE I.P. | I.P. | 50 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
118 | CLONAZEPAM TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
CLONAZEPAM | I.P. | 0.25 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
119 | CLONAZEPAM TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
CLONAZEPAM | I.P. | 0.50 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
120 | CLONAZEPAM MOUTH DISSOLVING TABLETS | EACH UNCOATED MOUTH DISSOLVING TABLET CONTAINS: | DOMESTIC | ||
CLONAZEPAM | U.S.P. | 0.25 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
121 | CLONAZEPAM MOUTH DISSOLVING TABLETS | EACH UNCOATED MOUTH DISSOLVING TABLET CONTAINS: | DOMESTIC | ||
CLONAZEPAM | U.S.P. | 0.50 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
122 | CLONAZEPAM MOUTH DISSOLVING TABLETS | EACH UNCOATED MOUTH DISSOLVING TABLET CONTAINS: | DOMESTIC | ||
CLONAZEPAM | I.P. | 1 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
123 | CLONAZEPAM MOUTH DISSOLVING TABLETS | EACH UNCOATED MOUTH DISSOLVING TABLET CONTAINS: | DOMESTIC | ||
CLONAZEPAM | I.P. | 2 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
124 | CLONAZEPAM, PAROXETINE (CONTROLLED RELEASED) TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
PAROXETINE HYDROCHLORIDE | I.P. | ||||
EQ TO PAROXETINE (AS CONTROLLED RELEASE) | 12.5 MG | ||||
CLONAZEPAM (AS IMMEDIATE RELEASE) | I.P. | 0.5 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
125 | CLONAZEPAM, PROPRANOLOL HYDROCHLORIDE TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
CLONAZEPAM | I.P. | 0.5 MG | |||
PROPRANOLOL HYDROCHLORIDE | I.P. | 20 MG | |||
EXCIPIENTS | Q.S | ||||
126 | CLONAZEPAM, PROPRANOLOL HYDROCHLORIDE TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
CLONAZEPAM | I.P. | 0.5 MG | |||
PROPRANOLOL HYDROCHLORIDE | I.P. | 10 MG | |||
EXCIPIENTS | Q.S | ||||
127 | CLONIDINE HYDROCHLORIDE TABLETS | EACH UNCOATED TABLET CONTAINS: | EXPORT | ||
CLONIDINE HYDROCHLORIDE | U.S.P. | 0.15 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
128 | CLOTRIMAZOLE VAGINAL TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
CLOTRIMAZOLE | I.P. | 100 MG | |||
EXCIPIENTS | Q.S | ||||
129 | CLOZAPINE TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
CLOZAPINE | I.P. | 25 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
130 | CLOZAPINE TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
CLOZAPINE | I.P. | 50 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
131 | CLOZAPINE TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
CLOZAPINE | I.P. | 100 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
132 | CLOZAPINE TABLETS | EACH UNCOATED TABLET CONTAINS: | EXPORT | ||
CLOZAPINE | U.S.P. | 100 MG | |||
EXCIPIENTS | Q.S | ||||
133 | CYPROHEPTADINE HYDROCHLORIDE TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
CYPROHEPTADINE HYDROCHLORIDE | I.P. | ||||
EQ. TO CYPROHEPTADINE (ANHYDROUS) | 4 MG | ||||
EXCIPIENTS | Q.S | ||||
134 | DEFLAZACORT TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
DEFLAZACORT | 1 MG | ||||
EXCIPIENTS | Q.S | ||||
135 | DEFLAZACORT TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
DEFLAZACORT | 6 MG | ||||
EXCIPIENTS | Q.S | ||||
136 | DESLORATADINE TABLETS | EACH UNCOATED TABLET CONTAINS: | EXPORT | ||
DESLORATADINE | B.P. | 5 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
137 | DESLORATADINE TABLETS | EACH UNCOATED TABLET CONTAINS: | EXPORT | ||
DESLORATADINE | U.S.P. | 5 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
138 | DESVENLAFAXINE EXTENDED RELEASE TABLETS | EACH FILM COATED EXTENDED RELEASE TABLET CONTAINS: | DOMESTIC | ||
DESVENLAFAXINE SUCCINATE | I.P. | ||||
EQ. TO DESVENLAFAXINE | 50 MG | ||||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
139 | DESVENLAFAXINE EXTENDED RELEASE TABLETS | EACH FILM COATED EXTENDED RELEASE TABLET CONTAINS: | DOMESTIC | ||
DESVENLAFAXINE SUCCINATE | I.P. | ||||
EQ. TO DESVENLAFAXINE | 100 MG | ||||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
140 | DEXAMETHASONE TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
DEXAMETHASONE | I.P. | 0.5 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
141 | DEXAMETHASONE TABLETS | EACH UNCOATED TABLET CONTAINS: | EXPORT | ||
DEXAMETHASONE | B.P. | 0.5 MG | |||
EXCIPIENTS | Q.S | ||||
142 | DEXAMETHASONE TABLETS | EACH UNCOATED TABLET CONTAINS: | EXPORT | ||
DEXAMETHASONE | U.S.P. | 0.5 MG | |||
EXCIPIENTS | Q.S | ||||
143 | DEXAMETHASONE TABLETS | EACH UNCOATED TABLET CONTAINS: | EXPORT | ||
DEXAMETHASONE | U.S.P. | 4 MG | |||
EXCIPIENTS | Q.S | ||||
144 | DEXTROMETHORPHAN TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
DEXTROMETHORPHAN HYDROBROMIDE | I.P. | 20 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
145 | DEXTROMETHORPHAN TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
DEXTROMETHORPHAN HYDROBROMIDE | I.P. | 30 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
146 | DIAZEPAM TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
DIAZEPAM | I.P. | 10 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
147 | DIAZEPAM TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
DIAZEPAM | I.P. | 30 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
148 | DICLOFENAC SODIUM TABLETS | EACH ENTERIC COATED TABLET CONTAINS: | EXPORT | ||
DICLOFENAC SODIUM | B.P. | 50 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
149 | DICLOFENAC SODIUM TABLETS | EACH ENTERIC COATED TABLET CONTAINS: | EXPORT | ||
DICLOFENAC SODIUM | U.S.P. | 25 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
150 | DICLOFENAC SODIUM TABLETS | EACH ENTERIC COATED TABLET CONTAINS: | EXPORT | ||
DICLOFENAC SODIUM | U.S.P. | 50 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
151 | DICLOFENAC SODIUM SUSTAINED RELEASED TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
DICLOFENAC SODIUM | I.P. | 100 MG | |||
EXCIPIENTS | Q. S | ||||
152 | DICLOFENAC SODIUM, PARACETAMOL TABLETS | EACH UNCOATED TABLET CONTAINS: | EXPORT | ||
DICLOFENAC SODIUM | B.P. | 50 MG | |||
PARACEAMOL | B.P. | 325 MG | |||
EXCIPIENTS | Q.S | ||||
153 | DICLOFENAC SODIUM, PARACETAMOL TABLETS | EACH UNCOATED TABLET CONTAINS: | EXPORT | ||
DICLOFENAC SODIUM | B.P. | 50 MG | |||
PARACETAMOL | B.P. | 500 MG | |||
EXCIPIENTS | Q.S | ||||
154 | DICLOFENAC SODIUM, PARACETAMOL TABLETS | EACH UNCOATED TABLET CONTAINS: | EXPORT | ||
DICLOFENAC SODIUM | B.P. | 50 MG | |||
PARACETAMOL | B.P. | 650 MG | |||
EXCIPIENTS | Q.S | ||||
155 | DICLOFENAC SODIUM, PARACETAMOL TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
DICLOFENAC SODIUM | I.P. | 50 MG | |||
PARACEAMOL | I.P. | 325 MG | |||
EXCIPIENTS | Q. S | ||||
156 | DICLOFENAC SODIUM, PARACETAMOL, CHLORZOXAZONE TABLETS | EACH UNCOATED TABLET CONTAINS: | EXPORT | ||
DICLOFENAC SODIUM | B.P. | 50 MG | |||
PARACETAMOL | B.P. | 325 MG | |||
CHLORZOXAZONE | U.S.P. | 250 MG | |||
EXCIPIENTS | Q.S | ||||
157 | DICLOFENAC SODIUM, PARACETAMOL, CHLORZOXAZONE TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
DICLOFENAC SODIUM | I.P. | 50 MG | |||
PARACETAMOL | I.P. | 325 MG | |||
CHLORZOXAZONE | U.S.P | 250 MG | |||
EXCIPIENTS | Q.S | ||||
158 | DICLOFENAC SODIUM, PARACETAMOL, CHLORPHENAMINE MALEATE, MAGNESIUM TRISILICATE TABLETS | EACH UNCOATED TABLET CONTAINS: | EXPORT | ||
DICLOFENAC SODIUM | B.P. | 50 MG | |||
PARACETAMOL | B.P. | 500 MG | |||
CHLORPHENAMINE MALEATE | B.P. | 4 MG | |||
MAGNESIUM TRISILICATE | B.P. | 100 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
159 | DICLOFENAC POTASSIUM TABLETS | EACH ENTERIC COATED TABLET CONTAINS: | EXPORT | ||
DICLOFENAC POTASSIUM | U.S.P. | 50 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
160 | DICLOFENAC POTASSIUM, PARACETAMOL TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
DICLOFENAC POTASSIUM | B.P. | 50 MG | |||
PARACETAMOL | I.P. | 325 MG | |||
EXCIPIENTS | Q.S | ||||
161 | DICLOFENAC POTASSIUM, PARACETAMOL, SERRATIOPEPTIDASE TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
DICLOFENAC POTASSIUM | B.P. | 50 MG | |||
PARACETAMOL | B.P. | 325 MG | |||
SERRATIOPEPTIDASE | B.P. | 15 MG | |||
(EQ TO 30000 ENZYME ACTIVTY UNITS OF SERRATIOPEPTIDASE) | |||||
(AS ENTERIC COATED) | |||||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
162 | DICLOFENAC POTASSIUM, PARACETAMOL, SERRATIOPEPTIDASE TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
DICLOFENAC POTASSIUM | B.P. | 50 MG | |||
PARACETAMOL | I.P. | 325 MG | |||
SERRATIOPEPTIDASE | I.P. | 10 MG | |||
(EQ TO 20000 ENZYME ACTIVTY UNITS OF SERRATIOPEPTIDASE) | |||||
(AS ENTERIC COATED) | |||||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
163 | DICYCLOMINE HYDROCHLORIDE, PARACETAMOL TABLETS | EACH UNCOATED TABLET CONTAINS: | EXPORT | ||
DICYCLOMINE HYDROCHLORIDE | U.S.P. | 20 MG | |||
PARACETAMOL | B.P. | 500 MG | |||
EXCIPIENTS | Q.S | ||||
164 | DICYCLOMINE HYDROCHLORIDE, PARACETAMOL TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
DICYCLOMINE HYDROCHLORIDE | I.P. | 20 MG | |||
PARACETAMOL | I.P. | 325 MG | |||
EXCIPIENTS | Q. S | ||||
165 | DIETHYLCARBAMAZINE CITRATE, CHLORPHENIRAMINE MALEATE TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
DIETHYLCARBAMAZINE CITRATE | I.P. | 150 MG | |||
CHLORPHENIRAMINE MALEATE | I.P. | 2.5 MG | |||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED IN EMPTY HARD GELATIN CAPSULE SHELLS | |||||
166 | DIETHYLCARBAMAZINE CITRATE, CHLORPHENIRAMINE MALEATE TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
DIETHYLCARBAMAZINE CITRATE | I.P. | 250 MG | |||
CHLORPHENIRAMINE MALEATE | I.P. | 5 MG | |||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
167 | DIETHYLCARBAMAZINE CITRATE, CHLORPHENIRAMINE MALEATE TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
DIETHYLCARBAMAZINE CITRATE | I.P. | 200 MG | |||
CHLORPHENIRAMINE MALEATE | I.P. | 5 MG | |||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
168 | DIGOXIN TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
DIGOXIN | B.P. | 0.25 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
169 | DIGOXIN TABLETS | EACH UNCOATED TABLET CONTAINS: | EXPORT | ||
DIGOXIN | B.P. | 0.25 MG | |||
EXCIPIENTS | Q.S | ||||
170 | DILUTED ISOSORBIDE MONONITRATE TABLET | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
DILUTED ISOSORBIDE MONONITRATE | I.P. | ||||
EQ TO ISOSORBIDE | 20 MG | ||||
EXCIPIENTS | Q. S | ||||
171 | DIPHENOXYLATE HYDROCHLORIDE, ATROPINE SULPHATE TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
DIPHENOXYLATE HYDROCHLORIDE | I.P. | 2.5 MG | |||
ATROPINE SULPHATE | I.P. | 0.025 MG | |||
EXCIPIENTS | Q. S | ||||
172 | DIPHENHYDRAMINE HYDROCHLORIDE TABLETS | EACH UNCOATED TABLET CONTAINS: | EXPORT | ||
DIPHENHYDRAMINE HYDROCHLORIDE | B.P. | 50 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
173 | DIPYRIDAMOLE TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
DIPYRIDAMOLE | U.S.P. | 25 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
174 | DIVALPROEX SODIUM EXTENDED RELEASE TABLETS | EACH FILM COATED EXTENDED RELEASE TABLET CONTAINS: | DOMESTIC | ||
DIVALPROEX SODIUM | I.P. | ||||
EQ TO VALPROIC ACID | 250 MG | ||||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
175 | DIVALPROEX SODIUM EXTENDED RELEASE TABLETS | EACH FILM COATED EXTENDED RELEASE TABLET CONTAINS: | DOMESTIC | ||
DIVALPROEX SODIUM | I.P. | ||||
EQ TO VALPROIC ACID | 500 MG | ||||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
176 | DOMPERIDONE TABLETS | EACH UNCOATED TABLET CONTAINS: | EXPORT | ||
DOMPERIDONE MALEATE | B.P. | ||||
EQ TO DOMPERIDONE | 10 MG | ||||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
177 | DOMPERIDONE TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
DOMPERIDONE | B.P. | 10 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
178 | DOXEPIN HYDROCHLORIDE TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
DOXEPIN HYDROCHLORIDE | I.P. | ||||
EQ TO DOXEPIN | 25 MG | ||||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
179 | DOXEPIN HYDROCHLORIDE TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
DOXEPIN HYDROCHLORIDE | I.P. | ||||
EQ TO DOXEPIN | 75 MG | ||||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
180 | DOXYLAMINE SUCCINATE, PYRIDOXINE HYDROCHLORIDE TABLETS | EACH ENTERIC COATED TABLET CONTAINS: | DOMESTIC | ||
DOXYLAMINE SUCCINATE | U.S.P. | 10 MG | |||
PYRIDOXINE HYDROCHLORIDE | I.P. | 10 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
181 | DOXYLAMINE SUCCINATE, PYRIDOXINE HYDROCHLORIDE, FOLIC ACID TABLETS | EACH ENTERIC COATED TABLET CONTAINS: | DOMESTIC | ||
DOXYLAMINE SUCCINATE | U.S.P. | 10 MG | |||
PYRIDOXINE HYDROCHLORIDE | I.P. | 10 MG | |||
FOLIC ACID | I.P. | 2.5 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
182 | DROTAVERINE HYDROCHLORIDE TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
DROTAVERINE HYDROCHLORIDE | B.P. | 40 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
183 | DROTAVERINE HYDROCHLORIDE TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
DROTAVERINE HYDROCHLORIDE | I.P. | 40 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
184 | DROTAVERINE HYDROCHLORIDE TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
DROTAVERINE HYDROCHLORIDE | B.P. | 80 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
185 | DROTAVERINE HYDROCHLORIDE TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
DROTAVERINE HYDROCHLORIDE | I.P. | 80 MG | |||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
186 | DROTAVERINE HYDROCHLORIDE, PARACETAMOL TABLETS | EACH FILM COATED TABLET CONTAIN: | DOMESTIC | ||
DROTAVERINE HYDROCHLORIDE | I.P. | 80 MG | |||
PARACETAMOL | I.P. | 325 MG | |||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
187 | DROTAVERINE HYDROCHLORIDE, MEFENAMIC ACID TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
DROTAVERINE HYDROCHLORIDE | I.P. | ||||
EQ. TO DROTAVERINE | 80 MG | ||||
MEFENAMIC ACID | I.P. | 250 MG | |||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
188 | DULOXETINE GASTRO-RESISTANT TABLETS | EACH ENTERIC COATED TABLET CONTAINS: | DOMESTIC | ||
DULOXETINE HYDROCHLORIDE | I.P. | ||||
EQ TO DULOXETINE | 20 MG | ||||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
189 | DULOXETINE GASTRO-RESISTANT TABLETS | EACH ENTERIC COATED TABLET CONTAINS: | DOMESTIC | ||
DULOXETINE HYDROCHLORIDE | I.P. | ||||
EQ TO DULOXETINE | 30 MG | ||||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
190 | DULOXETINE GASTRO-RESISTANT TABLETS | EACH ENTERIC COATED TABLET CONTAINS: | DOMESTIC | ||
DULOXETINE HYDROCHLORIDE | I.P. | ||||
EQ TO DULOXETINE | 40 MG | ||||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
191 | DULOXETINE HYDROCHLORIDE TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
DULOXETINE HYDROCHLORIDE | U.S.P. | ||||
EQ TO DULOXETINE | 20 MG | ||||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
192 | DULOXETINE HYDROCHLORIDE TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
DULOXETINE HYDROCHLORIDE | U.S.P. | ||||
EQ TO DULOXETINE | 30 MG | ||||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
193 | ERYTHROMYCIN TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
ERYTHROMYCIN ESTOLATE | U.S.P. | ||||
EQ.TO ERYTHROMYCIN | 250 MG | ||||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
194 | ERYTHROMYCIN TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
ERYTHROMYCIN ESTOLATE | U.S.P. | ||||
EQ.TO ERYTHROMYCIN | 500 MG | ||||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
195 | ESCITALOPRAM OXALATE TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
ESCITALOPRAM OXALATE | I.P. | ||||
EQ.TO ESCITALOPRAM | 5 MG | ||||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
196 | ESCITALOPRAM OXALATE TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
ESCITALOPRAM OXALATE | I.P. | ||||
EQ.TO ESCITALOPRAM | 10 MG | ||||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
197 | ESCITALOPRAM OXALATE TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
ESCITALOPRAM OXALATE | I.P. | ||||
EQ.TO ESCITALOPRAM | 20 MG | ||||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
198 | ESCITALOPRAM OXALATE, CLONAZEPAM TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
ESCITALOPRAM OXALATE | I.P. | ||||
EQ.TO ESCITALOPRAM | 5 MG | ||||
CLONAZEPAM | I.P. | 0.50 MG | |||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
199 | ESCITALOPRAM OXALATE, CLONAZEPAM TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
ESCITALOPRAM OXALATE | I.P. | ||||
EQ.TO ESCITALOPRAM | 10 MG | ||||
CLONAZEPAM | I.P. | 0.50 MG | |||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
200 | ESCITALOPRAM OXALATE, CLONAZEPAM TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
ESCITALOPRAM OXALATE | I.P. | ||||
EQ.TO ESCITALOPRAM | 20 MG | ||||
CLONAZEPAM | I.P. | 0.50 MG | |||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
201 | ESOMEPRAZOLE GASTRO RESISTANCE TABLETS | EACH ENTERIC COATED TABLET CONTAINS: | EXPORT | ||
ESOMEPRAZOLE MAGNESIUM TRIHYDRATE | B.P. | ||||
EQ TO ESOMEPRAZOLE | 20 MG | ||||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
202 | ESOMEPRAZOLE GASTRO RESISTANCE TABLETS | EACH ENTERIC COATED TABLET CONTAINS: | EXPORT | ||
ESOMEPRAZOLE MAGNESIUM TRIHYDRATE | B.P. | ||||
EQ TO ESOMEPRAZOLE | 40 MG | ||||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
203 | ESOMEPRAZOLE MAGNESIUM TABLETS | EACH ENTERIC COATED TABLET CONTAINS: | DOMESTIC | ||
ESOMEPRAZOLE MAGNESIUM TRIHYDRATE | I.P. | ||||
EQ TO ESOMEPRAZOLE | 40 MG | ||||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
204 | ETAMSYLATE, MEFENAMIC ACID, TRANEXAMIC ACID TABLETS | EACH UNCOATED TABLET CONTAINS: | EXPORT | ||
ETAMSYLATE | B.P. | 250 MG | |||
MEFENAMIC ACID | B.P. | 250 MG | |||
TRANEXAMIC ACID | B.P. | 500 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
205 | ETHAMSYLATE TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
ETHAMSYLATE | B.P. | 250 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
206 | ETIZOLAM TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
ETIZOLAM | I.P. | 0.25 MG | |||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
207 | ETIZOLAM TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
ETIZOLAM | I.P. | 0.5 MG | |||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
208 | ETIZOLAM TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
ETIZOLAM | I.P. | 1 MG | |||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
209 | ETORICOXIB TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
ETORICOXIB | I.P. | 60 MG | |||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
210 | ETORICOXIB TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
ETORICOXIB | I.P. | 90 MG | |||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
211 | ETORICOXIB TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
ETORICOXIB | I.P. | 120 MG | |||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
212 | ETORICOXIB TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
ETORICOXIB | B.P. | 90 MG | |||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
213 | ETORICOXIB TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
ETORICOXIB | B.P. | 120 MG | |||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
214 | ETORICOXIB, THIOCOLCHICOSIDE TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
ETORICOXIB | I.P. | 60 MG | |||
THIOCOLCHICOSIDE | I.P. | 4 MG | |||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
215 | FAMOTIDINE TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
FAMOTIDINE | B.P. | 10 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
216 | FAMOTIDINE TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
FAMOTIDINE | B.P. | 20 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
217 | FAMOTIDINE TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
FAMOTIDINE | B.P. | 40 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
218 | FERROUS ASCORBATE, FOLIC ACID TABLETS | EACH FILM COTAED TABLET CONTAINS: | DOMESTIC | ||
FERROUS ASCORBATE | I.P. | ||||
EQ.TO ELEMENTAL IRON | 100 MG | ||||
FOLIC ACID | I.P. | 1.5 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
219 | FERROUS ASCORBATE, FOLIC ACID TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
FERROUS FUMARATE | I.P. | ||||
EQ TO 50 MG ELEMENTAL IRON | 152 MG | ||||
FOLIC ACID | I.P. | 1.5 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
220 | FERROUS ASCORBATE, ZINC, FOLIC ACID TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
FERROUS ASCORBATE | I.P. | ||||
EQ TO ELEMENTAL IRON | 100 MG | ||||
FOLIC ACID | I.P. | 1.5 MG | |||
ZINC SULPHATE MONOHYDRATE | I.P. | 61.8 MG | |||
EQ. TO 22.5 MG ELEMENTAL ZINC | |||||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
221 | FERROUS ASCORBATE, ZINC, FOLIC ACID TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
FERROUS FUMARATE | I.P. | 150 MG | |||
EQ TO 50 MG ELEMENTAL IRON | |||||
FOLIC ACID | I.P. | 750 MCG | |||
ZINC SULPHATE MONOHYDRATE | I.P. | 61.8 MG | |||
EQ. TO 22.5 MG ELEMENTAL ZINC | |||||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
222 | FERROUS FUMARATE, CYANOCOBALAMIN, ZINC, FOLIC ACID TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
FERROUS FUMARATE | I.P. | 300 MG | |||
FOLIC ACID | I.P. | 1.5 MG | |||
CYANOCOBALAMIN | I.P. | 15 MCG | |||
ZINC SULPHATE MONOHYDRATE | I.P. | 61.8 MG | |||
EQ. TO 22.5 MG ELEMENTAL ZINC | |||||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
223 | FERROUS FUMARATE, CYANOCOBALAMIN, ZINC, FOLIC ACID TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
FERROUS FUMARATE | I.P. | 400 MG | |||
FOLIC ACID | I.P. | 1.5 MG | |||
CYANOCOBALAMIN | I.P. | 15 MCG | |||
ZINC SULPHATE MONOHYDRATE | I.P. | 61.8 MG | |||
(EQ. TO 22.5 MG ELEMENTAL ZINC) | |||||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
224 | FEXOFENADINE HYDROCHLORIDE DISPERSIBLE TABLETS | EACH UNCOATED DISPERSIBLE TABLET CONTAINS: | EXPORT | ||
FXOFENADINE HYDROCHLORIDE | U.S.P. | 60 MG | |||
EXCIPIENTS | Q.S | ||||
225 | FEXOFENADINE HYDROCHLORIDE TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
FEXOFENADINE HYDROCHLORIDE | U.S.P. | 60 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
226 | FEXOFENADINE HYDROCHLORIDE TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
FEXOFENADINE HYDROCHLORIDE | U.S.P. | 120 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
227 | FEXOFENADINE HYDROCHLORIDE TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
FEXOFENADINE HYDROCHLORIDE | U.S.P. | 180 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
228 | FEXOFENADINE HYDROCHLORIDE TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
FEXOFENADINE HYDROCHLORIDE | I.P. | 120 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
229 | FEXOFENADINE HYDROCHLORIDE TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
FEXOFENADINE HYDROCHLORIDE | I.P. | 180 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
230 | FEXOFENADINE HYDROCHLORIDE, MONTELUKAST TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
FEXOFENADINE HYDROCHLORIDE | I.P. | 120 MG | |||
MONTELUKAST SODIUM | I.P. | ||||
EQ TO MONTELUKAST | 10 MG | ||||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
231 | FLUCONAZOLE TABLETS | EACH UNCOATED TABLET CONTAINS: | EXPORT | ||
FLUCONAZOLE | U.S.P. | 150 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
232 | FLUCONAZOLE TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
FLUCONAZOLE | I.P. | 150 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
233 | FLUCONAZOLE TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
FLUCONAZOLE | I.P. | 200 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
234 | FLUCONAZOLE TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
FLUCONAZOLE | I.P. | 300 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
235 | FLUCONAZOLE TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
FLUCONAZOLE | I.P. | 400 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
236 | FLUNARIZINE TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
FLUNARIZINE DIHYDROCHLORIDE | I.P. | ||||
EQ TO FLUNARIZINE | 5 MG | ||||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
237 | FLUNARIZINE TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
FLUNARIZINE DIHYDROCHLORIDE | I.P. | ||||
EQ TO FLUNARIZINE | 10 MG | ||||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
238 | FLUOXETINE HYDROCHLORIDE TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
FLUOXETINE HYDROCHLORIDE | U.S.P. | ||||
EQ. TO FLUOXETINE | 20 MG | ||||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
239 | FLUOXETINE HYDROCHLORIDE TABLETS | EACH HARD GELATIN CAPSULE CONTAINS: | DOMESTIC | ||
FLUOXETINE HYDROCHLORIDE | I.P. | ||||
EQ. TO FLUOXETINE | 20 MG | ||||
EXCIPIENT | Q. S | ||||
APPROVED COLOUR USED | |||||
240 | FLUOXETINE HYDROCHLORIDE TABLETS | EACH HARD GELATIN CAPSULE CONTAINS: | DOMESTIC | ||
FLUOXETINE HYDROCHLORIDE | I.P. | ||||
EQ. TO FLUOXETINE | 40 MG | ||||
EXCIPIENT | Q. S | ||||
APPROVED COLOUR USED | |||||
241 | FLUOXETINE HYDROCHLORIDE TABLETS | EACH HARD GELATIN CAPSULE CONTAINS: | DOMESTIC | ||
FLUOXETINE HYDROCHLORIDE | I.P. | ||||
EQ. TO FLUOXETINE | 60 MG | ||||
EXCIPIENT | Q. S | ||||
APPROVED COLOUR USED | |||||
242 | FLUVOXAMINE MALEATE TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
FLUVOXAMINE MALEATE | I.P. | 50 MG | |||
EXCIPIENT | Q. S | ||||
APPROVED COLOUR USED | |||||
243 | FLUVOXAMINE MALEATE TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
FLUVOXAMINE MALEATE | I.P. | 100 MG | |||
EXCIPIENT | Q. S | ||||
APPROVED COLOUR USED | |||||
244 | FLUVOXAMINE MALEATE SUSTIANED RELEASE TABLETS | EACH UNCOATED SUSTAINED RELEASE TABLET CONTAINS: | DOMESTIC | ||
FLUVOXAMINE MALEATE | I.P. | 100 MG | |||
EXCIPIENT | Q. S | ||||
APPROVED COLOUR USED | |||||
245 | FOLIC ACID TABLETS | EACH UNCOATED TABLET CONTAINS: | EXPORT | ||
FOLIC ACID | B.P. | 1 MG | |||
EXCIPIENTS | Q.S | ||||
246 | FOLIC ACID TABLETS | EACH UNCOATED TABLET CONTAINS: | EXPORT | ||
FOLIC ACID | B.P. | 5 MG | |||
EXCIPIENTS | Q.S | ||||
247 | FOLIC ACID TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
FOLIC ACID | I.P. | 5 MG | |||
EXCIPIENTS | Q.S | ||||
248 | GLIBENCLAMIDE TABLETS | EACH UNCOATED TABLET CONTAINS: | EXPORT | ||
GLIBENCLAMIDE | B.P. | 5 MG | |||
EXCIPIENTS | Q.S | ||||
249 | GLIMEPIRIDE TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
GLIMEPIRIDE | I.P. | 2 MG | |||
EXCIPIENTS | Q. S | ||||
250 | GLIMEPIRIDE TABLET | EACH UNCOATED TABLET CONTAINS: | EXPORT | ||
GLIMEPIRIDE | U.S.P. | 1 MG | |||
EXCIPIENTS | Q.S | ||||
251 | GLIMEPIRIDE TABLET | EACH UNCOATED TABLET CONTAINS: | EXPORT | ||
GLIMEPIRIDE | U.S.P. | 2 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
252 | GLIMEPIRIDE TABLET | EACH UNCOATED TABLET CONTAINS: | EXPORT | ||
GLIMEPIRIDE | U.S.P. | 3 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
253 | GLIMEPIRIDE TABLET | EACH UNCOATED TABLET CONTAINS: | EXPORT | ||
GLIMEPIRIDE | U.S.P. | 4 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
254 | GLIMEPIRIDE, METFORMIN HYDROCHLORIDE TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
GLIMEPIRIDE | U.S.P. | 1 MG | |||
METFORMIN HYDROCHLORIDE | U.S.P. | 500 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
255 | GLIMEPIRIDE, METFORMIN HYDROCHLORIDE TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
GLIMEPIRIDE | U.S.P. | 2 MG | |||
METFORMIN HYDROCHLORIDE | U.S.P. | 500 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
256 | GLIMEPIRIDE, METFORMIN HYDROCHLORIDE (PROLONGED RELEASE) TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
GLIMEPIRIDE | I.P. | 1 MG | |||
METFORMIN HYDROCHLORIDE (PROLONGED RELEASE) | I.P. | 500 MG | |||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
257 | GLIMEPIRIDE, METFORMIN HYDROCHLORIDE (PROLONGED RELEASE) TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
GLIMEPIRIDE | I.P. | 2 MG | |||
METFORMIN HYDROCHLORIDE (PROLONGED RELEASE) | I.P. | 500 MG | |||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
258 | HALOPERIDOL TABLET | EACH UNCOATED TABLET CONTAINS: | EXPORT | ||
HALOPERIDOL | B.P. | 5 MG | |||
EXCIPIENTS | |||||
259 | HALOPERIDOL TABLET | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
HALOPERIDOL | I.P. | 1.5 MG | |||
EXCIPIENTS | Q. S | ||||
260 | HALOPERIDOL TABLET | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
HALOPERIDOL | I.P. | 5 MG | |||
EXCIPIENTS | Q. S | ||||
261 | HALOPERIDOL TABLET | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
HALOPERIDOL | I.P. | 10 MG | |||
EXCIPIENTS | Q. S | ||||
262 | HYDROXYCHLOROQUINE SULPHATE TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
HYDROXYCHLOROQUINE SULPHATE | I.P. | 200 MG | |||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
263 | HYDROXYZINE HYDROCHLORIDE TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
HYDROXYZINE HYDROCHLORIDE | I.P. | 10 MG | |||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
264 | HYDROXYZINE HYDROCHLORIDE TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
HYDROXYZINE HYDROCHLORIDE | I.P. | 25 MG | |||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
265 | IBUPROFEN TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
IBUPROFEN | B.P. | 200 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
266 | IBUPROFEN TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
IBUPROFEN | B.P. | 400 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
267 | IBUPROFEN TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
IBUPROFEN | I.P. | 600 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
268 | IBUPROFEN, PARACETAMOL TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
IBUPROFEN | B.P. | 400 MG | |||
PARACETAMOL | B.P. | 325 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
269 | IBUPROFEN, PARACETAMOL TABLETS | EACH UNCOATED TABLET CONTAINS: | EXPORT | ||
IBUPROFEN | B.P. | 400 MG | |||
PARACETAMOL | B.P. | 325 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
270 | IBUPROFEN, PARACETAMOL TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
IBUPROFEN | I.P. | 400 MG | |||
PARACETAMOL | I.P. | 325 MG | |||
EXCIPIENTS | I.P. | Q.S | |||
APPROVED COLOUR USED | |||||
271 | IMIPRAMINE HYDROCHLORIDE TABLET | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
IMIPRAMINE HYDROCHLORIDE | I.P. | 25 MG | |||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
272 | IMIPRAMINE HYDROCHLORIDE TABLET | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
IMIPRAMINE HYDROCHLORIDE | I.P. | 75 MG | |||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
273 | INDOMETHACIN TABLETS | EACH UNCOATED TABLET CONTAINS: | EXPORT | ||
INDOMETHACIN | U.S.P. | 25 MG | |||
EXCIPIENTS | Q.S | ||||
274 | ISOXSUPRINE HYDROCHLORIDE TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
ISOXSUPRINE HYDROCHLORIDE | I.P. | 10 MG | |||
EXCIPIENTS | Q. S | ||||
275 | ISOXSUPRINE HYDROCHLORIDE TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
ISOXSUPRINE HYDROCHLORIDE | I.P. | 20 MG | |||
EXCIPIENTS | Q. S | ||||
276 | ISOXSUPRINE HYDROCHLORIDE SUSTAINED RELEASE TABLETS | EACH UNCOATED SUSTAINED RELEASE TABLET CONTAINS: | DOMESTIC | ||
ISOXSUPRINE HYDROCHLORIDE | I.P. | 40 MG | |||
EXCIPIENTS | Q. S | ||||
277 | IVERMECTIN TABLET | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
IVERMECTIN | I.P. | 6 MG | |||
AQUEOUS BASE | Q. S | ||||
APPROVED COLOUR USED | |||||
278 | IVERMECTIN TABLET | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
IVERMECTIN | I.P. | 12 MG | |||
AQUEOUS BASE | Q. S | ||||
APPROVED COLOUR USED | |||||
279 | KETOCONAZOLE TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
KETOCONAZOLE | I.P. | 200 MG | |||
EXCIPIENTS | Q.S | ||||
280 | KETOCONAZOLE TABLETS | EACH UNCOATED TABLET CONTAINS: | EXPORT | ||
KETOCONAZOLE | U.S.P. | 200 MG | |||
EXCIPIENTS | Q.S | ||||
281 | KETOROLAC TROMETHAMINE DISPERSIBLE TABLETS | EACH UNCOATED DISPERSIBLE TABLET CONTAINS: | DOMESTIC | ||
KETOROLAC TROMETHAMINE | I.P. | 10 MG | |||
EXCIPIENTS | Q. S | ||||
282 | KETOROLAC TROMETHAMINE DISPERSIBLE TABLETS | EACH UNCOATED DISPERSIBLE TABLET CONTAINS: | EXPORT | ||
KETOROLAC TROMETHAMINE | U.S.P. | 10 MG | |||
EXCIPIENTS | Q.S | ||||
283 | KETOROLAC TROMETHAMINE TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
KETOROLAC TROMETHAMINE | U.S.P. | 10 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
284 | KETOTIFEN FUMARATE TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
KETOTIFEN FUMARATE | B.P. | 1 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
285 | LACTIC ACID BACILLUS TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
LACTIC ACID BACILLUS | I.P. | 100 MLN SPORES | |||
EXCIPIENTS | Q.S | ||||
286 | LACTIC ACID BACILLUS TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
LACTIC ACID BACILLUS | I.P. | 120 MLN SPORES | |||
EXCIPIENTS | Q.S | ||||
287 | LAMOTRIGINE DISPERSIBLE TABLETS | EACH UNCOATED DISPERSIBLE TABLET CONTAINS: | DOMESTIC | ||
LAMOTRIGINE | I.P. | 25 MG | |||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
288 | LAMOTRIGINE DISPERSIBLE TABLETS | EACH UNCOATED DISPERSIBLE TABLET CONTAINS: | DOMESTIC | ||
LAMOTRIGINE | I.P. | 50 MG | |||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
289 | LEFLUNOMIDE TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
LEFLUNOMIDE | I.P. | 10 MG | |||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
290 | LEVAMISOLE TABLET | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
LEVAMISOLE HYDROCHLORIDE | I.P. | ||||
EQ TO LEVAMISOLE | 50 MG | ||||
EXCIPIENTS | Q. S | ||||
291 | LEVETIRACETAM TABLES | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
LEVETIRACETAM | I.P. | 250 MG | |||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
292 | LEVETIRACETAM TABLES | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
LEVETIRACETAM | I.P. | 500 MG | |||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
293 | LEVETIRACETAM TABLES | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
LEVETIRACETAM | I.P. | 1000 MG | |||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
294 | LEVETIRACETAM TABLES | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
LEVETIRACETAM | U.S.P. | 750 MG | |||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
295 | LEVOCETIRIZINE DIHYDROCHLORIDE TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
LEVOCETIRIZINE DIHYDROCHLORIDE | I.P. | 5 MG | |||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
296 | LEVOCETIRIZINE DIHYDROCHLORIDE TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
LEVOCETIRIZINE DIHYDROCHLORIDE | I.P. | 5 MG | |||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
297 | LEVOCETIRIZINE DIHYDROCHLORIDE TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
LEVOCETIRIZINE DIHYDROCHLORIDE | U.S.P. | 5 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
298 | LEVOCETIRIZINE DIHYDROCHLORIDE TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
LEVOCETIRIZINE DIHYDROCHLORIDE | I.P. | 10 MG | |||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
299 | LEVOCETIRIZINE DIHYDROCHLORIDE, MONTELUKAST SODIUM DISPERSIBLE TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
LEVOCETIRIZINE DIHYDROCHLORIDE | U.S.P. | 5 MG | |||
MONTELUKAST SODIUM | B.P. | ||||
EQ. TO MONTELUKAST | 10 MG | ||||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
300 | LEVOCETIRIZINE DIHYDROCHLORIDE, MONTELUKAST SODIUM DISPERSIBLE TABLETS | EACH UNCOATED DISPERSIBLE TABLET CONTAINS: | DOMESTIC | ||
LEVOCETIRIZINE DIHYDROCHLORIDE | I.P. | 2.5 MG | |||
MONTELUKAST SODIUM | I.P. | ||||
EQ. TO MONTELUKAST | 4 MG | ||||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
301 | LEVOCETIRIZINE DIHYDROCHLORIDE, MONTELUKAST TABLETS I.P. | EACH FILM COATED TABLET CONTAINS : | DOMESTIC | ||
LEVOCETIRIZINE DIHYDROCHLORIDE | I.P. | 5 MG | |||
MONTELUKAST SODIUM | I.P. | ||||
EQ. TO MONTELUKAST | 10 MG | ||||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
302 | LEVOCETIRIZINE HYDROCHLORIDE, AMBROXOL HYDROCHLORIDE TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
LEVOCETIRIZINE HYDROCHLORIDE | I.P. | 5 MG | |||
AMBROXOL HYDROCHLORIDE | I.P. | 60 MG | |||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
303 | LEVOCETIRIZINE HYDROCHLORIDE, PHENYLEPHRINE HYDROCHLORIDE TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
LEVOCETIRIZINE HYDROCHLORIDE | I.P. | 2.5 MG | |||
PHENYLEPHRINE HYDROCHLORIDE | I.P. | 10 MG | |||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
304 | LEVOFLOXACIN TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
LEVOFLOXACIN HEMIHYDRATE | I.P. | ||||
EQ. TO LEVOFLOXACIN | 250 MG | ||||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
305 | LEVOFLOXACIN TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
LEVOFLOXACIN HEMIHYDRATE | I.P. | ||||
EQ. TO LEVOFLOXACIN | 500 MG | ||||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
306 | LEVOFLOXACIN TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
LEVOFLOXACIN HEMIHYDRATE | U.S.P. | ||||
EQ. TO LEVOFLOXACIN | 500 MG | ||||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
307 | LINEZOLID TABLETS | EACH UNCOATED DISPERSIBLE TABLET CONTAINS: | DOMESTIC | ||
LINEZOLID | I.P. | 400 MG | |||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
308 | LINEZOLID TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
LINEZOLID | I.P. | 600 MG | |||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
309 | LINEZOLID TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
LINEZOLID | I.P. | 600 MG | |||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
310 | LISINOPRIL DIHYDRATE TABLETS | EACH UNCOATED TABLET CONTAINS: | EXPORT | ||
LISINOPRIL DIHYDRATE | B.P. | ||||
EQ TO ANHYDROUS LISINOPRIL | 5 MG | ||||
EXCIPIENTS | Q.S | ||||
311 | LISINOPRIL DIHYDRATE TABLETS | EACH UNCOATED TABLET CONTAINS: | EXPORT | ||
LISINOPRIL DIHYDRATE | B.P. | ||||
EQ TO ANHYDROUS LISINOPRIL | 10 MG | ||||
EXCIPIENTS | Q.S | ||||
312 | LOPERAMIDE HYDROCHLORIDE TABLETS | EACH UNCOATED TABLET CONTAINS: | EXPORT | ||
LOPERAMIDE HYDROCHLORIDE | U.S.P. | 2 MG | |||
EXCIPIENTS | Q.S | ||||
313 | LORATADINE TABLETS | EACH UNCOATED TABLET CONTAINS: | EXPORT | ||
LORATADINE | U.S.P. | 10 MG | |||
EXCIPIENTS | Q.S | ||||
314 | LORAZEPAM TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
LORAZEPAM | I.P. | 1 MG | |||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
315 | LORAZEPAM TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
LORAZEPAM | I.P. | 2 MG | |||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
316 | LORAZEPAM TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
LORAZEPAM | I.P. | 3 MG | |||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
317 | LORAZEPAM TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
LORAZEPAM | I.P. | 4 MG | |||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
318 | LORAZEPAM MOUTH DISSOLVING TABLETS | EACH UNCOATED MOUTH DISSOLVING TABLET CONTAINS: | DOMESTIC | ||
LORAZEPAM | I.P. | 1 MG | |||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
319 | LORAZEPAM MOUTH DISSOLVING TABLETS | EACH UNCOATED MOUTH DISSOLVING TABLET CONTAINS: | DOMESTIC | ||
LORAZEPAM | I.P. | 2 MG | |||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
320 | LORAZEPAM MOUTH DISSOLVING TABLETS | EACH UNCOATED MOUTH DISSOLVING TABLET CONTAINS: | DOMESTIC | ||
LORAZEPAM | I.P. | 3 MG | |||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
321 | LOSARTAN POTASSIUM TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
LOSARTAN POTTASIUM | I.P. | 25 MG | |||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
322 | LOSARTAN POTASSIUM TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
LOSARTAN POTTASIUM | I.P. | 50 MG | |||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
323 | LOSARTAN POTASSIUM TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
LOSARTAN POTTASIUM | I.P. | 100 MG | |||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
324 | LOSARTAN POTASSIUM TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
LOSARTAN POTASSIUM | U.S.P. | 50 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
325 | LOSARTAN POTASSIUM TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
LOSARTAN POTASSIUM | U.S.P. | 100 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
326 | LOSARTAN POTASSIUM, HYDROCHLORTHIAZIDE TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
LOSARTAN POTASSIUM | I.P. | 25 MG | |||
HYDROCHLORTHIAZIDE | I.P. | 12.5 MG | |||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
327 | MAGNESIUM LACTATE DIHYDRATE, PYRIDOXINE HYDROCHLORIDE TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
MAGNESIUM LACTATE DIHYDRATE | B.P. | ||||
EQ. TO ELEMENTAL MAGNESIUM | 48 MG | ||||
PYRIDOXINE HYDROCHLORIDE | B.P. | 5 MG | |||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
328 | MEBENDAZOLE TABLETS | EACH UNCOATED TABLET CONTAINS: | EXPORT | ||
MEBENDAZOLE | U.S.P. | 100 MG | |||
EXCIPIENTS | Q.S | ||||
329 | MEBHYDROLINE NAPADISYLATE TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
MEBHYDROLINE NAPADISYLATE | U.S.P. | 100 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
330 | MEFENAMIC ACID, DICYCLOMINE HYDROCHLORIDE TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
MEFENAMIC ACID | I.P. | 250 MG | |||
DICYCLOMINE HYDROCHLORIDE | I.P. | 10 MG | |||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
331 | MELOXICAM TABLETS | EACH UNCOATED TABLET CONTAINS: | EXPORT | ||
MELOXICAM | B.P. | 7.5 MG | |||
EXCIPIENTS | Q.S | ||||
332 | MELOXICAM TABLETS | EACH UNCOATED TABLET CONTAINS: | EXPORT | ||
MELOXICAM | B.P. | 15 MG | |||
EXCIPIENTS | Q.S | ||||
333 | METAMIZOLE SODIUM TABLETS | EACH UNCOATED TABLET CONTAINS: | EXPORT | ||
METAMIZOLE SODIUM | B.P. | 500 MG | |||
EXCIPIENTS | Q.S | ||||
334 | METAMIZOLE SODIUM, PITOFENONE HYDROCHLORIDE, FENPIVERINIUM BROMIDE TABLETS | EACH UNCOATED TABLET CONATINS: | EXPORT | ||
METAMIZOLE SODIUM | B.P. | 12 MG | |||
PITOFENONE HYDROCHLORIDE | B.P. | 5 MG | |||
FENPIVERINIUM BROMIDE | B.P. | 0.1 MG | |||
EXCIPIENTS | Q.S | ||||
335 | METFORMIN HYDROCHLORIDE TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
METFORMIN HYDROCHLORIDE | U.S.P. | 500 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
336 | METFORMIN HYDROCHLORIDE TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
METFORMIN HYDROCHLORIDE | U.S.P. | 850 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
337 | METFORMIN HYDROCHLORIDE TABLETS | EACH UNCOATED TABLET CONTAINS: | EXPORT | ||
METFORMIN HYDROCHLORIDE | U.S.P. | 1000 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
338 | METFORMIN HYDROCHLORIDE SUSTAINED RELEASE TABLETS | EACH UNCOATED SUSTAINED RELEASE TABLET CONTAINS: | EXPORT | ||
METFORMIN HYDROCHLORIDE | U.S.P. | 500 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
339 | METHYLCOBALAMIN TABLETS | EACH UNCOATED MOUTH DISSOLVING TABLET CONTAINS: | DOMESTIC | ||
METHYLCOBALAMIN | I.P. | 5000 MCG | |||
EXCIPIENTS | Q.S | ||||
340 | METHYLCOBALAMIN, PYRIDOXINE HYDROCHLORIDE, FOLIC ACID TABLETS | EACH UNCOATED SUBLINGUAL TABLET CONTAINS: | DOMESTIC | ||
METHYLCOBALAMIN | I.P. | 1500 MCG | |||
PYRIDOXINE HYDROCHLORIDE | I.P. | 20 MG | |||
FOLIC ACID | I.P. | 5 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
341 | METHYLPREDNISOLONE TABLETS | EACH UNCOATED TABLET CONTAINS: | EXPORT | ||
METHYLPREDNISOLONE | B.P. | 4 MG | |||
EXCIPIENTS | Q.S | ||||
342 | METOCLOPRAMIDE TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
METOCLOPRAMIDE HYDROCHLORIDE | B.P. | ||||
EQ TO METOCLOPRAMIDE | 10 MG | ||||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
343 | METRONIDAZOLE TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
METRONIDAZOLE | B.P. | 250 MG | |||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
344 | METRONIDAZOLE, FURAZOLIDINE TABLETS | EACH UNCOATED TABLET CONTAINS: | EXPORT | ||
METRONIDAZOLE | B.P. | 400 MG | |||
FURAZOLIDINE | B.P. | 100 MG | |||
EXCIPIENTS | Q. S | ||||
345 | METOPROLOL TARTRATE TABLETS | EACH UNCOATED TABLET CONTAINS: | EXPORT | ||
METOPROLOL TARTRATE | U.S.P. | 50 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
346 | MINOCYCLINE TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
MINOCYCLINE HYDROCHLORIDE U.S.P. | U.S.P. | ||||
EQ TO MINOCYCLINE | 100 MG | ||||
EXCIPIENTS | Q. S | ||||
347 | MIRTAZAPINE TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
MIRTAZAPINE | I.P. | 7.5 MG | |||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
348 | MIRTAZAPINE TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
MIRTAZAPINE | I.P. | 15 MG | |||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
349 | MIRTAZAPINE TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
MIRTAZAPINE | I.P. | 15 MG | |||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
350 | NALIDIXIC ACID TABLETS | EACH FILM COATED TABLET.CONTAINS: | EXPORT | ||
NALIDIXIC ACID | B.P. | 500 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
351 | MULTIVITAMIN AND MINERAL TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
BIOTIN | 30 MCG | ||||
NIACINAMIDE | B.P. | 12 MCG | |||
VITAMIN B 12 | B.P. | 1 MCG | |||
VITAMIN E ACETATE (50% POWDER FORM) | B.P. | 10 MG | |||
ZINC SULPHATE MONOHYDRATE | B.P. | ||||
EQ TO ELEMENTAL ZINC | 10 MG | ||||
THIAMINE HYDROCHLORIDE | B.P. | 1 MG | |||
MAGNESIUM SULPHATE ANHYDROUS | B.P. | ||||
EQ TO ELEMENTEL MAGNESE | 1.8 MG | ||||
VITAMIN B2 | 1.1 MG | ||||
COPPER SULPHATE | B.P. | ||||
EQ TO ELEMENTAL COPPER | 0.5 MG | ||||
CALCIUM PANTOTHENATE | B.P. | 5 MG | |||
POTASSIUM IODINE | B.P. | ||||
EQ TO ELEMENTAL IODINE | 150 MCG | ||||
PYRIDOXINE HYDROCHLORIDE (VIT.B6) | B.P. | 2 MG | |||
SODIUM SALENATE | B.P. | ||||
EQ TO ELEMENTAL SELENIUM | 25 MCG | ||||
FOLIC ACID | B.P. | 200 MCG | |||
CHROMIUM PICOLINATE | B.P. | ||||
EQ TO CHROMIUM | 25 MCG | ||||
VITAMIN A | B.P. | 200 I.U | |||
VITAMIN D3 | B.P. | 400 I.U | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
352 | NICLOSAMIDE (ANHYDROUS) TABLETS | EACH UNCOATED CHEWABLE TABLET CONTAINS: | EXPORT | ||
ANHYDROUS NICLOSAMIDE | B.P. | 500 MG | |||
EXCIPIENTS | Q.S | ||||
353 | NIMESULIDE TABLETS | EACH UNCOATED TABLET CONTAINS: | EXPORT | ||
NIMESULIDE | B.P. | 100 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED NOT TO BE USED FOR CHILDREN BELOW 12 YEAR OLD | |||||
354 | NIMESULIDE TABLETS | EACH UNCOATED TABLETS CONTAINS: | DOMESTIC | ||
NIMESULIDE | B.P. | 100 MG | |||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
355 | NIMESULIDE MOUTH DISSOLVING TABLETS | EACH UNCOATED MOUTH DISSOLVING TABLET CONTAINS: | DOMESTIC | ||
NIMESULIDE | B.P. | 100 MG | |||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
356 | NIMESULIDE, PARACETAMOL TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
NIMESULIDE | B.P. | 100 MG | |||
PARACETAMOL | I.P. | 325 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
NOT TO BE USED FOR CHILDREN BELOW 12 YEAR OLD | |||||
357 | NITRAZEPAM TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
NITRAZEPAM | I.P. | 5 MG | |||
EXCIPIENTS | Q. S | ||||
358 | NITRAZEPAM TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
NITRAZEPAM | I.P. | 10 MG | |||
EXCIPIENTS | Q. S | ||||
359 | NITROXOLINE TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
NITROXOLINE | B.P. | 50 MG | |||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
360 | NORFLOXACIN TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
NORFLOXACIN | I.P. | 400 MG | |||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
361 | NORFLOXACIN, TINIDAZOLE TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
NORFLOXACIN | I.P. | 400 MG | |||
TINIDAZOLE | I.P. | 600 MG | |||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
362 | NORTRIPTYLINE TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
NORTRIPTYLINE HYDROCHLORIDE | I.P. | ||||
EQ.TO NORTRIPTYLINE | 10 MG | ||||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
363 | NORTRIPTYLINE TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
NORTRIPTYLINE HYDROCHLORIDE | I.P. | ||||
EQ.TO NORTRIPTYLINE | 50 MG | ||||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
364 | NYSTATIN TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
NYSTATIN | B.P. | 500000 IU | |||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
365 | OFLOXACIN TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
OFLOXACIN | I.P. | 200 MG | |||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
366 | OFLOXACIN TABLETS | EACH FILM COATED TABET CONTAINS: | EXPORT | ||
OFLOXACIN | B.P. | 200 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
367 | OFLOXACIN TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
OFLOXACIN | B.P. | 400 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
368 | OFLOXACIN TABLETS | EACH FILM COATED TABET CONTAINS: | EXPORT | ||
OFLOXACIN | U.S.P. | 200 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
369 | OFLOXACIN TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
OFLOXACIN | U.S.P. | 400 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
370 | OFLOXACIN, ORNIDAZOLE TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
OFLOXACIN | I.P. | 100 MG | |||
ORNIDAZOLE | I.P. | 250 MG | |||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
371 | OFLOXACIN, ORNIDAZOLE TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
OFLOXACIN | B.P. | 200 MG | |||
ORNIDAZOLE | B.P. | 500 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
372 | OFLOXACIN, ORNIDAZOLE TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
OFLOXACIN | I.P. | 200 MG | |||
ORNIDAZOLE | I.P. | 500 MG | |||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
373 | OFLOXACIN, TINIDAZOLE TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
OFLOXACIN | I.P. | 200 MG | |||
TINIDAZOLE | I.P. | 600 MG | |||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
374 | OLANZAPINE MOUTH DISSOLVING TABLETS | EACH UNCOATED MOUTH DISSOLVING TABLET CONTAINS: | DOMESTIC | ||
OLANZAPINE | I.P. | 2.5 MG | |||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
375 | OLANZAPINE MOUTH DISSOLVING TABLETS | EACH UNCOATED MOUTH DISSOLVING TABLET CONTAINS: | DOMESTIC | ||
OLANZAPINE | I.P. | 5 MG | |||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
376 | OLANZAPINE MOUTH DISSOLVING TABLETS | EACH UNCOATED MOUTH DISSOLVING TABLET CONTAINS: | DOMESTIC | ||
OLANZAPINE | I.P. | 10 MG | |||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
377 | OLANZAPINE MOUTH DISSOLVING TABLETS | EACH UNCOATED MOUTH DISSOLVING TABLET CONTAINS: | DOMESTIC | ||
OLANZAPINE | I.P. | 15 MG | |||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
378 | OMEPRAZOLE MAGNESIUM, DOMPERIDONE TABLETS | EACH ENTERIC COATED TABLET CONTAINS: | DOMESTIC | ||
OMEPRAZOLE MAGNESIUM | U.S.P. | ||||
EQ TO OMEPRAZOLE | 10 MG | ||||
DOMPERIDONE | I.P. | 10 MG | |||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
379 | OMEPRAZOLE MAGNESIUM, DOMPERIDONE TABLETS | EACH ENTERIC COATED TABLET CONTAINS: | DOMESTIC | ||
OMEPRAZOLE MAGNESIUM | I.P. | ||||
EQ TO OMEPRAZOLE | 10 MG | ||||
DOMPERIDONE | I.P. | 15 MG | |||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
380 | OMEPRAZOLE MAGNESIUM, DOMPERIDONE TABLETS | EACH ENTERIC COATED TABLET CONTAINS: | DOMESTIC | ||
OMEPRAZOLE MAGNESIUM | U.S.P. | ||||
EQ TO OMEPRAZOLE | 10 MG | ||||
DOMPERIDONE | I.P. | 15 MG | |||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
381 | ONDANSETRON HYDROCHLORIDE ORALLY DISINTEGRATING TABLETS | EACH UNCOATED ORALLY DISINTEGRATING TABLET CONTAINS: | DOMESTIC | ||
ONDANSETRON HYDROCHLORIDE | I.P. | ||||
EQ.TO ONDANSETRON | 4 MG | ||||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
382 | ORNIDAZOLE TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
ORNIDAZOLE | B.P. | 500 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
383 | PANTOPRAZOLE TABLETS | EACH ENTERIC COATED TABLET CONTAINS: | DOMESTIC | ||
PANTOPRAZOLE SOD. SESQUIHYDRATE | I.P. | ||||
EQ TO PANTOPRAZOLE | 40 MG | ||||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
384 | PANTOPRAZOLE GASTRO-RESISTANCE TABLETS | EACH ENTERIC COATED TABLET CONTAINS: | EXPORT | ||
PANTOPRAZOLE SOD. SESQUIHYDRATE | B.P. | ||||
EQ TO PANTOPRAZOLE | 40 MG | ||||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
385 | PANTOPRAZOLE DELAYED RELEASE TABLETS | EACH ENTERIC COATED TABLET CONTAINS: | EXPORT | ||
PANTOPRAZOLE SOD. SESQUIHYDRATE | U.S.P. | ||||
EQ TO PANTOPRAZOLE | 20 MG | ||||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
386 | PANTOPRAZOLE DELAYED RELEASE TABLETS | EACH ENTERIC COATED TABLET CONTAINS: | EXPORT | ||
PANTOPRAZOLE SOD. SESQUIHYDRATE | B.P. | ||||
EQ TO PANTOPRAZOLE | 40 MG | ||||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
387 | PANTOPRAZOLE SODIUM, DOMPERIDONE TABLETS | EACH ENTERIC COATED TABLET. CONTAINS: | DOMESTIC | ||
PANTOPRAZOLE SODIUM SESQUIHYDRATE | I.P. | ||||
EQ.TO PANTOPRAZOLE | 20 MG | ||||
DOMPERIDONE | I.P. | 10 MG | |||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
388 | PANTOPRAZOLE SODIUM, DOMPERIDONE TABLETS | EACH ENTERIC COATED TABLET. CONTAINS: | DOMESTIC | ||
PANTOPRAZOLE SODIUM SESQUIHYDRATE | I.P. | ||||
EQ.TO PANTOPRAZOLE | 40 MG | ||||
DOMPERIDONE | I.P. | 10 MG | |||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
389 | PARACETAMOL TABLETS | EACH UNCOATED TABLET CONTAINS: | EXPORT | ||
PARACETAMOL | B.P. | 200 MG | |||
EXCIPIENTS | Q.S | ||||
390 | PARACETAMOL TABLETS | EACH UNCOATED TABLET CONTAINS: | EXPORT | ||
PARACETAMOL | B.P. | 500 MG | |||
EXCIPIENTS | Q.S | ||||
391 | PARACETAMOL TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
PARACETAMOL | I.P. | 500 MG | |||
EXCIPIENTS | Q. S | ||||
392 | PARACETAMOL TABLETS | EACH UNCOATED TABLET CONTAINS: | EXPORT | ||
PARACETAMOL | B.P. | 650 MG | |||
EXCIPIENTS | Q.S | ||||
393 | PARACETAMOL TABLETS | EACH UNCOATED TABLET. CONTAINS: | DOMESTIC | ||
PARACETAMOL | I.P. | 650 MG | |||
EXCIPIENTS | Q.S | ||||
394 | PARACETAMOL TABLETS | EACH UNCOATED TABLET. CONTAINS: | DOMESTIC | ||
PARACETAMOL | I.P. | 1000 MG | |||
EXCIPIENTS | Q.S | ||||
395 | PARACETAMOL DISPERSIBLE TABLETS | EACH UNCOATED DISPERSIBLE TABLET CONTAINS: | DOMESTIC | ||
PARACETAMOL | I.P. | 650 MG | |||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
396 | PARACETAMOL, CAFFEINE TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
PARACETAMOL | I.P. | 325 MG | |||
CAFFEINE ANHYDROUS | I.P. | 50 MG | |||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
397 | PARACETAMOL, CAFFEINE, ACETYLSALICYLIC ACID TABLETS | EACH UNCOATED TABLET CONTAINS: | EXPORT | ||
PARACETAMOL | B.P. | 180 MG | |||
CAFFEINE (ANHYDROUS) | B.P. | 30 MG | |||
ACETYLSALICYLI ACID | B.P. | 240 MG | |||
EXCIPIENTS | Q.S | ||||
398 | PARACETAMOL, ETODOLAC TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
ETODOLAC | I.P. | 400 MG | |||
PARACETAMOL | I.P. | 200 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
399 | PARACETAMOL, ETODOLAC TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
ETODOLAC | I.P. | 400 MG | |||
PARACETAMOL | I.P. | 325 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
400 | PARACETAMOL, PHENYLEPHRINE HCL, CAFFEINE, CETIRIZINE HYDROCHLORIDE TABLETS | EACH UNCOATED TABLET CONTAINS: | EXPORT | ||
PARACETAMOL | B.P. | 500 MG | |||
CAFFEINE (ANHYDROUS) | B.P. | 30 MG | |||
PHENYLEPHRINE HYDROCHLORIDE | B.P. | 2.5 MG | |||
CETIRIZINE HYDROCHLORIDE | B.P. | 4 MG | |||
EXCIPIENTS | Q.S | ||||
401 | PARACETAMOL, PHENYLEPHRINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE TABLETS | EACH UNCOATED TABLET. CONTAINS: | DOMESTIC | ||
PARACETAMOL | I.P. | 325 MG | |||
PHENYLEPHRINE HYDROCHLORIDE | I.P. | 5 MG | |||
CETIRIZINE HYDROCHLORIDE | I.P. | 5 MG | |||
EXCPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
402 | PARACETAMOL, PHENYLEPHRINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
PARACETAMOL | I.P. | 325 MG | |||
PHENYLEPHRINE HYDROCHLORIDE | I.P. | 10 MG | |||
CETIRIZINE HYDROCHLORIDE | I.P. | 5 MG | |||
EXCPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
403 | PARACETAMOL, PHENYLEPHRINE HYDROCHLORIDE, CETIRIZINE DI-HYDROCHLORIDE TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
PARACETAMOL | I.P. | 325 MG | |||
PHENYLEPHRINE HYDROCHLORIDE | I.P. | 5 MG | |||
CETIRIZINE DI- HYDROCHLORIDE | I.P. | 5 MG | |||
EXCPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
404 | PARACETAMOL, PHENYLEPHRINE HYDROCHLORIDE LEVOCETIRIZINE HYDROCHLORIDE TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
PARACETAMOL | I.P. | 325 MG | |||
PHENYLE PHRINE HYDROCHLORIDE | I.P. | 5 MG | |||
LEVOCETIRIZINE HYDROCHLORIDE | I.P. | 5 MG | |||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
405 | PARACETAMOL, CAFFEINE, PHENYLEPHRINE HYDROCHLORIDE, CHLORPHENIRAMINE MALEATE TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
PARACETAMOL | B.P. | 500 MG | |||
CAFFEINE ANHYDROUS | B.P. | 30 MG | |||
PHENYEPHRINE HYDROCHLORIDE | B.P. | 12 MG | |||
CHLORPHENIRAMINE MALEATE | B.P. | 2 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
406 | PARACETAMOL, CAFFEINE, PHENYLEPHRINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
PARACETAMOL | I.P. | 325 MG | |||
CAFFEINE ANHYDROUS | I.P. | 30 MG | |||
PHENYLEPHRINE HYDROCHLORIDE | I.P. | 5 MG | |||
DIPHENHYDRAMINE HYDROCHLORIDE | I.P. | 25 MG | |||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
407 | PAROXETINE HYDROCHLORIDE TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
PAROXETINE HYDROCHLORIDE HEMIHYDRATE | U.S.P. | ||||
EQ TO PAROXETINE | 12.5 MG | ||||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
408 | PAROXETINE HYDROCHLORIDE CONTROLLED RELEASE TABLETS | EACH FILM COATED CONTROLLED RELEASE TABLET CONTAINS: | DOMESTIC | ||
PAROXETINE HYDROCHLORIDE | I.P. | ||||
EQ TO PAROXETINE | 12.5 MG | ||||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
409 | PAROXETINE HYDROCHLORIDE TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
PAROXETINE HYDROCHLORIDE HEMIHYDRATE | I.P. | ||||
EQ TO PAROXETINE | 20 MG | ||||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
410 | PAROXETINE HYDROCHLORIDE TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
PAROXETINE HYDROCHLORIDE HEMIHYDRATE | U.S.P. | ||||
EQ TO PAROXETINE | 25 MG | ||||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
411 | PAROXETINE HYDROCHLORIDE CONTROLLED RELEASE TABLETS | EACH FILM COATED CONTROLLED RELEASE TABLET CONTAINS: | DOMESTIC | ||
PAROXETINE HYDROCHLORIDE | I.P. | ||||
EQ TO PAROXETINE | 25 MG | ||||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
412 | PIRACETAM TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
PIRACETAM | B.P. | 400 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
413 | POTASSIUM OROTATE TABLETS | EACH UNCOATED TABLET CONTAINS: | EXPORT | ||
ORITIC ACID (AS POTASSIUM OROTATE) | B.P. | 500 MG | |||
EXCIPIENTS | Q.S | ||||
414 | PRAMIPEXOLE TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE | U.S.P. | 0.5 MG | |||
EXCIPIENTS | Q. S | ||||
415 | PRAZIQUANTEL TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
PRAZIQUANTEL | U.S.P. | 600 MG | |||
EXCIPIENTS | Q. S | ||||
416 | PREDNISOLONE TABLETS | EACH UNCOATED TABLET CONTAINS: | EXPORT | ||
PREDNISOLONE | B.P. | 5 MG | |||
EXCIPIENTS | Q.S | ||||
417 | PRIMAQUINE PHOSPHATE DISPERSIBLE TABLETS | EACH UNCOATED DISPERSIBLE TABLET CONTAINS: | DOMESTIC | ||
PRIMAQUINE PHOSPHATE | I.P. | ||||
EQ TO PRIMAQUINE | 2.5 MG | ||||
EXCIPIENTS | Q. S | ||||
418 | PRIMAQUINE PHOSPHATE TABLETS | EACH FILM COATED TABLET CONTAINS | DOMESTIC | ||
PRIMAQUINE PHOSPHATE | I.P. | ||||
EQ TO PRIMAQUINE | 7.5 MG | ||||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
419 | PRIMAQUINE PHOSPHATE TABLETS | EACH FILM COATED TABLET CONTAINS | DOMESTIC | ||
PRIMAQUINE PHOSPHATE | I.P. | ||||
EQ TO PRIMAQUINE | 15 MG | ||||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
420 | PROCHLORPERAZINE MALEATE TABLET | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
PROCHLORPERAZINE MALEATE | I.P. | 5 MG | |||
EXCIPIENTS | Q. S | ||||
421 | PROCHLORPERAZINE MALEATE DISPERSIBLE TABLET | EACH UNCOATED DISPERSIBLE TABLET CONTAINS: | DOMESTIC | ||
PROCHLORPERAZINE MALEATE | I.P. | 5 MG | |||
EXCIPIENTS | Q. S | ||||
422 | PROMETHAZINE HYDROCHLORIDE TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
PROMETHAZINE HYDROCHLORIDE | B.P. | 25 MG | |||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
423 | PROPRANOLOL HYDROCHLORIDE TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
PROPRANOLOL HYDROCHLORIDE | I.P. | 10 MG | |||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
424 | PROPRANOLOL HYDROCHLORIDE TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
PROPRANOLOL HYDROCHLORIDE | I.P. | 20 MG | |||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
425 | PROPRANOLOL HYDROCHLORIDE SUSTAINED RELEASE TABLETS | EACH UNCOATED SUSTAINED RELEASE TABLET CONTAINS: | DOMESTIC | ||
PROPRANOLOL HYDROCHLORIDE | I.P. | 20 MG | |||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
426 | PROPRANOLOL HYDROCHLORIDE SUSTAINED RELEASE TABLETS | EACH UNCOATED SUSTAINED RELEASE TABLET CONTAINS: | DOMESTIC | ||
PROPRANOLOL HYDROCHLORIDE | I.P. | 40 MG | |||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
427 | PROPRANOLOL HYDROCHLORIDE (EXTENDED RELEASE), FLUNARIZINE DIHYDROCHLORIDE TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
PROPRANOLOL HYDROCHLORIDE (AS EXTENDED RELEASE) | I.P. | 40 MG | |||
FLUNARIZINE DIHYDROCHLORIDE | I.P. | ||||
EQ TO FLUNARIZINE | 10 MG | ||||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
427 | PROPRANOLOL HYDROCHLORIDE (SUSTAINED RELEASE), FLUNARIZINE DIHYDROCHLORIDE TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
PROPRANOLOL HYDROCHLORIDE (AS EXTENDED RELEASE) | I.P. | 40 MG | |||
FLUNARIZINE DIHYDROCHLORIDE | B.P. | ||||
EQ TO FLUNARIZINE | 5 MG | ||||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
428 | PROPRANOLOL HYDROCHLORIDE (SUSTAINED RELEASE), FLUNARIZINE DIHYDROCHLORIDE TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
PROPRANOLOL HYDROCHLORIDE (AS EXTENDED RELEASE) | I.P. | 40 MG | |||
FLUNARIZINE DIHYDROCHLORIDE | B.P. | ||||
EQ TO FLUNARIZINE | 10 MG | ||||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
428 | PYRIDOXINE HYDROCHLORIDE TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
PYRIDOXINE HYDROCHLORIDE | I.P. | 50 MG | |||
EXCIPIENTS | Q.S | ||||
429 | QUETIAPINE TABLET | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
QUETIAPINE FUMARATE | I.P. | ||||
EQ TO QUETIAPINE | 25 MG | ||||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
430 | QUETIAPINE TABLET | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
QUETIAPINE FUMARATE | I.P. | ||||
EQ TO QUETIAPINE | 50 MG | ||||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
431 | QUETIAPINE TABLET | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
QUETIAPINE FUMARATE | I.P. | ||||
EQ TO QUETIAPINE | 100 MG | ||||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
432 | QUETIAPINE TABLET | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
QUETIAPINE FUMARATE | I.P. | ||||
EQ TO QUETIAPINE | 200 MG | ||||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
433 | RABEPRAZOLE SODIUM TABLETS | EACH ENTERIC COATED TABLET CONTAINS: | DOMESTIC | ||
RABEPRAZOLE SODIUM | I.P. | 20 MG | |||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
434 | RABEPRAZOLE SODIUM, DOMPERIDONE TABLETS | EACH ENTERIC COATED TABLET CONTAINS: | DOMESTIC | ||
RABEPRAZOLE SODIUM | I.P. | 20 MG | |||
DOMPERIDONE | I.P. | 10 MG | |||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
435 | RISPERIDONE TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
RISPERIDONE | B.P. | 1 MG | |||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
436 | RISPERIDONE TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
RISPERIDONE | B.P. | 2 MG | |||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
437 | RISPERIDONE MOUTH DISSOLVING TABLETS | EACH UNCOATED MOUTH DISSOLVING TABLET CONTAINS: | DOMESTIC | ||
RISPERIDONE | B.P. | 1 MG | |||
EXCIPIENTS | Q. S | ||||
438 | RISPERIDONE, TRIHEXYPHENIDYL HYDROCHLORIDE TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
RISPERIDONE | I.P. | 2 MG | |||
TRIHEXYPHENIDYL HYDROCHLORIDE | I.P. | 2 MG | |||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
439 | RISPERIDONE, TRIHEXYPHENIDYL HYDROCHLORIDE TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
RISPERIDONE | I.P. | 3 MG | |||
TRIHEXYPHENIDYL HYDROCHLORIDE | I.P. | 2 MG | |||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
440 | ROSUVASTATIN CALCIUM TABLETS | EACH FILM COATED TABLET. CONTAINS: | DOMESTIC | ||
ROSUVASTATIN CALCIUM | I.P. | ||||
EQ.TO ROSUVASTATIN | 10 MG | ||||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
441 | ROSUVASTATIN CALCIUM TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
ROSUVASTATIN CALCIUM | U.S.P. | ||||
EQ.TO ROSUVASTATIN | 10 MG | ||||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
442 | ROSUVASTATIN CALCIUM TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
ROSUVASTATIN CALCIUM | U.S.P. | ||||
EQ.TO ROSUVASTATIN | 20 MG | ||||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
443 | ROXITHROMYCIN TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
ROXITHROMYCIN | I.P. | 150 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
444 | SALBUTAMOL SULPHATE TABLETS | EACH UNCOATED TABLET CONTAINS: | EXPORT | ||
SALBUTAMOL SULPHATE | B.P. | ||||
EQ TO SALBUTAMOL | 4 MG | ||||
EXCIPIENTS | Q.S | ||||
445 | SALBUTAMOL, THEOPHYLLINE TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
SALBUTAMOL SULPHATE | I.P. | ||||
EQ. TO SALBUTAMOL | 4 MG | ||||
THEOPHYLLINE (ANHYDROUS) | I.P. | 100 MG | |||
EXCIPIENTS | Q. S | ||||
446 | SALBUTAMOL, ETOFYLLINE, BROMHEXINE HYDROCHLORIDE TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
SALBUTAMOL SULPHATE | I.P. | ||||
EQ TO SALBUTAMOL | 4 MG | ||||
ETOPHYLLINE (ANHYDROUS) | I.P. | 200 MG | |||
BROMHEXINE HYDROCHLORIDE | I.P. | 16 MG | |||
EXCIPIENTS | Q. S | ||||
447 | SERRATIOPEPTIDASE TABLETS | EACH ENTERIC COATED TABLET CONTAINS: | EXPORT | ||
SERRATIOPEPTIDASE | B.P. | 10 MG | |||
(EQ TO 20000 ENZYME ACTIVITY) | |||||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
448 | SERRATIOPEPTIDASE TABLETS | EACH ENTERIC COATED TABLET CONTAINS: | DOMESTIC | ||
SERRATIOPEPTIDASE | I.P. | 10 MG | |||
(EQ TO 20000 UNITS OF ENZYME ACTIVITY) | |||||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
449 | SERTRALINE HYDROCHLORIDE TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
SERTRALINE HYDROCHLORIDE | I.P. | ||||
EQ TO SERTRALINE | 25 MG | ||||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
450 | SERTRALINE HYDROCHLORIDE TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
SERTRALINE HYDROCHLORIDE | I.P. | ||||
EQ TO SERTRALINE | 50 MG | ||||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
451 | SERTRALINE HYDROCHLORIDE TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
SERTRALINE HYDROCHLORIDE | I.P. | ||||
EQ TO SERTRALINE | 100 MG | ||||
EXCIPIENT | Q. S | ||||
APPROVED COLOUR USED | |||||
452 | SILDENAFIL CITRATE TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
SILDENAFIL CITRATE | B.P. | ||||
EQ.TO SILDENAFIL | 100 MG | ||||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
453 | SILDENAFIL CITRATE TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
SILDENAFIL CITRATE | I.P. | ||||
EQ.TO SILDENAFIL | 100 MG | ||||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
454 | SILYMARIN TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
SILYMARIN (AS SILYBIN) | I.P. | 70 MG | |||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
455 | SILYMARIN TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
SILYMARIN (AS SILYBIN) | I.P. | 140 MG | |||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
455 | SITAGLIPTIN PHOSPHATE TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
SITAGLIPTIN PHOSPHATE MONOHYDRATE | U.S.P. | ||||
EQ. TO SITAGLIPTIN | 50 MG | ||||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
456 | SITAGLIPTIN PHOSPHATE TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
SITAGLIPTIN PHOSPHATE MONOHYDRATE | U.S.P. | ||||
EQ. TO SITAGLIPTIN | 100 MG | ||||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
456 | SITAGLIPTIN PHOSPHATE, METFORMIN HYDROCHLORIDE TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
64.25 MG OF SITAGLIPTIN PHOSPHATE MONOHYDRATE | U.S.P. | ||||
EQ. TO SITAGLIPTIN | 50 MG | ||||
METFORMIN HYDROCHLORIDE | U.S.P. | 500 MG | |||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
457 | SITAGLIPTIN PHOSPHATE, METFORMIN HYDROCHLORIDE TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
64.25 MG OF SITAGLIPTIN PHOSPHATE MONOHYDRATE | U.S.P. | ||||
EQ. TO SITAGLIPTIN | 50 MG | ||||
METFORMIN HYDROCHLORIDE | U.S.P. | 1000 MG | |||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
458 | SODIUM FEREDETATE, FOLIC ACID, VITAMIN B12 TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
SODIUM FEREDETATE | B.P. | ||||
EQ. TO 33 MG ELEMENTAL IRON | 231 MG | ||||
FOLIC ACID | I.P. | 1.5 MG | |||
VITAMIN B12 | I.P. | 15 MCG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
459 | SODIUM VALPROATE GASTRO-RESISTANT TABLETS | EACH ENTERIC COATED TABLET CONTAINS: | DOMESTIC | ||
SODIUM VALPROATE | I.P. | 200 MG | |||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
460 | SODIUM VALPROATE, VALPROIC ACID CONTROLLED RELEASE TABLETS | EACH FILM COATED CONTROLLED RELEASE TABLET CONTAINS: | DOMESTIC | ||
SODIUM VALPROATE | I.P. | 200 MG | |||
VALPROIC ACID | I.P. | 87 MG | |||
(BOTH TOGETHER CORRESPONDS TO SODIUM VALPROATE 300 MG) | |||||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
461 | SODIUM VALPROATE, VALPROIC ACID CONTROLLED RELEASE TABLETS | EACH FILM COATED CONTROLLED RELEASE TABLET CONTAINS: | DOMESTIC | ||
SODIUM VALPROATE | I.P. | 333 MG | |||
VALPROIC ACID | I.P. | 145 MG | |||
(BOTH TOGETHER CORRESPONDS TO SODIUM VALPROATE IP 500 MG) | |||||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
462 | SPARFLOXACIN TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
SPARFLOXACIN | I.P. | 200 MG | |||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
463 | SULFASALZINE DELAYED RELEASE TABLETS | EACH ENTERIC COATED DELAYED RELEASE TABLET CONTEINS: | EXPORT | ||
SULFASALAZINE | U.S.P. | 500 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
464 | TADALAFIL TABETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
TADALAFIL | I.P. | 20 MG | |||
EXCIPINTS | Q. S | ||||
APPROVED COLOUR USED | |||||
465 | TELMISARTAN TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
TELMISARTAN | I.P. | 20 MG | |||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
466 | TELMISARTAN TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
TELMISARTAN | I.P. | 40 MG | |||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
467 | TELMISARTAN TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
TELMISARTAN | I.P. | 80 MG | |||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
468 | TELMISARTAN, CHLORTHALIDONE TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
TELMISARTAN | I.P. | 40 MG | |||
CHLORTHALIDONE | I.P. | 12.5 MG | |||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
469 | TELMISARTAN, HYDROCHLORTHIAZIDE TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
TELMISARTAN | I.P. | 40 MG | |||
HYDROCHLORTHIAZIDE | I.P. | 12.5 MG | |||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
470 | TELMISARTAN, HYDROCHLORTHIAZIDE TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
TELMISARTAN | I.P. | 80 MG | |||
HYDROCHLORTHIAZIDE | I.P. | 12.5 MG | |||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
471 | TELMISARTAN, HYDROCHLORTHIAZIDE TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
TELMISARTAN | B.P. | 40 MG | |||
HYDROCHLORTHIAZIDE | B.P. | 12.5 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
472 | TELMISARTAN, HYDROCHLORTHIAZIDE TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
TELMISARTAN | B.P. | 80 MG | |||
HYDROCHLORTHIAZIDE | B.P. | 12.5 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
473 | TERBINAFINE HYDROCHLORIDE TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
TERBINAFINE HYDROCHLORIDE | I.P. | ||||
EQ.TO TERBINAFINE (IN BETACYCLODEXTRIN) | 250 MG | ||||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
474 | TERBINAFINE HYDROCHLORIDE TABLETS | EACH UNCOATED TABLET CONTAINS: | EXPORT | ||
TERBINAFINE HYDROCHLORIDE | U.S.P. | ||||
EQ.TO TERBINAFINE (IN BETACYCLODEXTRIN) | 250 MG | ||||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
475 | THIAMINE MONONITRATE, PYRIDOXINE HYDROCHLORIDE, CYANOCOBALAMIN TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
THIAMINE MONONITRATE | B.P. | 10 MG | |||
PYRIDOXINE HCL | B.P. | 3 MG | |||
CYANOCOBALAMIN | B.P. | 15 MCG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
476 | THIAMINE HYDROCHLORIDE, PYRIDOXINE HYDROCHLORIDE, CYNOCOBALAMIN TABLETS | EACH FILM COATED TABLET. CONTAINS: | EXPORT | ||
THIAMINE HYDROCHLORIDE | B.P. | 100 MG | |||
PYRIDOXINE HCL | B.P. | 200 MG | |||
CYNOCOBALAMIN | B.P. | 200 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
477 | TINIDAZOLE TABLETS | EACH FILMCOATED TABLET CONTAINS: | EXPORT | ||
TINIDAZOLE | B.P. | 500 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
478 | TOPIRAMATE TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
TOPIRAMATE | I.P. | 25 MG | |||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
479 | TOPIRAMATE TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
TOPIRAMATE | I.P. | 50 MG | |||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
480 | TRAMADOL HYDROCHLORIDE TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
TRAMADOL HYDROCHLORIDE | I.P. | 100 MG | |||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
481 | TRAMADOL HYDROCHLORIDE SUSTAINED RELEASE TABLETS | EACH FILM COATED SUSTAINED RELEASE TABLET CONTAINS: | DOMESTIC | ||
TRAMADOL HYDROCHLORIDE | I.P. | 100 MG | |||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
482 | TRAMADOL HYDROCHLORIDE, PARACETAMOL TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
TRAMADOL HYDROCHLORIDE | I.P. | 37.5 MG | |||
PARACETAMOL | I.P. | 325 MG | |||
EXCIPIENTS | Q.S | ||||
483 | TRAMADOL HYDROCHLORIDE, PARACETAMOL TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
TRAMADOL HYDROCHLORIDE | I.P. | 50 MG | |||
PARACETAMOL | I.P. | 325 MG | |||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
484 | TRAMADOL HYDROCHLORIDE, PARACETAMOL TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
TRAMADOL HYDROCHLORIDE | I.P. | 50 MG | |||
PARACETAMOL | I.P. | 325 MG | |||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
485 | TRANEXAMIC ACID TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
TRANEXAMIC ACID | B.P. | 500 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
486 | TRANEXAMIC ACID, ETAMSYLATE TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
TRANEXAMIC ACID | B.P. | 250 MG | |||
ETAMSYLATE | B.P. | 250 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
487 | TRANEXAMIC ACID, ETAMSYLATE TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
TRANEXAMIC ACID | I.P. | 250 MG | |||
ETAMSYLATE | I.P. | 250 MG | |||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
488 | TRANEXAMIC ACID, MEFENAMIC ACID TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
TRANEXAMIC ACID | I.P. | 500 MG | |||
MEFENAMIC ACID | I.P. | 250 MG | |||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
489 | TRAZODONE HYDROCHLORIDE TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
TRAZODONE HYDROCHLORIDE | U.S.P. | 25 MG | |||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
490 | TRAZODONE HYDROCHLORIDE TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
TRAZODONE HYDROCHLORIDE | U.S.P. | 50 MG | |||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
491 | TRAZODONE HYDROCHLORIDE TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
TRAZODONE HYDROCHLORIDE | U.S.P. | 100 MG | |||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
492 | TRIHEXYPHENIDYL HYDROCHLORIDE TABLETS | EACH UNCOATED TABLET CONTAINS: | EXPORT | ||
TRIHEXYPHENIDYL HYDROCHLORIDE | U.S.P. | 2 MG | |||
EXCIPIENTS | Q.S | ||||
493 | TRIHEXYPHENIDYL HYDROCHLORIDE TABLETS | EACH UNCOATED TABLET CONTAINS: | DOMESTIC | ||
TRIHEXYPHENIDYL HYDROCHLORIDE | I.P. | 2 MG | |||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
494 | TRIHEXYPHENIDYL HYDROCHLORIDE, TRIFLUOPERAZINE TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
TRIHEXYPHENIDYL HYDROCHLORIDE | I.P. | 2 MG | |||
TRIFLUOPERAZINE HYDROCHLORIDE | I.P. | ||||
EQ. TO TRIFLUOPERAZINE | 5 MG | ||||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED | |||||
495 | TRIMETHOPRIM, SULFAMETHOXAZOLE TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
TRIMETHOPRIM | B.P. | 80 MG | |||
SULFAMETHOXAZOLE | B.P. | 400 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
496 | TRIMETHOPRIM, SULFAMETHOXAZOLE TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
TRIMETHOPRIM | B.P. | 160 MG | |||
SULFAMETHOXAZOLE | B.P. | 800 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
497 | TRIOXSALEN TABLETS | EACH FILM COATED TABLET CONTAINS: | DOMESTIC | ||
TRIOXSALEN | U.S.P. | 25 MG | |||
EXCIPIENT | Q. S | ||||
APPROVED COLOUR USED | |||||
498 | URSODIOL TABLETS (URSODESOXYCHOLIC ACID) TABLETS | EACH UNCOATED TABLET CONATINS: | DOMESTIC | ||
URSODEOXYCHOLIC ACID | I.P. | 150 MG | |||
EXCIPIENTS | Q. S | ||||
499 | URSODIOL TABLETS (URSODESOXYCHOLIC ACID) TABLETS | EACH UNCOATED TABLET CONATINS: | DOMESTIC | ||
URSODEOXYCHOLIC ACID | I.P. | 300 MG | |||
EXCIPIENTS | Q. S | ||||
500 | URSODIOL TABLETS (URSODESOXYCHOLIC ACID) TABLETS | EACH UNCOATED TABLET CONATINS: | EXPORT | ||
URSODEOXYCHOLIC ACID | U.S.P. | 300 MG | |||
EXCIPIENTS | Q.S | ||||
501 | VALACYCLOVIR TABLETS | EACH FILM COATED TABLET CONTAINS: | EXPORT | ||
VALACYCLOVIR HCL | U.S.P. | ||||
EQ.TO VALACYCLOVIR | 500 MG | ||||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
502 | VALACYCLOVIR TABLETS | EACH UNCOATED TABLET CONTAINS: | EXPORT | ||
VALACYCLOVIR HYDROCHLORIDE | U.S.P. | ||||
EQ.TO VALACYCLOVIR | 500 MG | ||||
EXCIPIENTS | Q.S | ||||
503 | VENLAFAXINE HYDROCHLORIDE EXTEND RELEASE TABLETS | EACH UNCOATED EXTENDE RELEASE TABLET CONTAINS: | DOMESTIC | ||
VENLAFAXINE HYDROCHLORIDE | B.P. | ||||
EQ TO VENLAFAXINE | 75 MG | ||||
EXCIPIENTS | Q. S | ||||
504 | VENLAFAXINE HYDROCHLORIDE EXTENDED RELEASE TABLETS | EACH UNCOATED EXTENDED RELEASE TABLET CONTAINS: | DOMESTIC | ||
VENLAFAXINE HYDROCHLORIDE | I.P. | ||||
EQ TO VENLAFAXINE | 75 MG | ||||
EXCIPIENTS | Q. S | ||||
505 | ZINC SULPHATE DISPERSIBLE TABLETS | EACH UNCOATED DISPERSIBLE TABLET CONTAINS: | DOMESTIC | ||
ZINC SULPHATE MONOHYDRATE | I.P. | 55 MG | |||
EQ. TO 20 MG ELEMENTAL ZINC | |||||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED | |||||
506 | ZOPICLONE TABLETS | EACH FILMCOATED TABLET CONTAINS: | EXPORT | ||
ZOPICLONE | B.P. | 7.5 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOURED USED |
NO | NAME OF PRODUCT | COMPOSITION | GRADE | STRENGTH | MARKET |
1 | AZITHROMYCIN CAPSULE | EACH HARD GELATIN CAPSULE CONTAINS: | EXPORT | ||
AZITHROMYCIN DIHYDRATE | U.S.P. | ||||
EQ. TO ANHYDROUS AZITHROMYCIN | 250 MG | ||||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED IN HARD GELATIN CAPSULE SHELLS | |||||
2 | AZITHROMYCIN CAPSULE | EACH HARD GELATIN CAPSULE CONTAINS: | EXPORT | ||
AZITHROMYCIN DIHYDRATE | U.S.P. | ||||
EQ. TO ANHYDROUS AZITHROMYCIN | 500 MG | ||||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED IN EMPTY HARD GELATIN CAPSULE SHELL | |||||
3 | AZITHROMYCIN CAPSULES | EACH HARD GELATIN CAPSULE CONTAINS: | DOMESTIC | ||
AZITHROMYCIN DIHYDRATE | I.P. | ||||
EQ TO ANHYDROUS AZITHROMYCIN | 500 MG | ||||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED IN EMPTY CAPSULES SHELL | |||||
4 | BUDESONIDE CAPSULES | EACH HARD GELATIN CAPSULE CONTAINS: | EXPORT | ||
BUDESONIDE (AS CONTROLLED RELEASE PELLETS) | B.P. | 3 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED IN EMPTY HARD GELATIN CAPSULES SHELL & PELLETS | |||||
5 | BUDESONIDE CAPSULES | EACH HARD GELATIN CAPSULE CONTAINS: | DOMESTIC | ||
BUDESONIDE (AS CONTROLLED RELEASE PELLETS) | I.P. | 100 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED IN EMPTY HARD GELATIN CAPSULES SHELLS & PELLETS | |||||
6 | CLINDAMYCIN CAPSULES | EACH HARD GELATIN CAPSULE CONTAINS: | DOMESTIC | ||
CLINDAMYCIN HYDROCHLORIDE | |||||
EQ TO CLINDAMYCIN | 300 MG | ||||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED IN EMPTY HARD GELATIN CAPSULE SHELLS | |||||
7 | DICYCLOMINE HYDROCHLORIDE, TRAMADOL HYDROCHLORIDE, ACETAMINOPHEN CAPSULES | EACH HARD GELATIN CAPSULE CONTAINS: | DOMESTIC | ||
TRAMADOL HYDROCHLORIDE | I.P. | 50 MG | |||
DICYCLOMINE HYDROCHLORIDE | I.P. | 10 MG | |||
ACETAMINOPHEN | I.P. | 325 MG | |||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED IN EMPTY HARD GELATIN CAPSULE SHELLS | |||||
8 | DOXYCYCLINE HYDROCHLORIDE CAPSULES | EACH HARD GELATIN CAPSULES CONTAINS: | EXPORT | ||
DOXYCYCLINE HYDROCHLORIDE | U.S.P. | 100 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED IN EMPTY HARD GELATIN CAPSULE SHELL & PELLETS | |||||
9 | DOXYCYCLINE HYDROCHLORIDE, LACTIC ACID BACILLUS CAPSULES | EACH HARD GELATIN CAPSULES CONTAINS: | EXPORT | ||
DOXYCYCLINE HYDROCHLORIDE | B.P. | ||||
EQ.TO DOXYCYCLINE (PELLETS) | 100 MG | ||||
LACTIC ACID BACILLUS 5 BILLION SPORES (AS ENTRIC COATED PELLETS) | 5 MLN SPORES | ||||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED IN EMPTY HARD GELATIN CAPSULE SHELL & PELLETS | |||||
10 | DRIED FERROUS SULFATE, VITAMIN C, THIAMINE MONONITRATE, PYRIDOXINE HYDROCHLORIDE, RIBOFLAVIN NICOTINAMIDE, CALCIUM PANTOTHENATE, FOLIC ACID, ZINC SULFATE MONOHYDRATE CAPSULES | EACH HARD GELATIN CAPSULE CONTAINS: | EXPORT | ||
DRIED FERROUS SULFATE | B.P. | 150 MG | |||
EQ. TO 46 MG ELEMENTARY IRON | |||||
VITAMIN C(AS COATED | B.P. | 50 MG | |||
THIAMINE MONONITRATE | U.S.P. | 2 MG | |||
PYRIDOXINE HYDROCHLORIDE | B.P. | 1 MG | |||
RIBOFLAVIN | B.P. | 2 MG | |||
NICOTINAMIDE | B.P. | 15 MG | |||
CALCIUM PANTOTHENATE | B.P. | 2.5 MG | |||
FOLIC ACID | B.P. | 0.5 MG | |||
ZINC SULFATE MONOHYDRATE | B.P. | 5 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED IN EMPTY HARD GELATIN CAPSULE SHELL | |||||
11 | ESOMEPRAZOLE (ENTERIC COATED), DOMPERIDONE SUSTAINED RELEASE CAPSULES | EACH HARD GELATIN CAPSULE CONTAINS: | DOMESTIC | ||
ESOMEPRAZOLE MAGNESIUM TRIHYDRATE | I.P. | ||||
EQ. TO ESOMEPRAZOLE | 40 MG | ||||
(AS ENTERIC COATED PELLETS) | |||||
DOMPERIDONE | I.P. | 30 MG | |||
(AS SUSTAINED RELEASE PELLETS) | |||||
EXCIPIENTS: | Q. S | ||||
APPROVED COLOUR USED IN HARD GELATIN CAPSULE SHELL & PELLETS. | |||||
12 | FERROUS FUMARATE, FOLIC ACID, CYANOCOBALAMIN, ASCORBIC ACID, ZINC CAPSULES | EACH HARD GELATIN CAPSULE CONTAINS: | EXPORT | ||
FERROUS FUMARATE | B.P. | 304 MG | |||
EQ. TO 100 MG ELEMENTAL IRON | |||||
FOLIC ACID | B.P. | 0.75 MG | |||
CYANOCOBALAMIN | B.P. | 5 MCG | |||
ASCORBIC ACID | B.P. | 75 MG | |||
ZINC SULPHATE MONO HYDRATE | B.P. | 5 MG | |||
EXCIPIENTS | Q.S | ||||
APPROPRIATE OVERAGE OF VITAMINS ADDED | |||||
APPROVED COLOUR USED IN EMPTY HARD GELATIN CAPSULE SHELLS | |||||
13 | FERROUS FUMARATE, CYANOCOBALAMIN, FOLIC ACID, ZINC CAPSULES | EACH HARD GELATIN CAPSULES CONTAINS: | DOMESTIC | ||
FERROUS FUMARATE | I.P. | 200 MG | |||
EQ. TO ELEMENTAL IRON | 65 MG | ||||
CYANOCOBALAMIN | I.P. | 10 MCG | |||
FOLIC ACID | I.P. | 1 MG | |||
ZINC SULPHATE MONOHYDRATE | I.P. | 61.8 MG | |||
EQ. TO 22.5 MG ELEMENTAL ZINC | |||||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED IN HARD GELATIN CAPSULE SHELL | |||||
14 | FERROUS FUMARATE, CYANOCOBALAMIN, FOLIC ACID, ZINC CAPSULES | EACH HARD GELATIN CAPSULES CONTAINS: | DOMESTIC | ||
FERROUS FUMARATE | I.P. | 300 MG | |||
EQ. TO 98.6 MG OF ELEMENTAL IRON | |||||
CYANOCOBALAMIN | I.P. | 15 MCG | |||
FOLIC ACID | I.P. | 1.5 MG | |||
ZINC SULPHATE MONOHYDRATE | I.P. | 61.8 MG | |||
EQ. TO 22.5 MG ELEMENTAL ZINC | |||||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED IN HARD GELATIN CAPSULE SHELL | |||||
15 | FERROUS FUMARATE, CYANOCOBALAMIN, FOLIC ACID, ZINC CAPSULES | EACH HARD GELATIN CAPSULE CONTAINS: | DOMESTIC | ||
FERROUS FUMARATE | I.P. | 400 MG | |||
FOLIC ACID | I.P. | 1.5 MG | |||
CYANOCOBALAMIN | I.P. | 15 MCG | |||
ZINC SULPHATE MONOHYDRATE | I.P. | 61.8 MG | |||
EQ. TO 22.5 MG ELEMENTAL ZINC | |||||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED IN HARD GELATIN CAPSULE SHELL | |||||
16 | FLUCONAZOLE CAPSULES | EACH HARD GELATIN CAPSULE CONTAINS: | EXPORT | ||
FLUCONAZOLE | U.S.P. | 50 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED IN EMPTY HARD GELATIN CAPSULE SHELL | |||||
17 | FLUCONAZOLE CAPSULES | EACH HARD GELATIN CAPSULE CONTAINS: | EXPORT | ||
FLUCONAZOLE | B.P. | 150 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED IN EMPTY HARD GELATIN CAPSULE SHELL | |||||
18 | FLUCONAZOLE CAPSULES | EACH HARD GELATIN CAPSULE CONTAINS: | DOMESTIC | ||
FLUCONAZOLE | I.P. | 150 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED IN EMPTY HARD GELATIN CAPSULE SHELLS | |||||
19 | FLUOXETINE HYDROCHLORIDE CAPSULES | EACH HARD GELATIN CAPSULE CONTAINS: | EXPORT | ||
FLUOXETINE HYDROCHLORIDE | B.P. | ||||
EQ. TO FLUOXETINE | 20 MG | ||||
EXCIPIENT | Q.S | ||||
APPROVED COLOUR USED IN EMPTY HARD GELATINS CAPSULE SHELLS | |||||
20 | FLUOXETINE HYDROCHLORIDE CAPSULES | EACH HARD GELATIN CAPSULE CONTAINS: | DOMESTIC | ||
FLUOXETINE HYDROCHLORIDE | I.P. | ||||
EQ. TO FLUOXETINE | 20 MG | ||||
EXCIPIENT | Q. S | ||||
APPROVED COLOUR USED IN EMPTY HARD GELATIN CAPSULE SHELLS | |||||
21 | FLUOXETINE HYDROCHLORIDE CAPSULES | EACH HARD GELATIN CAPSULE CONTAINS: | DOMESTIC | ||
FLUOXETINE HYDROCHLORIDE | I.P. | ||||
EQ. TO FLUOXETINE | 40 MG | ||||
EXCIPIENT | Q. S | ||||
APPROVED COLOUR USED IN EMPTY HARD GELATIN CAPSULE SHELLS | |||||
22 | FLUOXETINE HYDROCHLORIDE CAPSULES | EACH HARD GELATIN CAPSULE CONTAINS: | DOMESTIC | ||
FLUOXETINE HYDROCHLORIDE | I.P. | ||||
EQ. TO FLUOXETINE | 60 MG | ||||
EXCIPIENT | Q. S | ||||
APPROVED COLOUR USED IN EMPTY HARD GELATIN CAPSULE SHELLS | |||||
23 | ILAPRAZOLE, DOMPERIDONE CAPSULES | EACH HARD GELATIN CAPSULE CONTAINS: | DOMESTIC | ||
ILAPRAZOLE (AS ENTERIC COATED PELLETS) | I.P. | 10 MG | |||
DOMPERIDONE (AS SUSTAINED RELEASE PELLETS) | I.P. | 30 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED IN EMPTY HARD GELATIN CAPSULES | |||||
24 | ISOTRETINOIN CAPSULES | EACH HARD GELATIN CAPSULE CONTAINS: | DOMESTIC | ||
ISOTRETINOIN | I.P. | 10 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED IN EMPTY CAPSULES SHELLS | |||||
25 | ISOTRETINOIN CAPSULES | EACH HARD GELATIN CAPSULE CONTAINS: | DOMESTIC | ||
ISOTRETINOIN | I.P. | 20 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED IN EMPTY HARD GLATIN CAPSULES SHELL | |||||
26 | ISOXSUPRINE HYDROCHLORIDE CAPSULES | EACH HARD GELATIN CAPSULE CONTAINS: | DOMESTIC | ||
ISOXSUPRINE HYDROCHLORIDE | I.P. | 20 MG | |||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED IN HARD GELATIN CAPSULES SHELL | |||||
27 | ITRACONAZOLE CAPSULES | EACH HARD GELATIN CAPSULE CONTAINS: | EXPORT | ||
ITRACONAZOLE PELLETS | B.P. | ||||
EQ.TO ITRACONAZOLE | 50 MG | ||||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED IN EMPTY CAPSULE SHELLS & PELLETS | |||||
28 | ITRACONAZOLE CAPSULES | EACH HARD GELATIN CAPSULE CONTAINS: | EXPORT | ||
ITRACONAZOLE PELLETS | B.P. | ||||
EQ.TO ITRACONAZOLE | 100 MG | ||||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED IN EMPTY HARD GELATIN CAPSULE SHELLS & PELLETS | |||||
29 | ITRACONAZOLE CAPSULES | EACH HARD GELATIN CAPSULE CONTAINS: | EXPORT | ||
ITRACONAZOLE PELLETS | B.P. | ||||
EQ.TO ITRACONAZOLE | 200 MG | ||||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED IN EMPTY HARD GELATIN CAPSULE SHELLS & PELLETS | |||||
30 | ITRACONAZOLE CAPSULES | EACH HARD GELATIN CAPSULE CONTAINS: | DOMESTIC | ||
ITRACONAZOLE PELLETS | I.P. | ||||
EQ.TO ITRACONAZOLE | 100 MG | ||||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED IN EMPTY HARD GELATIN CAPSULE SHELLS & PELLETS | |||||
31 | ITRACONAZOLE CAPSULES | EACH HARD GELATIN CAPSULE CONTAINS: | DOMESTIC | ||
ITRACONAZOLE PELLETS | I.P. | ||||
EQ.TO ITRACONAZOLE | 200 MG | ||||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED IN EMPTY HARD GELATIN CAPSULE SHELLS & PELLETS | |||||
32 | LOPERAMIDE HYDROCHLORIDE CAPSULES | EACH HARD GELATIN CAPSULE CONTAINS: | EXPORT | ||
LOPERAMIDE HYDROCHLORIDE | U.S.P. | 2 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED IN EMPTY HARD GELATIN CAPSULE SHELLS | |||||
33 | LOPERAMIDE HYDOCHLORIDE, DICYCLOVERINE HYDROCHLORIDE, LACTIC ACID BACILLUS CAPSULES | EACH HARD GELATIN CAPSULE CONTAINS: | EXPORT | ||
LOPERAMIDE HYDROCHLORIDE | B.P. | 2 MG | |||
DICYCLOVERINE HYDROCHLORIDE | B.P. | 10 MG | |||
LACTIC ACID BACILLUS (BACILLUS COAGULANS (LB SPOROGENES)) | 60 MLN SPORES | ||||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED IN EMPTY HARD GELATIN CAPSULE SHELLS | |||||
34 | OMEPRAZOLE GASTRO-RESISTANT CAPSULES | EACH HARD GELATIN CAPSULE CONTAINS: | EXPORT | ||
OMEPRAZOLE (AS ENTERIC COATED PELLETS) | B.P. | 20 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED IN EMPTY HARD GELATIN CAPSULE SHELLS & PELLETS | |||||
35 | OMEPRAZOLE, DOMPERIDONE CAPSULES | EACH HARD GELATIN CAPSULE CONTAINS: | EXPORT | ||
OMEPRAZOLE (AS ENTERIC COATED PELLETS) | B.P. | 20 MG | |||
DOMPERIDONE (AS IMMIDIATE RELEASE PELLETS) | B.P. | 10 MG | |||
APPROVED COLOUR USED IN EMPTY HARD GELATIN CAPSULE SHELLS & PELLETS | |||||
36 | OMEPRAZOLE, DOMPERIDONE CAPSULES | EACH HARD GELATIN CAPSULE CONTAINS: | EXPORT | ||
OMEPRAZOLE (AS ENTERIC COATED PELLETES) | B.P. | 20 MG | |||
DOMPERIDONE (AS SUSTAINED RELEASE PELLETS) | B.P. | 30 MG | |||
APPROVED COLOUR USED IN EMPTY HARD GELATIN CAPSULE SHELLS & PELLETS | |||||
37 | OMEPRAZOLE CAPSULES | EACH HARD GELATIN CAPSULE CONTAINS: | DOMESTIC | ||
OMEPRAZOLE | I.P. | 20 MG | |||
(AS ENTERIC COATED) | |||||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED IN EMPTY HARD GELATIN CAPSULE SHELL | |||||
38 | PANTOPRAZOLE SODIUM DELAYED-RELEASE CAPSULES | EACH HARD GELATIN CAPULE CONTAINS: | EXPORT | ||
PANTOPRAZOLE SODIUM SESQUIHYDRATE | B.P. | ||||
EQ TO PANTOPRAZOLE (AS ENTERIC COATED PELLETS) | 40 MG | ||||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED IN EMPTY HARD GELATIN CAPSULE SHELLS & PELLETS | |||||
39 | PANTOPRAZOLE (ENTERIC COATED), DOMPERIDONE (SUSTAINED RELEASE) CAPSULES | EACH HARD GELATIN CAPULE CONTAINS: | EXPORT | ||
PANTOPRAZOLE SODIUM SESQUIHYDRATE | B.P. | ||||
EQ TO PANTOPRAZOLE (AS ENTERIC COATED PELLETS) | 40 MG | ||||
DOMPERIDONE (AS SUSTAINED RELEASE PELLETS) | B.P. | 30 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED IN EMPTY HARD GELATIN CAPSULE SHELLS & PELLETS | |||||
40 | PANTOPRAZOLE (ENTERIC COATED), DOMPERIDONE (SUSTAINED RELEASE) CAPSULES | EACH HARD GELATIN CAPULE CONTAINS: | EXPORT | ||
PANTOPRAZOLE SODIUM SESQUIHYDRATE | I.P. | ||||
EQ TO PANTOPRAZOLE (AS ENTERIC COATED PELLETS) | 40 MG | ||||
DOMPERIDONE (AS SUSTAINED RELEASE PELLETS) | I.P. | 10 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED IN EMPTY HARD GELATIN CAPSULE SHELLS & PELLETS | |||||
41 | PANTOPRAZOLE (ENTERIC COATED), DOMPERIDONE (SUSTAINED RELEASE) CAPSULES | EACH HARD GELATIN CAPSULE CONTAINS: | EXPORT | ||
PANTOPRAZOLE SODIUM SESQUIHYDRATE | I.P. | ||||
EQ. TO PANTOPRAZOLE (AS ENTRIC COATED PELLETS) | 40 MG | ||||
DOMPERIDONE (AS IR PELLETS) | I.P. | 30 MG | |||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED IN HARD GELATIN EMPTY CAPSULE SHELL & PELLETS | |||||
42 | PHENYLEPHRINE HYDROCHLORIDE, CHLORPHENAMINE MALEATE, PARACETAMOL, ASCORBIC ACID, CAFFEINE CAPSULES | EACH HARD GELATIN CAPSULE CONTAINS: | DOMESTIC | ||
PHENYLEPHRINE HYDROCHLORIDE | B.P. | 5 MG | |||
CHLORPHENAMINE MALEATE | B.P. | 2 MG | |||
PARACETAMOL | B.P. | 300 MG | |||
ASCORBIC ACID | B.P. | 75 MG | |||
CAFFEINE (ANHYDROUS) | B.P. | 30 MG | |||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED IN EMPTY CAPSULES SHELLS & PELLETS | |||||
43 | PANTOPRAZOLE SODIUM, LEVOSULPIRIDE SUSTAINED RELEASE CAPSULES | EACH HARD GELATIN CAPSULE CONTAINS: | DOMESTIC | ||
PANTOPRAZOLE SODIUM SESQUIHYDRATE | I.P. | ||||
EQ.TO PANTOPRAZOLE (AS ENTERIC COATED PELLETS) | 40 MG | ||||
LEVOSULPIRIDE (AS SUSTAINED RELEASE PELLETS) | I.P. | 75 MG | |||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED IN EMPTY CAPSULES SHELLS & PELLETS | |||||
44 | PIRACETAM CAPSULES | EACH HARD GELATIN CAPSULE CONTAINS: | EXPORT | ||
PIRACETAM | B.P. | 400 MG | |||
EXCIPIENTS | Q.S | ||||
EXCIPIENTS | |||||
45 | PREGABALIN CAPSULES | EACH HARD GELATIN CAPSULE CONTAINS: | EXPORT | ||
PREGABALIN | U.S.P. | 75 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED IN EMPTY HARD GELATIN CAPSULE SHELLS | |||||
46 | PREGABALIN CAPSULES | EACH HARD GELATIN CAPSULE CONTAINS: | EXPORT | ||
PREGABALIN | U.S.P. | 300 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED IN EMPTY HARD GELATIN CAPSULE SHELLS | |||||
47 | PREGABALIN, METHYLCOBALAMIN CAPSULES | EACH HARD GELATIN CAPSULE CONTAINS: | DOMESTIC | ||
PREGABALIN | I.P. | 75 MG | |||
METHYLCOBALAMIN | I.P. | 1500 MCG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED IN EMPTY HARD GELATIN CAPSULE SHELL | |||||
48 | PREGABALIN, METHYLCOBALAMIN CAPSULES | EACH HARD GELATIN CAPSULE CONTAINS: | EXPORT | ||
PREGABALIN | U.S.P. | 75 MG | |||
METHYLCOBALAMIN | U.S.P. | 750 MCG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED IN EMPTY HARD GELATIN CAPSULE SHELL | |||||
49 | PREGABALIN, METHYLCOBALAMIN CAPSULES | EACH HARD GELATIN CAPSULE CONTAINS: | EXPORT | ||
PREGABALIN | U.S.P. | 150 MG | |||
METHYLCOBALAMIN | U.S.P. | 750 MCG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED IN EMPTY HARD GELATIN CAPSULE SHELL | |||||
50 | PROPRANOLOL HYDROCHLORIDE (SUSTAINED RELEASE), FLUNARIZINE DIHYDROCHLORIDE CAPSULES | EACH HARD GELATIN CAPSULE CONTAINS: | DOMESTIC | ||
PROPRANOLOL HYDROCHLORIDE (AS EXTENDED RELEASE) | I.P. | 40 MG | |||
FLUNARIZINE DIHYDROCHLORIDE | B.P. | ||||
EQ TO FLUNARIZINE | 5 MG | ||||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED IN EMPTY HARD GELATIN CAPSULES SHELLS | |||||
51 | PROPRANOLOL HYDROCHLORIDE (SUSTAINED RELEASE), FLUNARIZINE DIHYDROCHLORIDE CAPSULES | EACH HARD GELATIN CAPSULE CONTAINS: | DOMESTIC | ||
PROPRANOLOL HYDROCHLORIDE (AS EXTENDED RELEASE) | I.P. | 40 MG | |||
FLUNARIZINE DIHYDROCHLORIDE | B.P. | ||||
EQ TO FLUNARIZINE | 10 MG | ||||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED IN EMPTY HARD GELATN CAPSULE SHELL | |||||
52 | RABEPRAZOLE SODIUM (ENTERIC COATED) CAPSULES | EACH HARD GELATIN CAPSULE CONTAINS: | EXPORT | ||
RABEPRAZOLE SODIUM (AS ENTERIC COATED PELLETS) | B.P. | 20 MG | |||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED IN EMPTY HARD GELATIN CAPSULE SHELLS & PELLETS | |||||
53 | RABEPRAZOLE SODIUM (ENTERIC COATED), DOMPERIDONE (SUSTAINED RELEASE) CAPSULES | EACH HARD GELATIN CAPSULE CONTAINS: | DOMESTIC | ||
RABEPRAZOLE SODIUM (AS ENTERIC COATED PELLETS) | I.P. | 20 MG | |||
DOMPERIDONE (AS SUSTAINED RELEASE PELLETS) | I.P. | 30 MG | |||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED IN EMPTY HARD GELATIN CAPSULE SHELLS & PELLETS | |||||
54 | RABEPRAZOLE (ENTERIC COATED), DICLOFENAC SODIUM (SUSTAINED RELEASE) CAPSULES | EACH HARD GELATIN CAPSULE CONTAINS: | DOMESTIC | ||
RABEPRAZOLE SODIUM (AS ENTERIC COATED PELLETS) | I.P. | 20 MG | |||
DICLOFENAC SODIUM (AS SUSTAINED RELEASE PELLETS) | I.P. | 100 MG | |||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED IN EMPTY HARD GELATIN CAPSULES SHELLS & PELLETS | |||||
55 | RABEPRAZOLE (ENTERIC COATED), LEVOSULPIRIDE SUSTAINED RELEASE CAPSULES | EACH HARD GELATIN CAPSULE CONTAINS: | DOMESTIC | ||
RABEPRAZOLE SODIUM (AS ENTERIC COATED PELLETS) | I.P. | 20 MG | |||
LEVOSULPIRIDE (AS SUSTAINED RELEASE PELLETS) | I.P. | 75 MG | |||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED IN EMPTY HARD GELATIN CAPSULES SHELLS & PELLETS | |||||
56 | TAMSULOSIN HYDROCHLORIDE PROLONGED RELEASE AND DUTASTERIDE CAPSULES | EACH HARD GELATIN CAPSULE CONTAINS: | EXPORT | ||
DUTASTERIDE | 0.5 MG | ||||
TAMSULOSIN HYDROCHLORIDE | B.P. | 0.4 MG | |||
(AS PROLONGED RELEASE) | Q.S | ||||
APPROVED COLOUR USED IN EMPTY HARD GELATIN CAPSULE SHELLS & PELLETS | |||||
57 | TRAMADOL HYDROCHLORIDE CAPSULES | EACH HARD GELATIN CAPSULE CONTAINS: | DOMESTIC | ||
TRAMADOL HYDROCHLORIDE | I.P. | 50 MG | |||
EXCIPIENTS | Q. S | ||||
APPROVED COLOUR USED IN EMPTY CAPSULE SHELL | |||||
58 | UMIFENOVIR HYDROCHLORIDE CAPSULES | EACH HARD GELATIN CAPSULE CONTAINS: | EXPORT | ||
UMIFENOVIR HYDROCHLORIDE | B.P. | 100 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED IN EMPTY HARD GELATIN CAPSULES SHELL & PELLETS | |||||
59 | UMIFENOVIR HYDROCHLORIDE CAPSULES | EACH HARD GELATIN CAPSULE CONTAINS: | EXPORT | ||
UMIFENOVIR HYDROCHLORIDE | B.P. | 200 MG | |||
EXCIPIENTS | Q.S | ||||
APPROVED COLOUR USED IN EMPTY HARD GELATIN CAPSULE SHELL |
NO | NAME OF PRODUCT | COMPOSITION | GRADE | STRENGTH | FORM | MARKET |
1 | ACYCLOVIR OINTMENT | EACH GM CONTAINS: | OINTMENT | EXPORT | ||
ACYCLOVIR | U.S.P. | 50 MG | ||||
WATER MISCIBLE OINTMENT BASE | Q.S | |||||
2 | AMOROLFINE HYDROCHLORIDE CREAM | COMPOSITION: | CREAM | DOMESTIC | ||
AMOROLFINE HYDROCHLORIDE | I.P. | |||||
EQ. TO AMOROLFINE | 0.25%W/W | |||||
CREAM BASE | Q.S | |||||
3 | BECLOMETHASONE DIPROPIONATE, CLOTRIMAZOLE LOTION | COMPOSITION: | LOTION | DOMESTIC | ||
BECLOMETHASONE DIPROPIONATE | I.P. | 0.025%W/V | ||||
CLOTRIMAZOLE | I.P. | 1.000%W/V | ||||
NON AQUEOUS BASE | Q.S | |||||
4 | BECLOMETHASONE DIPROPIONATE, FUSIDIC ACID CREAM | COMPOSITION: | CREAM | DOMESTIC | ||
BECLOMETHASONE DIPROPIONATE | I.P. | 0.025%W/W | ||||
FUSIDIC ACID | I.P. | 2.0% W/W | ||||
IN CREAM BASE | Q.S | |||||
5 | BECLOMETHASONE DIPROPIONATE, NEOMYCIN, CLOTRIMAZOLE CREAM | COMPOSITION: | CREAM | DOMESTIC | ||
BECLOMETHASONE DIPROPIONATE | I.P. | 0.025%W/W | ||||
NEOMYCIN SULPHATE | I.P. | |||||
EQ.TO NEOMYCIN BASE | 0.5%W/W | |||||
CLOTRIMAZOLE | I.P. | 1.0%W/W | ||||
CHLOROCRESOL (AS PRESERVATIVE) | I.P. | 0.1%W/W | ||||
CREAM BASE | Q.S | |||||
6 | BECLOMETHASONE DIPROPIONATE, CLOTRIMAZOLE, NEOMYCIN CREAM | COMPOSITION: | CREAM | DOMESTIC | ||
BECLOMETHASONE DIPROPIONATE | I.P. | 0.05 % W/W | ||||
CLOTRIMAZOLE | I.P. | 1.00 % W/W | ||||
NEOMYCIN SULPHATE | I.P. | |||||
EQ. TO NEOMYCIN BASE | 0.50 % W/W | |||||
CREAM BASE | Q.S | |||||
7 | BENZOYL PEROXIDE GEL | COMPOSITION: | GEL | EXPORT | ||
HYDROUS BENZOYL PEROXIDE | B.P. | |||||
EQ. TO ANHYDROUS BENZOYL PEROXIDE | 5.0%W/W | |||||
AQUEOUS GEL BASE | Q.S | |||||
8 | BENZOYL PEROXIDE GEL | COMPOSITION: | GEL | EXPORT | ||
HYDROUS BENZOYL PEROXIDE | B.P. | |||||
EQ. TO HYDROUS BENZOYL PEROXIDE | 5.0%W/W | |||||
AQUEOUS GEL BASE | Q.S | |||||
9 | BETAMETHASONE DIPROPIONATE, GENTAMYCIN CREAM | COMPOSITION: | CREAM | EXPORT | ||
BETAMETHASONE DIPROPIONATE | B.P. | 0.1% W/W | ||||
GENTAMYCIN SULFATE | B.P. | 0.1% W/W | ||||
CREAM BASE | Q.S | |||||
10 | BETAMETHASONE DIPROPIONATE, CLOTRIMAZOLE, GENTAMICIN OINTMENT | COMPOSITION: | OINTMENT | EXPORT | ||
BETAMETHASONE DIPROPIONATE | B.P. | |||||
EQ. TO BETAMETHASONE | 0.05%W/W | |||||
GENTAMICIN SULFATE | B.P. | |||||
EQ. TO GENTAMICIN | 0.1%W/W | |||||
CLOTRIMAZOLE | B.P. | 1.0%W/W | ||||
OINTMENT BASE | Q.S | |||||
11 | BETAMETHASONE DIPROPIONATE, CLOTRIMAZOLE, GENTAMICIN CREAM | COMPOSITION: | CREAM | EXPORT | ||
BETAMETHASONE DIPROPIONATE | B.P. | |||||
EQ. TO BETAMETHASONE | 0.1%W/W | |||||
GENTAMICIN SULFATE | B.P. | 0.1%W/W | ||||
CLOTRIMAZOLE | B.P. | 0.5%W/W | ||||
CREAM BASE | Q.S | |||||
12 | BETAMETHASONE DIPROPIONATE, CLOTRIMAZOLE, GENTAMICIN OINTMENT | COMPOSITION: | OINTMENT | EXPORT | ||
BETAMETHASONE DIPROPIONATE | B.P. | |||||
EQ. TO BETAMETHASONE | 1 MG | |||||
GENTAMICIN SULFATE | B.P. | |||||
EQ. TO GENTAMICIN | 1 MG | |||||
CLOTRIMAZOLE | B.P. | 10 MG | ||||
OINTMENT BASE | Q.S | |||||
13 | BETAMETHASONE DIPROPIONATE, GENTAMICIN SULPHATE ,TOLNAFTATE, IODOCHLORHYDROXYQUINOLINE CREAM CREAM | EACH GM CONATINS: | CREAM | EXPORT | ||
BETAMETHASONE DIPROPIONATE | U.S.P. | 0.50 MG | ||||
GENTAMICIN SULPHATE | B.P. | |||||
EQ. TO GENTAMICIN BASE | 1 MG | |||||
TOLNAFTATE | U.S.P. | 10 MG | ||||
IODOCHLORHYDROXYQUINOLINE | U.S.P. | 10 MG | ||||
CHLOROCRESOL (AS PRESERVATIVE) | B.P. | 1 MG | ||||
CREAM BASE | Q.S | |||||
14 | BETAMETHASONE VALERATE, GENTAMICIN CREAM | COMPOSITION: | CREAM | EXPORT | ||
BETAMETHASONE VALERATE | B.P. | 0.1% W/W | ||||
GENTAMYCIN SULFATE | B.P. | 0.1% W/W | ||||
CREAM BASE | Q.S | |||||
15 | BETAMETHASONE VALERATE, NEOMYCIN SULPHATE, TOLNAFTATE, IODOCHLORHYDROXQUINOLINE CREAM | EACH GM CONATINS: | CREAM | DOMESTIC | ||
BETAMETHASOMNE VALERATE | I.P. | 0.50 MG | ||||
NEOMYCIN SULPHAE | I.P. | 5 MG | ||||
TOLNAFTATE | I.P. | 10 MG | ||||
IODOCHLORHYDROXYQUINOLINE | I.P. | 10 MG | ||||
CREAM BASE | Q.S | |||||
16 | BORIC ACID, METHENAMINE, TALC, SODIUM TETRABORATE, SALICYLIC ACID, LEAD ACETATE, FORMALDEHYDE, ZINC OXIDE PASTE | COMPOSITIONS: | PASTE | EXPORT | ||
BORIC ACID | B.P. | 70 MG | ||||
METHENAMINE | B.P. | 35 MG | ||||
TALC | B.P. | 250 MG | ||||
SODIUM TETRABORATE | 70 MG | |||||
SALICYLIC ACID | B.P. | 15 MG | ||||
LEAD ACETATE | 3 MG | |||||
FORMALDEHYDE | B.P. | 35 MG | ||||
ZINC OXIDE | B.P. | 250 MG | ||||
CREAM BASE | Q.S | |||||
17 | CALAMINE, ZINC OXIDE SKIN SOLUTION | COMPOSITION: | SOLUTION | DOMESTIC | ||
CALAMINE | I.P. | 15% W/V | ||||
ZINC OXIDE | I.P. | 5% W/V | ||||
AQUEOUS BASE | Q.S | |||||
18 | CALAMINE, ZINC OXIDE SKIN LOTION | COMPOSITION: | LOTION | DOMESTIC | ||
CALAMINE | I.P. | 15 % W/V | ||||
ZINC OXIDE | I.P. | 5 % W/V | ||||
AQUEOUS BASE | ||||||
19 | CHLORHEXIDINE GLUCONATE, METRONIDAZOLE GEL | COMPOSITION: | GEL | EXPORT | ||
CHLORHEXIDINE GLUCONATE SOLUTION | B.P. | 0.25%W/W | ||||
METRONIDAZOLE BENZOATE | B.P. | |||||
EQ TO METRONIDAZOLE | 1.00%W/W | |||||
WATER SOLUBLE GEL BASE | Q.S | |||||
20 | CHLORPHENESIN, ZINC OXIDE, STARCH, MENTHOL DUSTING POWDER | COMPOSITION: | POWDER | DOMESTIC | ||
CHLORPHENESIN | I.P. | 1.0%W/W | ||||
ZINC OXIDE | I.P. | 16.0%W/W | ||||
STARCH | I.P. | 51.0%W/W | ||||
MENTHOL POWDER | I.P. | 0.3%W/W | ||||
PURIFIED TALC | Q.S | |||||
21 | CHOLINE SALICYLATE, LIGNOCAINE HYDROCHLORIDE, BENZALKONIUM CHLORIDE GEL | COMPOSITION: | GEL | EXPORT | ||
CHOLINE SALICYLATE SOLUTION | B.P. | |||||
EQ TO CHOLINE SALICYLATE | 8.7%W/W | |||||
LIGNOCAINE HYDROCHLORIDE | B.P. | 2.0 %W/W | ||||
BENZALKONIUM CHLORIDE SOLUTION | B.P. | 0.01%W/W | ||||
FLAVOURED GEL BASE | Q.S | |||||
22 | CIPROFLOXACIN HYDROCHLORIDE, FLUOCINOLONE ACETONIDE, CLOTRIMAZOLE CREAM | COMPOSITION: | CREAM | EXPORT | ||
CIPROFLOXACIN HYDROCHLORIDE | B.P. | |||||
EQ. TO CIPROFLOXACIN | 0.500%W/W | |||||
FLUOCINOLONE ACETONIDE | B.P. | 0.025%W/W | ||||
CLOTRIMAZOLE | B.P. | 1.00%W/W | ||||
CREAM BASE | Q.S | |||||
23 | CLARITHROMYCIN CREAM | COMPOSITION: | CREAM | DOMESTIC | ||
CLARITHROMYCIN | I.P. | 1.00%W/W | ||||
CREAM BASE | Q.S | |||||
24 | CLINDAMYCIN PHOSPHATE GEL | COMPOSITION: | GEL | DOMESTIC | ||
CLINDAMYCIN PHOSPHATE | I.P. | |||||
EQ. TO CLINDAMYCIN | 1%W/W | |||||
GEL BASE | Q.S | |||||
25 | CLINDAMYCIN PHOSPHATE GEL | COMPOSITION: | GEL | DOMESTIC | ||
CLINDAMYCIN PHOSPHATE | I.P. | |||||
EQ. TO CLINDAMYCIN | 1.0% W/W | |||||
PRESERVATIVE: | ||||||
SODIUM METHYL PARABEN | I.P. | 0.114% W/W | ||||
SODIUM PROPYL PARABEN | I.P. | 0.056% W/W | ||||
GEL BASE | Q.S | |||||
26 | CLINDAMYCIN PHOSPHATE, NICOTINAMIDE GEL | COMPOSITION: | GEL | DOMESTIC | ||
CLINDAMYCIN PHOSPHATE | I.P. | |||||
EQ. TO CLINDAMYCIN | 1.0%W/W | |||||
NICOTINAMIDE | I.P. | 4.0%W/W | ||||
GEL BASE | Q.S | |||||
27 | CLINDAMYCIN PHOSPHATE, NICOTINAMIDE GEL | COMPOSITION: | GEL | DOMESTIC | ||
CLINDAMYCIN PHOSPHATE | I.P. | |||||
EQ. TO CLINDAMYCIN | 1.0% W/W | |||||
NICOTINAMIDE | I.P. | 4.0% W/W | ||||
IN ALOE, ALLANTION BASE WITH ETHYL LACTATE | ||||||
GEL BASE | Q.S | |||||
28 | CLOBETASOL PROPIONATE CREAM | COMPOSITION: | CREAM | EXPORT | ||
CLOBETASOL PROPIONATE | U.S.P. | 0.05% W/W | ||||
IN CREAM BASE | Q.S | |||||
29 | CLOBETASOL PROPIONATE CREAM | COMPOSITION: | CREAM | DOMESTIC | ||
CLOBETASOL PROPIONATE | I.P. | 2.0 % W/W | ||||
PRESERVATIVES | ||||||
METHYL PARABEN | I.P. | 0.1% W/W | ||||
PROPYL PARABEN | I.P. | 0.06% W/W | ||||
CREAM BASE | Q.S | |||||
30 | CLOBETASOL PROPIONATE OINTMENT | COMPOSITION: | OINTMENT | EXPORT | ||
CLOBETASOL PROPIONATE | U.S.P. | 0.05% W/W | ||||
OINTMENT BASE | Q.S | |||||
31 | CLOBETASOL PROPIONATE AND FUSIDIC ACID CREAM | COMPOSITION: | CREAM | DOMESTIC | ||
CLOBETASOLE PROPIONATE | I.P. | 0.05% W/W | ||||
FUSIDIC ACID | I.P. | 2.0% W/W | ||||
CREAM BASE | Q.S | |||||
32 | CLOBETASOL PROPIONATE, SALICYLIC ACID OINTMENT | COMPOSITION: | OINTMENT | DOMESTIC | ||
CLOBETASOL PROPIONATE | I.P. | 0.05%W/W | ||||
SALICYLIC ACID | I.P. | 3.00%W/W | ||||
IN AN OINTMENT BASE | Q.S | |||||
33 | CLOBETASOL PROPIONATE, GENTAMICIN, TOLNAFTATE, IODOCHLORHYDROXYQUINOLINE, CLOTRIMAZOLE CREAM | COMPOSITION: | CREAM | DOMESTIC | ||
CLOBETASOL PROPIONATE | I.P. | 0.05%W/W | ||||
GENTAMICIN SULPHATE | I.P. | |||||
EQ TO GENTAMICIN | 0.1%W/W | |||||
TOLNAFTATE | I.P. | 1.0%W/W | ||||
IODOCHLORHYDROXYQUINOLINE | I.P. | 1.0%W/W | ||||
CLOTRIMAZOLE | I.P. | 1.0%W/W | ||||
CHLOROCRESOL (PRESERVATIVE) | I.P. | 0.1%W/W | ||||
CREAM BASE | Q.S | |||||
34 | CLOBETASOL PROPIONATE, NEOMYCIN SULPHATE CREAM | COMPOSITION: | CREAM | DOMESTIC | ||
CLOBETASOL PROPIONATE | I.P. | 0.05%W/W | ||||
NEOMYCIN SULPHATE | I.P. | |||||
EQ TO NEOMYCIN BASE | 0.50%W/W | |||||
CHLOROCRESOL (AS PRESERVATIVE) | I.P. | 0.10%W/W | ||||
CREAM BASE | Q.S | |||||
35 | CLOBETASOL PROPIONATE, NEOMYCIN SULPHATE, CLOTRIMAZOLE CREAM | COMPOSITION: | CREAM | DOMESTIC | ||
CLOBETASOL PROPIONATE | I.P. | 0.05%W/W | ||||
CLOTRIMAZOLE | I.P. | 1.00%W/W | ||||
NEOMYCIN SULPHATE | I.P. | |||||
EQ TO NEOMYCIN BASE | 0.50%W/W | |||||
CHLOROCRESOL | I.P. | 0.10%W/W | ||||
(AS PRESERVATIVE) | ||||||
CREAM BASE | Q.S | |||||
36 | CLOBETASOL PROPIONATE, NEOMYCIN SULPHATE, MICONAZOLE CREAM | COMPOSITION: | CREAM | DOMESTIC | ||
CLOBETASOL PROPIONATE | I.P. | 0.05%W/W | ||||
NEOMYCIN SULPHATE | I.P. | |||||
EQ TO NEOMYCIN BASE | 0.50%W/W | |||||
MICONAZOLE NITRATE | I.P. | 2.0%W/W | ||||
CHLOROCRESOL | I.P. | 0.10%W/W | ||||
CREAM BASE | Q.S | |||||
37 | CLOBETASONE 17-BUTYRATE, GENTAMICIN SULPHATE CREAM | COMPOSITION: | CREAM | DOMESTIC | ||
CLOBETASONE 17-BUTYRATE | I.P. | 0.050%W/W | ||||
GENTAMICIN SULPHATE | I.P. | |||||
EQ. TO GENTAMICIN BASE | 0.100%W/W | |||||
CREAM BASE | Q.S | |||||
38 | CLOTRIMAZOLE CREAM | COMPOSITION: | CREAM | EXPORT | ||
CLOTRIMAZOLE | B.P. | 1.0%W/W | ||||
CREAM BASE | Q.S | |||||
39 | CLOTRIMAZOLE LOTION | COMPOSITION: | LOTION | DOMESTIC | ||
CLOTRIMAZOLE | I.P. | 1.0%W/W | ||||
NON AQUEOUS BASE | Q.S | |||||
40 | CLOTRIMAZOLE VAGINAL GEL | COMPOSITION: | GEL | DOMESTIC | ||
CLOTRIMAZOLE | I.P. | 2.0%W/W | ||||
BENZYL ALCOHOL | I.P. | 2.0%W/W | ||||
CHLOROCRESOL | I.P. | 0.10 %W/W | ||||
GEL BASE | Q.S | |||||
41 | CLOTRIMAZOLE, BECLOMETHASONE CREAM | COMPOSITION: | CREAM | DOMESTIC | ||
CLOTRIMAZOLE | I.P. | 1.0% W/W | ||||
BECLOMETHASONE DIPROPIONATE | I.P. | 0.025%W/W | ||||
CREAM BASE | Q.S | |||||
42 | CLOTRIMAZOLE, BECLOMETHASONE DIPROPIONATE, GENTAMYCIN SULPHATE OINTMENT | COMPOSITION: | OINTMENT | EXPORT | ||
CLOTRIMAZOLE | B.P. | 1.00%W/W | ||||
BECLOMETHASONE DIPROPIONATE | B.P. | 0.050%W/W | ||||
GENTAMYCIN SULPHATE | B.P. | |||||
EQ. TO GENTAMYCIN | 0.100%W/W | |||||
OINTMENT BASE | Q.S | |||||
43 | DEXAMETHASONE SODIUM PHOSPHATE, NEOMYCIN SULPHATE CREAM | EACH GM CONTAINS: | CREAM | EXPORT | ||
DEXAMETHASONE SODIUM PHOSPHATE | U.S.P. | |||||
EQ. TO DEXAMETHASONE PHOSPHATE | 1 MG | |||||
NEOMYCIN SULPHATE | U.S.P. | |||||
EQ TO NEOMYCIN | 3500 I.U | |||||
CREAM BASE | Q.S | |||||
44 | DEXAMETHASONE SODIUM PHOSPHATE, NEOMYCIN SULPHATE OINTMENT | EACH GM CONTAINS: | OINTMENT | EXPORT | ||
DEXAMETHASONE SODIUM PHOSPHATE | U.S.P. | |||||
EQ. TO DEXAMETHASONE PHOSPHATE | 1 MG | |||||
NEOMYCIN SULPHATE | U.S.P. | |||||
EQ. TO NEOMYCIN | 3500 I.U | |||||
OINTMENT BASE | Q.S | |||||
45 | DEXAMETHASONE, NEOMYCIN SULPHATE OINTMENT | EACH GM CONTAINS: | OINTMENT | EXPORT | ||
DEXAMETHASONE | B.P. | 1 MG | ||||
NEOMYCIN SULPHATE | B.P. | 3.5 MG | ||||
OINTMENT BASE | Q.S | |||||
46 | DEXPANTHENOL OINTMENT | COMPOSITION: | OINTMENT | EXPORT | ||
DEXPANTHENOL | B.P. | 5%W/W | ||||
OINTMENT BASE | Q.S | |||||
47 | DICLOFENAC GEL | COMPOSITION: | GEL | EXPORT | ||
DICLOFENAC DIETHYLAMINE | B.P. | 1.16% W/W | ||||
EQ TO DICLOFENAC SODIUM | 1.000%W/W | |||||
GEL BASE | Q.S | |||||
48 | DICLOFENAC GEL | COMPOSITION: | GEL | DOMESTIC | ||
DICLOFENAC DIETHYLAMINE | I.P. | 1.16% W/W | ||||
EQ. TO DICLOFENAC SODIUM | 1.00% W/W | |||||
BENZYL ALCOHOL | I.P. | 1.00% W/W | ||||
(AS PRESERVATIVE) | ||||||
GEL BASE | Q. S | |||||
49 | DICLOFENAC DIETHYLAMINE, BENZYL ALCOHOL GEL | COMPOSITION: | GEL | EXPORT | ||
DICLOFENAC DIETHYLAMINE | B.P. | 1.16%W/W | ||||
EQ TO DICLOFENAC SODIUM | 1.00%W/W | |||||
BENZYL ALCOHOL (AS PRESERVATIVE) | B.P. | 1.0%W/W | ||||
GEL BASE | Q.S | |||||
50 | DICLOFENAC DIETHYLAMINE, OLIUM LINI, MENTHOL, METHYL SALICYLATE, BENZYL ALCOHOL GEL | COMPOSITION: | GEL | EXPORT | ||
DICLOFENAC DIETHYLAMINE | B.P. | 1.16%W/W | ||||
EQ TO DICLOFENAC SODIUM | 1.0%W/W | |||||
OLEUM LINI (CONT. PREDOMINANTLY a-LINOLENIC ACID) | B.P. | 3.00%W/W | ||||
METHYL SALICYLATE | B.P. | 10.0 %W/W | ||||
MENTHOL | B.P. | 5.0% W/W | ||||
BENZYL ALCOHOL (AS PERSERVATIVE) | B.P. | 1.0%W/W | ||||
GEL BASE | Q.S | |||||
51 | DICLOFENAC DIETHYLAMINE, OLIUM LINI,MENTHOL , METHYL SALICYLATE, BENZYL ALCOHOL GEL | EACH GRAM CONTAINS: | GEL | EXPORT | ||
DICLOFENAC DIETHYLAMINE | B.P. | |||||
EQ TO DICLOFENAC SODIUM | 3.0%W/W | |||||
OLEUM LINI (CONT. PREDOMINANTLY a-LINOLENIC ACID) | B.P. | 3.00%W/W | ||||
METHYL SALICYLATE | B.P. | 10.0 %W/W | ||||
MENTHOL | B.P. | 5.0% W/W | ||||
BENZYL ALCOHOL (AS PERSERVATIVE) | B.P. | 1.0%W/W | ||||
GEL BASE | Q.S | |||||
52 | DICLOFENAC DIETHYLAMINE, LINSEED OIL, MENTHOL, METHYL SALICYLATE GEL | COMPOSITION: | GEL | DOMESTIC | ||
DICLOFENAC DIETHYLAMINE | I.P. | 1.16% W/W | ||||
EQ. TO DICLOFENAC SODIUM | 1.00% W/W | |||||
LINSEED OIL | B.P. | 3.000 % W/W | ||||
MENTHOL | I.P. | 0.50%W/W | ||||
METHYL SALICYLATE | I.P. | 10.000%W/W | ||||
GEL BASE | Q. S | |||||
53 | DICLOFENAC DIETHYLAMINE, LINSEED OIL, MENTHOL, METHYL SALICYLATE GEL | COMPOSITION: | GEL | EXPORT | ||
DICLOFENAC DIETHYLAMINE | B.P. | |||||
EQ. TO DICLOFENAC SODIUM | 3.00% W/W | |||||
LINSEED OIL | B.P. | 3.000 % W/W | ||||
(CONT. PREDOMINANTLY a-LINOLENIC ACID) | ||||||
METHYL SALICYLATE | B.P. | 10.000%W/W | ||||
MENTHOL | B.P. | 5.000%W/W | ||||
BENZYL ALCOHOL (AS PRESERVATIVE) | B.P. | 1.000%W/W | ||||
GEL BASE | Q. S | |||||
54 | DICLOFENAC DIETHYLAMINE, LINSEED OIL, MENTHOL, METHYL SALICYLATE, BENZYL ALCOHOL GEL | COMPOSITION: | GEL | DOMESTIC | ||
DICLOFENAC DIETHYLAMINE | I.P. | 2.30%W/W | ||||
EQ. TO DICLOFENAC SODIUM | 2.00%W/W | |||||
LINSEED OIL | B.P. | 3.00%W/W | ||||
MENTHOL | I.P. | 5.00%W/W | ||||
METHYL SALICYLATE | I.P. | 10.000%W/W | ||||
BENZYL ALCOHOL | I.P. | 1.0% W/W | ||||
GEL BASE | Q. S | |||||
55 | DICLOFENAC DIETHYLAMINE, LINSEED OIL,MENTHOL , METHYL SALICYLATE, BENZYL ALCOHOL GEL | COMPOSITION: | GEL | DOMESTIC | ||
DICLOFENAC DIETHYLAMINE | I.P. | 1.16% W/W | ||||
EQ. TO DICLOFENAC SODIUM | 1.00% W/W | |||||
LINSEED OIL | B.P. | 3.00%W/W | ||||
MENTHOL | I.P. | 5.00%W/W | ||||
METHYL SALICYLATE | I.P. | 10.000%W/W | ||||
BENZYL ALCOHOL | I.P. | 1.0% W/W | ||||
GEL BASE | Q. S | |||||
56 | DICLOFENAC DIETHYLAMINE, LINSEED OIL,MENTHOL , METHYL SALICYLATE, CAPSAICIN GEL | COMPOSITION: | GEL | DOMESTIC | ||
DICLOFENAC DIETHYLAMINE | I.P. | 1.16% W/W | ||||
EQ. TO DICLOFENAC SODIUM | 1.00% W/W | |||||
LINSEED OIL | B.P. | 3.00%W/W | ||||
MENTHOL | I.P. | 5.00%W/W | ||||
METHYL SALICYLATE | I.P. | 10.000%W/W | ||||
CAPSAICIN | USP | 0.025%W/W | ||||
GEL BASE | Q. S | |||||
57 | DICLOFENAC DIETHYLAMINE, MENTHOL, METHYL SALICYLATE GEL | COMPOSITION: | GEL | DOMESTIC | ||
DICLOFENAC DIETHYLAMINE | I.P. | 1.16% W/W | ||||
EQ. TO DICLOFENAC SODIUM | 1.00% W/W | |||||
MENTHOL | I.P. | 5.00%W/W | ||||
METHYL SALICYLATE | I.P. | 10.000%W/W | ||||
GEL BASE | Q. S | |||||
58 | EBERCONAZOLE NITRATE CREAM | COMPOSITION: | CREAM | DOMESTIC | ||
EBERCONAZOLE NITRATE | I.P. | |||||
EQ.TO EBERCONAZOLE | 1.00%W/W | |||||
CREAM BASE | Q.S | |||||
59 | FLUCONAZOLE CREAM | COMPOSITION: | CREAM | DOMESTIC | ||
FLUCONAZOLE | I.P. | 2.0% W/W | ||||
CREAM BASE | Q.S | |||||
60 | FLUOCINOLONE ACETONIDE OINTMENTS | COMPOSITION: | OINTMENT | EXPORT | ||
FLUOCINOLONE ACETONIDE | B.P. | 0.025% W/W | ||||
OINTMENT BASE | Q.S | |||||
61 | FLUOCINOLONE ACETONIDE, MICONAZOLE NITRATE CREAM | COMPOSITION: | CREAM | DOMESTIC | ||
FLUOCINOLONE ACETONIDE | I.P. | 0.01% W/W | ||||
MICONAZOLE NITRATE | I.P. | 2.0%W/W | ||||
CREAM BASE | Q. S | |||||
62 | FLUTICASONE PROPIONATE CREAM | COMPOSITION: | CREAM | EXPORT | ||
FLUTICASONE PROPIONATE | U.S.P. | 0.05% W/W | ||||
CREAM BASE | Q.S | |||||
63 | FUSIDIC ACID OINTMENT | EACH GM CONTAINS: | OINTMENT | DOMESTIC | ||
FUSIDIC ACID | I.P. | 20 MG | ||||
IN OINTMENT BASE | Q.S | |||||
64 | FUSIDIC ACID CREAM | EACH GM CONTAINS: | CREAM | DOMESTIC | ||
FUSIDIC ACID | I.P. | 20 MG | ||||
CREAM BASE | Q.S | |||||
65 | GAMMABENZENE HEXACHLORIDE LOTION | COMPOSITION: | LOTION | DOMESTIC | ||
GAMMABENZENE HEXACHLORIDE | I.P. | 1.0 % W/V | ||||
IN AQUEOUS BASE | Q. S | |||||
66 | GAMMABENZENE HEXACHLORIDE, CETRIMIDE LOTION | COMPOSITION: | LOTION | DOMESTIC | ||
GAMMABENZENE HEXACHLORIDE | I.P. | 1.0 % W/V | ||||
CETRIMIDE | I.P. | 0.06%W/V | ||||
IN EMULSION BASE | Q. S | |||||
67 | GAMMABENZENE HEXACHLORIDE, CETRIMIDE LOTION | COMPOSITION: | LOTION | DOMESTIC | ||
GAMMABENZENE HEXACHLORIDE | I.P. | 1.0% W/V | ||||
CETRIMIDE | I.P. | 0.1% W/V | ||||
IN EMULSION BASE | Q. S | |||||
68 | HALOBETASOLE PROPIONATE CREAM | COMPOSITION: | CREAM | DOMESTIC | ||
HALOBETASOL PROPIONATE | B.P. | 0.05% W/W | ||||
CREAM BASE | Q.S | |||||
69 | HALOBETASOLE PROPIONATE, SALICYLIC ACID OINTMENT | COMPOSITION: | OINTMENT | DOMESTIC | ||
HALOBETASOL PROPIONATE | U.S.P. | 0.050%W/W | ||||
SALICYLIC ACID | I.P. | 2.0%W/W | ||||
IN OINTMENT BASE | Q.S | |||||
70 | HALOBETASOLE PROPIONATE, SALICYLIC ACID OINTMENT | COMPOSITION: | OINTMENT | DOMESTIC | ||
HALOBETASOL PROPIONATE | U.S.P. | 0.050%W/W | ||||
SALICYLIC ACID | I.P. | 6.0%W/W | ||||
IN OINTMENT BASE | Q.S | |||||
71 | HALOBETASOLE PROPIONATE, CLOTRIMAZOLE CREAM | COMPOSITION: | CREAM | DOMESTIC | ||
HALOBETASOL PROPIONATE | U.S.P. | 0.050%W/W | ||||
CLOTRIMAZOLE | I.P. | 1.0%W/W | ||||
CREAM BASE | Q.S | |||||
72 | HYDROCORTISONE 1 % W/W CREAM | COMPOSITION: | CREAM | DOMESTIC | ||
HYDROCORTISONE | I.P. | 1.0% W/W | ||||
CREAM BASE | Q.S | |||||
73 | HYDROQUINONE ,TRETINOIN, MOMETASONE FUROATE CREAM | COMPOSITION: | CREAM | DOMESTIC | ||
HYDROQUINONE | I.P. | 2.000% W/W | ||||
TRETINOIN | I.P. | 0.025% W/W | ||||
MOMETASONE FUROATE | I.P. | 0.100% W/W | ||||
CREAM BASE | Q.S | |||||
74 | HYDROQUINONE ,TRETINOIN, MOMETASONE FUROATE CREAM | COMPOSITION: | CREAM | EXPORT | ||
HYDROQUINONE | U.S.P. | 2.000% W/W | ||||
TRETINOIN | U.S.P. | 0.025%W/W | ||||
MOMETASONE FUROATE | U.S.P. | 0.100% W/W | ||||
CREAM BASE | Q.S | |||||
75 | IBUPROFEN, MENTHOL, METHYL SALICYLATE, MEPHENESIN GEL | COMPOSITION: | GEL | EXPORT | ||
IBUPROFEN | B.P. | 5.0%W/W | ||||
MENTHOL | U.S.P. | 0.5%W/W | ||||
METHYL SALICYLATE | B.P. | 0.5%W/W | ||||
MEPHENESIN | B.P. | 5.0% W/W | ||||
IN GEL BASE | Q.S | |||||
76 | ITRACONAZOLE GEL 1% W/W | COMPOSITION: | GEL | DOMESTIC | ||
ITRACONAZOLE | B.P. | 1.00% W/W | ||||
METHYL PARABEN | I.P. | 0.10% W/W | ||||
PROPYL PARABEN | I.P. | 0.05% W/W | ||||
IN A GEL BASE | Q. S | |||||
77 | ITRACONAZOLE, OFLOXACIN, ORNIDAZOLE, CLOBETASOL PROPIONATE CREAM | COMPOSITION: | CREAM | DOMESTIC | ||
ITRACONAZOLE | B.P. | 1.00 % W/W | ||||
OFLOXACIN | I.P. | 0.75 % W/W | ||||
ORNIDAZOLE | I.P. | 2.00 % W/W | ||||
CLOBETASOL PROPIONATE | I.P. | 0.05 % W/W | ||||
METHYL PARABEN (AS PRESERVATIVE) | I.P. | 0.20 % W/W | ||||
PROPYL PARABEN (AS PRESERVATIVE) | I.P. | 0.02 % W/W | ||||
IN A CREAM BASE | Q.S | |||||
78 | IVERMECTIN CREAM | COMPOSITION: | CREAM | DOMESTIC | ||
IVERMECTIN | I.P. | 1.00%W/W | ||||
CREAM BASE | Q. S | |||||
79 | IVERMECTIN SHAMPOO | COMPOSITION: | SHAMPOO | DOMESTIC | ||
IVERMECTIN | I.P. | 0.50%W/V | ||||
AQUEOUS BASE | Q. S | |||||
APPROVED COLOUR USED | ||||||
80 | KETOCONAZOLE SHAMPOO | COMPOSITION: | SHAMPOO | DOMESTIC | ||
KETOCONAZOLE | I.P. | 2.00%W/V | ||||
SHAMPOO BASE | Q.S | |||||
APPROVED COLOUR USED | ||||||
81 | KETOCONAZOLE CREAM | COMPOSITION: | CREAM | DOMESTIC | ||
KETOCONAZOLE | I.P. | 2.00%W/W | ||||
CREAM BASE | Q.S | |||||
82 | KETOCONAZOLE, CLOBETASOLE PROPIONATE, NEOMYCIN CREAM | EACH GM CONTAINS: | CREAM | EXPORT | ||
KETOCONAZOLE | B.P. | 10 MG | ||||
CLOBETASOL PROPIONATE | B.P. | 0.25 MG | ||||
NEOMYCIN SULPHATE | B.P. | |||||
EQ TO NEOMYCIN BASE | 5000 IU | |||||
CREAM BASE | Q.S | |||||
83 | KETOCONAZOLE, IODOCHLORHYDROXYQUINOLINE, TOLNAFTATE, NEOMYCIN SULPHATE, CLOBETASOL PROPIONATE CREAM | COMPOSITION: | CREAM | DOMESTIC | ||
KETOCONAZOLE | I.P. | 2.00%W/W | ||||
IODOCHLORHYDROXYQUINOLINE | I.P. | 1.00%W/W | ||||
TOLNAFTATE | I.P. | 1.00%W/W | ||||
NEOMYCIN SULPHATE | I.P. | |||||
EQ. TO NEOMYCIN | 0.10%W/W | |||||
CLOBETASOL PROPIONATE | I.P. | 0.05%W/W | ||||
CREAM BASE | Q.S | |||||
84 | KETOCONAZOLE, ZINC PYRITHIONE SHAMPOO | COMPOSITION: | SHAMPOO | DOMESTIC | ||
KETOCONAZOLE | I.P. | 2.0%W/V | ||||
ZINC PYRITHIONE (ZPTO) | I.P. | 1.0%W/V | ||||
AQUEOUS BASE | Q.S | |||||
APPROVED COLOUR USED | ||||||
85 | KETOCONAZOLE, BECLOMETHASONE DIPROPIONATE CREAM | COMPOSITION: | CREAM | DOMESTIC | ||
KETOCONAZOLE | I.P. | 2.0%W/W | ||||
BECLOMETHASONE DIPROPIONATE | I.P. | 0.025%W/W | ||||
IN CREAM BASE | Q.S | |||||
86 | KETOPROFEN GEL | COMPOSITION: | GEL | EXPORT | ||
KETOPROFEN | B.P. | 2.5%W/W | ||||
GEL BASE | Q.S | |||||
87 | LIGNOCAINE HYDROCHLORIDE GEL | COMPOSITION: | GEL | DOMESTIC | ||
LIGNOCAINE HYDROCHLORIDE | I.P. | 2.00%W/W | ||||
METHYL PARABEN | I.P. | 0.061%W/W | ||||
PROPYL PARABEN | I.P. | 0.027%W/W | ||||
IN A WATER SOLUBLE GEL BASE | Q.S | |||||
88 | LULICONAZOLE LOTION | COMPOSITION: | LOTION | DOMESTIC | ||
LULICONAZOLE | I.P. | 1.0%W/W | ||||
NON AQUEOUS BASE | Q.S | |||||
89 | LULICONAZOLE CREAM 1%W/W | COMPOSITION: | CREAM | DOMESTIC | ||
LULICONAZOLE | I.P. | 1.0%W/W | ||||
BENZYL ALCOHOL (AS PRESERVATIVE) | I.P. | 1.0% W/W | ||||
CREAM BASE | Q.S | |||||
90 | LULICONAZOLE, CLOBETASOLE PROPIONATE CREAM | COMPOSITION: | CREAM | DOMESTIC | ||
LULICONAZOLE | I.P. | 1.0%W/W | ||||
CLOBETASOL PROPIONATE | I.P. | 0.05%W/W | ||||
CREAM BASE | Q.S | |||||
91 | MOMETASONE FUROATE CREAM | COMPOSITION: | CREAM | DOMESTIC | ||
MOMETASONE FUROATE | I.P. | 0.10%W/W | ||||
PRESERVATIVES | ||||||
METHYL PARABEN | I.P. | 0.20%W/W | ||||
PROPYL PARABEN | I.P. | 0.02%W/W | ||||
CREAM BASE | Q.S | |||||
92 | MOMETASONE FUROATE CREAM | COMPOSITION: | CREAM | DOMESTIC | ||
MOMETASONE FUROATE | I.P. | 0.10%W/W | ||||
CREAM BASE | Q.S | |||||
93 | MOMETASONE FUROATE, FUSIDIC ACID CREAM | COMPOSITION: | CREAM | DOMESTIC | ||
MOMETASONE FUROATE | I.P. | 0.1%W/W | ||||
FUSIDIC ACID | I.P. | 2.0%W/W | ||||
IN CREAM BASE | Q.S | |||||
94 | MOMETASONE FUROATE, SALICYLIC ACID CREAM | COMPOSITION: | CREAM | DOMESTIC | ||
MOMETASONE FUROATE | I.P. | 0.1%W/W | ||||
SALICYCLIC ACID | I.P. | 5.0%W/W | ||||
CREAM BASE | Q.S | |||||
95 | MOMETASONE FUROATE, TERBINAFINE HYDROCHLORIDE CREAM | COMPOSITION: | CREAM | DOMESTIC | ||
MOMETASONE FUROATE | I.P. | 0.10% W/W | ||||
TERBINAFINE HYDROCHLORIDE | I.P. | 1.00% W/W | ||||
IN A CREAM BASE | Q.S | |||||
96 | MUPIROCIN OINTMENT | COMPOSITION: | OINTMENT | DOMESTIC | ||
MUPIROCIN | I.P. | 2.0% W/W | ||||
OINTMENT BASE | Q.S | |||||
97 | MUPIROCIN OINTMENT | COMPOSITION: | OINTMENT | EXPORT | ||
MUPIROCIN | U.S.P. | 2.0% W/W | ||||
OINTMENT BASE | Q.S | |||||
98 | NADIFLOXACIN CREAM | COMPOSITION: | CREAM | EXPORT | ||
NADIFLOXACIN | 1.00%W/W | |||||
IN A CREAM BASE | Q.S | |||||
99 | NEOMYCIN SULPHATE, FLUOCINOLONE ACETONIDE OINTMENT | COMPOSITION: | OINTMENT | EXPORT | ||
NEOMYCIN SULPHATE | B.P. | |||||
EQ TO NEOMYCIN | 0.50%W/W | |||||
FLUOCINOLONE ACETONIDE | B.P. | 0.025%W/W | ||||
OINTMENT BASE | Q.S | |||||
100 | NEOMYCIN SULPHATE, CLOBETASOL PROPIONATE, MICONAZOLE CREAM | COMPOSITION: | CREAM | DOMESTIC | ||
NEOMYCIN SULPHATE | I.P. | 0.50%W/W | ||||
CLOBETASOL PROPIONATE | I.P. | 0.05% W/W | ||||
MICONAZOLE NITRATE | I.P. | 2.00% W/W | ||||
CREAM BASE | Q.S | |||||
101 | NIFEDIPINE, LIDOCAINE HYDROCHLORIDE CREAM | COMPOSITION: | CREAM | DOMESTIC | ||
NIFEDIPINE | I.P. | 0.30% W/W | ||||
LIDOCAINE HYDROCHLORIDE | I.P. | 1.50% W/W | ||||
IN CREAM BASE | Q. S | |||||
102 | OFLOXACIN, ORNIDAZOLE, TERBINAFINE HYDROCHLORIDE, CLOBETASOL PROPIONATE CREAM | COMPOSITION: | CREAM | EXPORT | ||
OFLOXACIN | B.P. | 0.75% W/W | ||||
ORNIDAZOLE | B.P. | 2.0% W/W | ||||
TERBINAFINE HYDROCHLORIDE | B.P. | 1.0% W/W | ||||
CLOBETASOL PROPIONATE | U.S.P. | 1.0% W/W | ||||
PRESERVATIVES | ||||||
METHYL PARABEN | B.P. | 0.20%W/W | ||||
PROPYL PARABEN | B.P. | 0.02%W/W | ||||
CREAM BASE | Q.S | |||||
103 | OFLOXACIN, ORNIDAZOLE, TERBINAFINE HYDROCHLORIDE, CLOBETASOL PROPIONATE CREAM | COMPOSITION: | CREAM | EXPORT | ||
OFLOXACIN | B.P. | 0.75% W/W | ||||
ORNIDAZOLE | B.P. | 2.0% W/W | ||||
TERBINAFINE HYDROCHLORIDE | B.P. | 1.0% W/W | ||||
CLOBETASOL PROPIONATE | U.S.P. | 0.05% W/W | ||||
PRESERVATIVES | ||||||
METHYL PARABEN | B.P. | 0.20%W/W | ||||
PROPYL PARABEN | B.P. | 0.02%W/W | ||||
CREAM BASE | Q.S | |||||
104 | OFLOXACIN, TERBINAFINE HYDROCHLORIDE, ORNIDAZOLE, BECLOMETHASONE DIPROPIONATE CREAM | COMPOSITION: | CREAM | DOMESTIC | ||
OFLOXACIN | I.P. | 0.75 % W/W | ||||
ORNIDAZOLE | I.P. | 2.00 %W/W | ||||
TERBINAFINE HYDROCHLORIDE | I.P. | |||||
EQ. TO TERBINAFINE | 1.00 % W/W | |||||
BECLOMETHASONE DIPROPIONATE | I.P. | 0.025 % W/W | ||||
METHYL PARABEN (AS PRESERVATIVE) | I.P. | 0.20 % W/W | ||||
PROPYL PARABEN (AS PRESERVATIVE) | I.P. | 0.02 % W/W | ||||
IN A NON GRESY BASE | Q.S | |||||
105 | ORNIDAZOLE, POVIDONE IODINE OINTMENT | COMPOSITION: | OINTMENT | DOMESTIC | ||
POVIDONE IODINE | I.P. | 5.0 %W/W | ||||
(0.5%W/W AVAILABLE IODINE) | ||||||
ORNIDAZOLE | I.P. | 1.0 %W/W | ||||
WATER SOLUBLE OINTMENT BASE | Q. S | |||||
106 | PERMETHRIN CREAM | EACH GM OF CREAM CONTAINS: | CREAM | DOMESTIC | ||
PERMETHRIN | I.P. | 50 MG | ||||
CREAM BASE | Q. S | |||||
107 | PERMETHRIN LOTION | COMPOSITION: | LOTION | DOMESTIC | ||
PERMETHRIN | I.P. | 5 % W/V | ||||
LOTION BASE | Q. S | |||||
108 | POVIDONE IODINE OINTMENT | COMPOSITION: | OINTMENT | EXPORT | ||
POVIDONE IODINE | U.S.P. | 5 % W/W | ||||
AVAILABLE IODINE | 0.5 % W/W | |||||
WATER SOLUBLE BASE | ||||||
109 | POVIDONE IODINE OINTMENT | COMPOSITION: | OINTMENT | DOMESTIC | ||
POVIDONE IODINE (0.5%W/W AVAILABLE IODINE) | I.P. | 5% W/W | ||||
OINTMENT BASE | Q. S | |||||
110 | POVIDONE IODINE OINTMENT | COMPOSITION: | OINTMENT | DOMESTIC | ||
POVIDONE IODINE (1.0 %W/W AVAILABLE IODINE) | I.P. | 10.0 % W/W | ||||
WATER WASHABLE BASE | Q. S | |||||
111 | POVIDONE IODINE OINTMENT | COMPOSITION: | OINTMENT | EXPORT | ||
POVIDONE IODINE | U.S.P. | 10 %W/W | ||||
AVAILABLE IODINE | 1.0%W/W | |||||
WATER SOLUBLE BASE | ||||||
112 | POVIDONE IODINE, SUCRALFATE OINTMENT | COMPOSITION: | OINTMENT | DOMESTIC | ||
POVIDONE IODINE | I.P. | 5.00% W/W | ||||
(AVAILABLE IODINE) | 0.50% W/W | |||||
SUCRALFATE | I.P. | 7.0% W/W | ||||
WATER SOLUBLE OINTMENT BASE | Q. S | |||||
113 | RACEMIC MENTHOL, PROCAINE HYDROCHLORIDE, BENZOCAINE OINTMENT | EACH GM CONTAINS: | OINTMENT | EXPORT | ||
RACEMIC MENTHOL | B.P. | 25 MG | ||||
PROCAINE HYDROCHLORIDE | B.P. | 10 MG | ||||
BENZOCAINE | B.P. | 10 MG | ||||
OINTMENT BASE | Q. S | |||||
114 | SALICYLIC ACID OINTMENT | COMPOSITION | OINTMENT | DOMESTIC | ||
SALICYLIC ACID | I.P. | 12.0% W/W | ||||
OINTMENT BASE | Q.S | |||||
115 | SALICYLIC ACID FOAMING FACE WASH | COMPOSITION: | FACE WASH | DOMESTIC | ||
SALICYLIC ACID | I.P. | 1.0% W/W | ||||
IN A AQUEOUS BASE | Q. S | |||||
116 | SERTACONAZOLE NITRATE CREAM | COMPOSITION: | CREAM | DOMESTIC | ||
SERTACONAZOLE NITRATE | I.P. | 2.0 % W/W | ||||
PRESERVATIVE | ||||||
BENZYL ALCOHOL | I.P. | 1.0% W/W | ||||
CREAM BASE | Q. S | |||||
117 | SILVER SULFADIAZINE, CHLORHEXADINE GLUCONATE CREAM | COMPOSITION: | CREAM | EXPORT | ||
SILVER SULFADIAZINE | U.S.P. | 1.0 W/W | ||||
CHLORHEXADINE GLUCONATE SOLUTION | U.S.P. | |||||
EQ TO CHLORHEXADINE GLUCONATE | 0.20%W/W | |||||
CREAM BASE | Q.S | |||||
118 | SILVER SULFADIAZINE, CHLORHEXADINE GLUCONATE OINTMENT | COMPOSITION: | OINTMENT | EXPORT | ||
SILVER SULFADIAZINE | U.S.P. | 1.0 % W/W | ||||
CHLORHEXADINE GLUCONATE SOLUTION | U.S.P. | |||||
EQ. TO CHLORHEXADINE GLUCONATE | 0.20 % W/W | |||||
OINTMENT BASE | Q.S | |||||
119 | SILVER SULFADIAZINE, LIGNOCAINE HYDROCHLORIDE, CHLORHEXIDINE GLUCONATE CREAM | COMPOSITION: | CREAM | DOMESTIC | ||
SILVER SULFADIAZINE | I.P. | 1.00 % W/W | ||||
LIGNOCAINE HYDROCHLORIDE | I.P. | 2.00 % W/W | ||||
CHLORHEXIDINE GLUCONATE SOLUTION | I.P. | |||||
EQ. TO CHLORHEXIDINE GLUCONATE | 0.20 % W/W | |||||
CREAM BASE | Q. S | |||||
120 | SODIUM FUSIDATE OINTMENT | EACH GM CONTAINS: | OINTMENT | DOMESTIC | ||
SODIUM FUSIDATE | I.P. | 20 MG | ||||
OINTMENT BASE | Q.S | |||||
121 | SUCRALFATE, METRONIDAZOLE, POVIDONE IODINE OINTMENT | COMPOSITION: | OINTMENT | DOMESTIC | ||
SUCRALFATE | U.S.P. | 7.0%W/W | ||||
METRONIDAZOLE | I.P. | 1.00%W/W | ||||
POVIDONE IODINE (AVIALABLE IODINE 0.50%W/W) | I.P. | 5.0%W/W | ||||
IN OINTMENT BASE | Q. S | |||||
122 | SUCRALFATE, METRONIDAZOLE, LIGNOCAINE HYDROCHORIDE CREAM | COMPOSITION: | CREAM | DOMESTIC | ||
SUCRALFATE | I.P. | 7.0%W/W | ||||
METRONIDAZOLE | I.P. | 1.00%W/W | ||||
LIGNOCAINE HYDROCHLORIDE | I.P. | 4.0%W/W | ||||
CREAM BASE | Q. S | |||||
123 | TACROLIMUS OINTMENT | COMPOSITION: | OINTMENT | DOMESTIC | ||
TACROLIMUS | I.P. | 0.01 % W/W | ||||
OINTMENT BASE | Q. S | |||||
124 | TACROLIMUS OINTMENT | COMPOSITION: | OINTMENT | DOMESTIC | ||
TACROLIMUS | I.P. | 0.03 % W/W | ||||
OINTMENT BASE | Q. S | |||||
125 | TERBINAFINE HYDROCHLORIDE CREAM | COMPOSITION: | CREAM | EXPORT | ||
TERBINAFINE HYDROCHLORIDE | B.P. | 1.00%W/W | ||||
CREAM BASE | Q.S | |||||
126 | TERBINAFINE HYDROCHLORIDE CREAM | COMPOSITION: | CREAM | DOMESTIC | ||
TERBINAFINE HYDROCHLORIDE | I.P. | 1.0%W/W | ||||
BENZYL ALCOHOL (AS PRESERVATIVE) | I.P. | 1.0%W/W | ||||
CREAM BASE | Q.S | |||||
127 | TERBINAFINE HYDROCHLORIDE, CHLORHEXIDINE GLUCONATE, SALICYLIC ACID LOTION | COMPOSITION: | LOTION | DOMESTIC | ||
TERBINAFINE HYDROCHLORIDE | I.P. | 1.00%W/V | ||||
CHLORHEXIDINE GLUCONATE SOLUTION | I.P. | 0.20%W/V | ||||
SALICYLIC ACID | I.P. | 5.00%W/V | ||||
IN A NON AQUEOUS BASE | Q.S | |||||
128 | THYMOL, MENTHOL, ICHTHAMMOL, LIGNOCAINE HCl OINTMENT | COMPOSITION: | OINTMENT | DOMESTIC | ||
THYMOL | I.P. | 0.50%W/W | ||||
MENTHOL | I.P. | 0.20%W/W | ||||
ICHTHAMMOL | B.P. | 1.00%W/W | ||||
LIGNOCAINE HYDROCHLORIDE | I.P. | 1.00%W/W | ||||
IN OINTMENT BASE | Q. S | |||||
129 | THYMOL, MENTHOL, ICHTHAMMOL, LIGNOCAINE HCl OINTMENT | COMPOSITION: | OINTMENT | DOMESTIC | ||
THYMOL | I.P. | 0.50%W/W | ||||
MENTHOL | I.P. | 1.00%W/W | ||||
ICHTHAMMOL | B.P. | 0.20%W/W | ||||
LIGNOCAINE HYDROCHLORIDE | I.P. | 1.00%W/W | ||||
IN OINTMENT BASE | Q. S | |||||
130 | TRETINOIN CREAM | COMPOSITION: | CREAM | DOMESTIC | ||
TRETINOIN | U.S.P. | 0.025%W/W | ||||
CREAM BASE | Q.S | |||||
131 | TRETINOIN CREAM | COMPOSITION: | CREAM | EXPORT | ||
TRETINOIN | U.S.P. | 0.025%W/W | ||||
CREAM BASE | Q.S | |||||
132 | TRETINOIN CREAM | COMPOSITION: | CREAM | EXPORT | ||
TRETINOIN | U.S.P. | 0.050%W/W | ||||
CREAM BASE | Q.S | |||||
133 | TROXERUTIN GEL | COMPOSITION: | GEL | EXPORT | ||
TROXERUTIN | B.P. | 2%W/W | ||||
GEL BASE | Q.S | |||||
134 | TRIAMCINOLONE ACETONIDE CREAM | COMPOSITION: | CREAM | DOMESTIC | ||
TRIAMCINOLONE ACETONIDE | I.P. | 1.00%W/W | ||||
CREAM BASE | Q.S | |||||
135 | UREA, LACTIC ACID, PROPYLENE GLYCOL, LIQUID PARAFFIN CREAM | COMPOSITION: | CREAM | DOMESTIC | ||
UREA | I.P. | 10.0%W/W | ||||
LACTIC ACID | I.P. | 10.0%W/W | ||||
PROPYLENE GLYCOL | I.P. | 10.0%W/W | ||||
LIQUID PARFAFFIN | I.P. | 10.0%W/W | ||||
IN A CREAM BASE | Q. S | |||||
136 | WHITE SOFT PARAFFIN, LIGHT LIQUID PARAFFIN CREAM | COMPOSITION: | CREAM | DOMESTIC | ||
WHITE SOFT PARAFFIN | I.P. | 13.2% W/W | ||||
LIGHT LIQUID PARAFFIN | I.P. | 10.2% W/W | ||||
CREAM BASE | Q. S | |||||
137 | WHITE PETROLIUM JELLY, LIGHT LIQUID PARAFFIN OINTMENT | COMPOSITION: | OINTMENT | EXPORT | ||
WHITE PETROLIUM JELLY | U.S.P | 50%W/W | ||||
LIGHT LIQUID PARAFFIN | 50%W/W | |||||
OINTMENT BASE | Q. S |
NO | NAME OF PRODUCT | COMPOSITION | GRADE | STRENGTH | FORM | MARKET |
1 | ACECLOFENAC, PARACETAMOL SUSPENSION | EACH 5 ML CONTAINS: | SUSPENSION | DOMESTIC | ||
ACECLOFENAC | I.P. | 50 MG | ||||
PARACETAMOL | I.P. | 125 MG | ||||
IN A FLAVOURED SYRUPY BASE | Q.S | |||||
APPROVED COLOUR USED | ||||||
2 | ACETAMINOPHEN ORAL SUSPENSION | EACH 5 ML CONTAINS : | SYRUP | DOMESTIC | ||
PARACETAMOL | I.P | 240 MG | ||||
FLAVOURED SYRUP BASE | Q.S | |||||
APPROVED COLOUR USED | ||||||
3 | ACETAMINOPHEN ORAL SUSPENSION | EACH 5 ML CONTAINS : | SUSPENSION | EXPORT | ||
PARACETAMOL | U.S.P. | 240 MG | ||||
FLAVOURED SYRUP BASE | Q.S | |||||
APPROVED COLOUR USED | ||||||
4 | ALBENDAZOLE SUSPENSION | EACH 5 ML CONTAINS: | SUSPENSION | DOMESTIC | ||
ALBENDAZOLE | I.P. | 200 MG | ||||
FLAVOURED SYRUPY BASE | Q.S | |||||
APPROVED COLOUR USED | ||||||
5 | ALBENDAZOLE SUSPENSION | EACH 5 ML CONTAINS: | SUSPENSION | EXPORT | ||
ALBENDAZOLE | U.S.P. | 200 MG | ||||
FLAVOURED SYRUPY BASE | Q.S | |||||
APPROVED COLOUR USED | ||||||
6 | ALBENDAZOLE, IVERMECTIN SUSPENSION | EACH 5 ML CONTAINS: | SUSPENSION | DOMESTIC | ||
ALBENDAZOLE | I.P. | 200 MG | ||||
IVERMECTIN | I.P. | 1.5 MG | ||||
FLAVOURED SYRUP BASE | ||||||
APPROVED COLOUR USED | ||||||
7 | ALBENDAZOLE, IVERMECTIN SUSPENSION | EACH 5 ML CONTAINS: | SUSPENSION | DOMESTIC | ||
ALBENDAZOLE | I.P. | 200 MG | ||||
IVERMECTIN | I.P. | 3 MG | ||||
FLAVOURED SYRUP BASE | ||||||
APPROVED COLOUR USED | ||||||
8 | ALPHA AMYLASE, PEPSIN SYRUP | EACH 5 ML CONTAINS: | SYRUP | DOMESTIC | ||
ALPHA AMYLASE I.P. (1:2000) | I.P. (1:2000) | 18.75 MG | ||||
(FUNGAL DIASTASE DERIVED FROM ASPERGILLUS ORYZAE DIGESTS NOT LESS THAN 37.50 GM OF COOKED STARCH) | ||||||
PEPSIN | I.P. (1:3000) | 12.50 MG | ||||
(DIGESTS NOT LESS THAN 37.50 GM OF COAGULATED EGG ALBUMIN) | ||||||
FLAVOURED SYRUPY BASE | Q.S | |||||
APPROVE COLOUR USED APPROPRIATE OVERAGE ARE ADDED | ||||||
9 | ALPHA AMYLASE, PAPAIN, DIL OIL, ANISE OIL, CARAWAY OIL DROPS | EACH ML CONTAINS: | DROPS | DOMESTIC | ||
ALPHA AMYLASE (1800) | I.P. | 20 MG | ||||
DIGEST NOT LESS THEN 60 GM OF COOKED STARCH | ||||||
PAPAIN | I.P. | 10 MG | ||||
DIL OIL | B.P. | 2 MG | ||||
ANISE OIL | B.P. | 2 MG | ||||
CARAWAY OIL | B.P. | 2 MG | ||||
FL. SYRUPY BASE | Q.S | |||||
APPROVED COLOUR USED APPROPRIATE OVERAGE ARE ADDED | ||||||
10 | AMBROXOL HYDROCHLORIDE SYRUP | EACH 5 ML CONTAINS: | SYRUP | EXPORT | ||
AMBROXOL HYDROCHLORIDE | B.P. | 15 MG | ||||
IN FLAVOURED SYRUPY BASE | Q.S | |||||
APPROVED COLOUR USED | ||||||
11 | AMBROXOL HYDROCHLORIDE SYRUP | EACH 5 ML CONTAINS: | SYRUP | EXPORT | ||
AMBROXOL HYDROCHLORIDE | B.P. | 30 MG | ||||
IN FLAVOURED SYRUPY BASE | Q.S | |||||
APPROVED COLOUR USED | ||||||
12 | AMBROXOL HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE SYRUP | EACH 5 ML CONTAINS: | SYRUP | EXPORT | ||
AMBROXOL HYDROCHLORIDE | B.P. | 15 MG | ||||
CETIRIZINE HYDROCHLORIDE | B.P. | 2.5 MG | ||||
FLAVOURED SYRUPY BASE | Q.S | |||||
13 | AMBROXOL HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE SYRUP | EACH 5 ML CONTAINS: | SYRUP | EXPORT | ||
AMBROXOL HYDROCHLORIDE | B.P. | 30 MG | ||||
CETIRIZINE HYDROCHLORIDE | B.P. | 5 MG | ||||
IN FLAVOURED BASE | Q.S | |||||
APPROVED COLOUR USED | ||||||
14 | AMBROXOL HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE SYRUP | EACH 5 ML CONTAINS: | SYRUP | EXPORT | ||
AMBROXOL HYDROCHLORIDE | B.P. | 30 MG | ||||
CETIRIZINE HYDROCHLORIDE | B.P. | 15 MG | ||||
FLAVOURED SYRUPY BASE | Q.S | |||||
15 | AMBROXOL HYDROCHLORIDE, LEVOCETIRIZINE HYDROCHLORIDE SUSPENSION | EACH 5 ML CONTAINS: | SUSPENSION | EXPORT | ||
AMBROXOL HYDROCHLORIDE | B.P. | 60 MG | ||||
LEVOCETIRIZINE HYDROCHLORIDE | B.P. | 5 MG | ||||
IN FLAVOURED SUSPENSION BASE | Q.S | |||||
APPROVED COLOUR USED | ||||||
16 | AMBROXOL HYDROCHLORIDE, TERBUTALINE SULPHATE, GUAIFENESIN SYRUP | EACH 5 ML CONTAINS: | SYRUP | DOMESTIC | ||
AMBROXOL HYDROCHLORIDE | I.P. | 15 MG | ||||
GUAIPHENESIN | I.P. | 50 MG | ||||
TERBUTALINE SULPHATE | I.P. | 2.5 MG | ||||
MENTHOL | I.P. | 2.5 MG | ||||
FLAVOURED SYRUP BASE | Q.S | |||||
APPROVED COLOUR USED | ||||||
17 | AMBROXOL HYDROCHLORIDE, TERBUTALINE SULPHATE, GUAIFENESIN SYRUP | EACH 5 ML CONTAINS: | SYRUP | EXPORT | ||
AMBROXOL HYDROCHLORIDE | B.P. | 30 MG | ||||
TERBUTALINE SULFATE | B.P. | 1.5 MG | ||||
GUAIFENESIN | B.P. | 50 MG | ||||
EXCIPIENTS | Q.S | |||||
APPROVED COLOUR USED | ||||||
18 | AMBROXOL HYDROCHLORIDE, GUAIPHENESIN, PHENYLEPHRINE HYDROCHLORIDE SYRUP | EACH 5 ML CONTAINS: | SYRUP | DOMESTIC | ||
AMBROXOL HYDROCHLORIDE | I.P. | 15 MG | ||||
GUAIPHENESIN | I.P. | 50 MG | ||||
PHENYLEPHRINE HYDROCHLORIDE | I.P. | 2.5 MG | ||||
IN A FLAVOURED SYRUP BASE | Q.S | |||||
APPROVED COLOUR USED | ||||||
19 | AMBROXOL HYDROCHLORIDE, GUAIPHENESIN, TERBUTALINE SULPHATE, MENTHOL SYRUP | EACH 10 ML CONTAINS: | SYRUP | DOMESTIC | ||
AMBROXOL HYDROCHLORIDE | I.P. | 30 MG | ||||
GUAIPHENESIN | I.P. | 100 MG | ||||
TERBUTALINE SULPHATE | I.P. | 2.5 MG | ||||
MENTHOL | I.P. | 5 MG | ||||
FLAVOURED SYRUPY BASE. | Q.S | |||||
APPROVED COLOUR USED | ||||||
20 | AMBROXOL HYDROCHLORIDE, GUAIPHENESIN, TERBUTALINE SULPHATE, MENTHOL SYRUP | EACH 5 ML CONTAINS: | SYRUP | DOMESTIC | ||
AMBROXOL HYDROCHLORIDE | I.P. | 15 MG | ||||
TERBUTALINE SULPHATE | I.P. | 1.25 MG | ||||
GUAIPHENESIN | I.P. | 50 MG | ||||
MENTHOL | I.P. | 2.5 MG | ||||
FLAVOURED BASE | Q.S | |||||
APPROVED COLOUR USED | ||||||
21 | ARTEMETHER, LUMEFENTRINE SUSPENSION | EACH 5 ML RECONSTITUTED SUSPENSION CONTAINS | SUSPENSION | DOMESTIC | ||
ARTEMETHER | I.P. | 20 MG | ||||
LUMEFANTRINE | I.P. | 120 MG | ||||
FLAVOURED SYRUPY BASE | Q.S | |||||
APPROVED COLOUR USED | ||||||
22 | AZITHROMYCIN SUSPENSION | EACH ML CONTAINS: | SUSPENSION | EXPORT | ||
AZITHROMYCIN DIHYDRATE | U.S.P. | |||||
EQ TO AZITHROMYCIN ANHYDROUS | 40 MG | |||||
EXCIPIENTS | Q.S | |||||
APPROVED COLOUR USED | ||||||
23 | AZITHROMYCIN SUSPENSION | EACH 5 ML CONTAINS: | SUSPENSION | EXPORT | ||
AZITHROMYCIN DIHYDRATE | U.S.P. | |||||
EQ. TO AZITHROMYCIN ANHYDROUS | 100 MG | |||||
FLAVOURED SYRUPY BASE | Q.S | |||||
APPROVED COLOUR USED | ||||||
24 | AZITHROMYCIN SUSPENSION | EACH 5 ML CONTAINS: | SUSPENSION | EXPORT | ||
AZITHROMYCIN DIHYDRATE | U.S.P. | |||||
EQ. TO AZITHROMYCIN ANHYDROUS | 200 MG | |||||
FLAVOURED SYRUPY BASE | Q.S | |||||
APPROVED COLOUR USED | ||||||
25 | AZITHROMYCIN SUSPENSION | EACH 5 ML CONTAINS: | SUSPENSION | DOMESTIC | ||
AZITHROMYCIN AS DIHYDRATE | I.P. | |||||
EQ TO ANHYDROUS AZITHROMYCIN | 200 MG | |||||
FLAVOURED SYRUPY BASE | Q.S | |||||
APPROVED COLOUR USED | ||||||
26 | BECLOMETHASONE, CLOTRIMAZOLE, LIGNOCAINE, NEOMYCIN EAR DROPS | COMPOSITION: | DROPS | DOMESTIC | ||
BECLOMETHASONE DIPROPIONATE | I.P. | 0.025%W/V | ||||
CLOTRIMAZOLE | I.P. | 1.0%W/V | ||||
LIGNOCAINE HYDROCHLORIDE | I.P. | 2.0%W/V | ||||
NEOMYCIN SULPHATE | I.P. | 0.5%W/V | ||||
IN AQUES BASE SOLUTION | Q. S | |||||
27 | BROMHEXINE HYDROCHLORIDE SYRUP | EACH 5 ML CONTAINS: | SYRUP | EXPORT | ||
BROMHEXINE HYDROCHLORIDE | B.P. | 4 MG | ||||
IN A FLA. SYRUPY BASE | Q.S | |||||
APPROVED COLOUR USED | ||||||
28 | BROMHEXINE HYDROCHLORIDE, GUAIPHENESIN, TERBUTALINE SULPHATE SYRUP | EACH 5 ML CONTAINS: | SYRUP | DOMESTIC | ||
BROMHEXINE HYDROCHLORIDE | I.P. | 2 MG | ||||
TERBUTALINE SULPHATE | I.P. | 2.5 MG | ||||
GUAIPHENESIN | I.P. | 100 MG | ||||
FLAVOURED SYRUPY BASE | Q.S | |||||
APPROVED COLOUR USED | ||||||
29 | BROMHEXINE HYDROCHLORIDE, SLABUTAMOL SULPHATE, GUAIPHENESIN, MENTHOL SYRUP | EACH 10 ML CONTAINS: | SYRUP | EXPORT | ||
BROMHEXINE HYDROCHLORIDE | B.P. | 4 MG | ||||
SALBUTAMOL SULPHATE | B.P. | |||||
EQ TO SALBUTAMOL | 2 MG | |||||
GUAIPHENESIN | B.P. | 100 MG | ||||
MENTHOL | B.P. | 1 MG | ||||
FLAVOURED SYRUPY BASE | Q.S | |||||
APPROVED COLOUR USED | ||||||
30 | BROMHEXINE HYDROCHLORIDE, TERBUTALINE, GUAIPHENESIN, MENTHOL SYRUP | EACH 5 ML CONTAINS: | SYRUP | DOMESTIC | ||
BROMHEXINE HYDROCHLORIDE | I.P. | 2 MG | ||||
TERBUTALINE SULPHATE | I.P. | 1.25 MG | ||||
GUAIPHENESIN | I.P. | 50 MG | ||||
MENTHOL | I.P. | 0.5 MG | ||||
FLAVOURED SYRUPY BASE | Q. S | |||||
APPROVED COLOUR USED | ||||||
31 | BROMHEXINE HYDROCHLORIDE, TERBUTALINE, GUAIPHENESIN, MENTHOL SYRUP | EACH 5 ML CONTAINS: | SYRUP | DOMESTIC | ||
BROMHEXINE HYDROCHLORIDE | I.P. | 4 MG | ||||
TERBUTALINE SULPHATE | I.P. | 2.50 MG | ||||
GUAIPHENESIN | I.P. | 100 MG | ||||
MENTHOL | I.P. | 0.5 MG | ||||
FLAVOURED SYRUPY BASE | Q. S | |||||
APPROVED COLOUR USED | ||||||
32 | CETIRIZINE ORAL SOLUTION | EACH 5 ML CONTAINS: | SOLUTION | EXPORT | ||
CETIRIZINE HYDROCHLORIDE | B.P. | 5 MG | ||||
FLAVOURED SYRUPY BASE | Q.S | |||||
APPROVED COLOUR USED | ||||||
33 | CETIRIZINE HYDROCHLORIDE ORAL SUSPENSION | EACH 5 ML CONTAINS: | SUSPENSION | EXPORT | ||
CETIRIZINE HYDROCHLORIDE | U.S.P. | 5 MG | ||||
FLAVOURED SUSPENSION BASE | Q.S | |||||
APPROVED COLOUR USED | ||||||
34 | CHLORBUTOL, BENZOCAINE, PARADICHLOROBENZENE EAR DROPS | COMPOSITION: | DROPS | DOMESTIC | ||
CHLORBUTOL | I.P. | 5.00% W/W | ||||
BENZOCAINE | I.P. | 2.50% W/W | ||||
PARADICHLOROBENZENE | 2.00% W/W | |||||
NON AQUEOUS BASE | Q.S | |||||
35 | CHLORHEXIDINE GLUCONATE, METRONIDAZOLE SOLUTION | COMPOSITION: | SOLUTION | EXPORT | ||
CHLORHEXIDINE GLUCONATE SOLUTION | B.P. | 0.25%W/W | ||||
METRONIDAZOLE | B.P. | 1.00%W/W | ||||
SOLUTION BASE | Q.S | |||||
36 | CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HYDROCHLORIDE SYRUP | EACH 5 ML CONTAINS: | SYRUP | DOMESTIC | ||
CHLORPHENIRAMINE MALEATE | I.P. | 2 MG | ||||
PHENYLEPHRINE HYDROCHLORIDE | I.P. | 5 MG | ||||
IN FLAVOURED SYRUPY BASE | Q.S | |||||
APPROVED COLOUR | ||||||
37 | CIPROFLOXACIN SUSPENSION | EACH 5 ML CONTAINS: | SUSPENSION | EXPORT | ||
CIPROFLOXACIN HYDROCHLORIDE | B.P. | |||||
EQ.TO CIPROFLOXACIN | 125 MG | |||||
FLAVOURED SYRUP BASE | Q.S | |||||
APPROVED COLOUR USED | ||||||
38 | CIPROFLOXACIN, TINIDAZOLE SUSPENSION | EACH 10 ML CONTAINS: | SUSPENSION | EXPORT | ||
CIPROFLOXACIN HYDROCHLORIDE | B.P. | |||||
EQ.TO CIPROFLOXACIN | 250 MG | |||||
TINIDAZOLE | B.P. | 300 MG | ||||
FLAVOURED SYRUP BASE | Q.S | |||||
APPROVED COLOUR USED | ||||||
39 | CIPROFLOXACIN, TINIDAZOLE SUSPENSION | EACH 5 ML CONTAINS: | SUSPENSION | EXPORT | ||
CIPROFLOXACIN HYDROCHLORIDE | B.P. | |||||
EQ.TO CIPROFLOXACIN | 500 MG | |||||
TINIDAZOLE | B.P. | 600 MG | ||||
FLAVOURED SYRUP BASE | Q.S | |||||
APPROVED COLOUR USED | ||||||
40 | CYPROHEPTADINE HYDROCHLORIDE SYRUP | EACH 5 ML CONTAINS: | SYRUP | DOMESTIC | ||
CYPROHEPTADINE HCL (ANHYDROUS) | I.P. | 2 MG | ||||
FLAVOURED SYRUPY BASE | Q.S | |||||
APPROVED COLOUR USED | ||||||
41 | CITICOLINE SODIUM SYRUP | EACH 5 ML CONTAINS: | SYRUP | EXPORT | ||
CITICOLINE SODIUM | B.P. | |||||
EQ TO. CITICOLINE | 500 MG | |||||
FLAVOURED SYRUPY BASE | Q.S | |||||
APPROVED COLOUR USED | ||||||
42 | CYPROHEPTADINE HYDROCHLORIDE, TRICHOLINE CITRATE DROPS | EACH 5 ML CONTAINS: | DROPS | DOMESTIC | ||
CYPROHEPTADINE HCL (ANHYDROUS) | I.P. | 1.5 MG | ||||
TRICHOLINE CITRATE (65%) | I.P. | 55 MG | ||||
FLAVOURED NON SYRUP BASE | Q.S | |||||
APPROVED COLOUR USED | ||||||
43 | CYPROHEPTADINE HYDROCHLORIDE, TRICHOLINE CITRATE SYRUP | EACH 5 ML CONTAINS: | SYRUP | DOMESTIC | ||
CYPROHEPTADINE HCL (ANHYDROUS) | I.P. | 2 MG | ||||
TRICHOLINE CITRATE (65%) | I.P. | 275 MG | ||||
FLAVOURED NON SYRUP BASE | Q.S | |||||
APPROVED COLOUR USED | ||||||
44 | DEFLAZACORT SUSPENSION | EACH 5 ML CONTAINS: | SUSPENSION | DOMESTIC | ||
DEFLAZACORT | I.P. | 6 MG | ||||
FLAVOURED SYRUPY BASE | Q.S | |||||
APPROVED COLOUR USED | ||||||
45 | DEXTROMETHORPHAN HYDROBROMIDE, CHLORPHENIRAMINE MALEATE SYRUP | EACH 5 ML CONTAINS: | SYRUP | DOMESTIC | ||
DEXTROMETHORPHAN HYDROBROMIDE | I.P. | 10 MG | ||||
CHLORPHENIRAMINE MALEATE | I.P. | 4 MG | ||||
FLAVOURED SYRUPY BASE | Q.S | |||||
APPROVED COLOUR USED | ||||||
46 | DEXTROMETHORPHAN, CHLORPHENIRAMINE MALEATE, HYDROBROMIDE, PHENYLEPHRINE HYDROCHLORIDE SYRUP | EACH 5 ML CONTAINS: | SYRUP | DOMESTIC | ||
DEXTROMETHORPHAN HYDROBROMIDE | I.P. | 10 MG | ||||
PHENYLEPHRINE HYDROCHLORIDE | I.P. | 5 MG | ||||
CHLORPHENIRAMINE MALEATE | I.P. | 2 MG | ||||
FLAVOURED SYRUPY BASE | Q.S | |||||
APPROVED COLOUR USED | ||||||
47 | DEXTROMETHORPHAN HYDROBROMIDE, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HYDROCHLORIDE SYRUP | EACH 5 ML CONTAINS: | SYRUP | DOMESTIC | ||
DEXTROMETHORPHAN HYDROBROMIDE | I.P. | 15 MG | ||||
PHENYLEPHRINE HYDROCHLORIDE | I.P. | 5 MG | ||||
CHLORPHENIRAMINE MALEATE | I.P. | 2 MG | ||||
FLAVOURED SYRUPY BASE | Q.S | |||||
APPROVED COLOUR USED | ||||||
48 | DICYCLOMINE HYDROCHLORIDE, SIMETHICONE SUSPENSION | EACH ML CONTAINS: | SUSPENSION | DOMESTIC | ||
DICYCLOMINE HYDROCHLORIDE | I.P. | 10 MG | ||||
SIMETHICONE | I.P. | 40 MG | ||||
FLAVOURED SYRUPY BASE | Q. S | |||||
APPROVED COLOUR USED | ||||||
49 | DIPHENHYDRAMINE HYDROCHLORIDE, AMMONIUM CHLORIDE, SODIUM CITRATE, MENTHOL SYRUP | EACH 5 ML CONTAINS: | SYRUP | DOMESTIC | ||
DIPHENHYDRAMINE HYDROCHLORIDE | I.P. | 14.08 MG | ||||
AMMONIUM CHLORIDE | I.P. | 138 MG | ||||
SODIUM CITRATE | I.P. | 100 MG | ||||
MENTHOL | I.P. | 1.14 MG | ||||
FLAVOURED SYRUPY BASE | Q. S | |||||
APPROVED COLOUR USED | ||||||
50 | DI-SODIUM HYDROGEN CITRATE SYRUP | EACH 5 ML CONTAINS: | SYRUP | DOMESTIC | ||
DI-SODIUM HYDROGEN CITRATE | I.P. | 1.38 MG | ||||
FLAVOURED SYRUP BASE | Q. S | |||||
APPROVED COLOUR USED | ||||||
51 | DI-SODIUM HYDROGEN CITRATE SYRUP | EACH 5 ML CONTAINS: | SYRUP | DOMESTIC | ||
DI-SODIUM HYDROGEN CITRATE | I.P. | 1.53 MG | ||||
FLAVOURED SYRUP BASE | Q. S | |||||
APPROVED COLOUR USED | ||||||
52 | DOMPERIDONE SUSPENSION | EACH ML CONTAINS: | SUSPENSION | DOMESTIC | ||
DOMPERIDONE | I.P. | 1 MG | ||||
IN FLAVOURED SYRUP BASE | Q. S | |||||
APPROVED COLOUR USED | ||||||
53 | DOMPERIDONE, SIMETHICONE SUSPENSION | EACH 5 ML CONTAINS: | SUSPENSION | EXPORT | ||
DOMPERIDONE | B.P. | 5 MG | ||||
SIMETHICONE | U.S.P. | 20 MG | ||||
IN FLAVOURED SYRUP BASE | Q.S | |||||
APPROVED COLOUR USED | ||||||
54 | DRIED ALUMINIUM HYDROXIDE, MAGNESIUM HYDROXIDE, ACTIVATED DIMETHICONE SUSPENSION | EACH 5 ML CONTAINS: | SUSPENSION | EXPORT | ||
DRIED ALUMINIUM HYDROXIDE GEL | U.S.P. | 250 MG | ||||
MAGNESIUM HYDROXIDE | U.S.P. | 250 MG | ||||
ACTIVATED DIMETHICONE | U.S.P. | 50 MG | ||||
IN A FLAVOURED NON CRYSTALLIZING SORBITOL BASE | Q.S | |||||
APPROVED COLOUR USED | ||||||
55 | ERYTHROMYCIN SUSPENSION | EACH 5 ML CONTAINS: | SUSPENSION | EXPORT | ||
ERYTHROMYCIN ESTOLATE | U.S.P. | |||||
EQ.TO ERYTHROMYCIN | 250 MG | |||||
FLAVOURED SUSPENSION BASE | Q.S | |||||
APPROVED COLOUR USED | ||||||
56 | FERRIC AMMONIUM CITRATE, VITAMIN B12, FOLIC ACID SYRUP | EACH 5 ML CONTAINS: | SYRUP | EXPORT | ||
FERRIC AMMONIUM CITRATE | U.S.P. | 235 MG | ||||
EQ. TO 41 MG ELEMENTAL IRON | ||||||
VITAMIN B12 | B.P. | 50 MG | ||||
FOLIC ACID | B.P. | 1.5 MG | ||||
FLAVOURED SYRUPY BASE | Q.S | |||||
APPROVED COLOUR USED | ||||||
57 | FERRIC AMMONIUM CITRATE, FOLIC ACID, CYANOCOBALAMIN SYRUP | EACH 5 ML CONTAINS: | SYRUP | DOMESTIC | ||
FERRIC AMMOUNIUM CITRATE | I.P. | 110 MG | ||||
CYANOCOBALAMIN | I.P. | 15 MCG | ||||
FOLIC ACID | I.P. | 1.5 MG | ||||
SORBITOL SOLUTION (70%) | I.P. | 10% W/V | ||||
(NONCRYSTALLISING) | ||||||
FLAVOURED SYRUPY BASE | Q.S | |||||
58 | FERRIC AMMONIUM CITRATE, IRON WITH VITAMIN B12, B- COMPLEX SYRUP | EACH 5 ML CONTAINS: | SYRUP | DOMESTIC | ||
FERRIC AMMONIUM CITRATE | I.P. | 150 MG | ||||
EQ. TO ELEMENTAL IRON 30 MG | ||||||
CYANOCOBALAMIN | I.P. | 5 MCG | ||||
FOLIC ACID | I.P. | 1 MG | ||||
ZINC SULPHATE MONOHYDRATE | I.P. | 7.42 MG | ||||
EQ. TO 2.7 MG ELEMENTAL ZINC | ||||||
FLAVOURED SYRUPY BASE | Q.S | |||||
APPROVED COLOUR USED | ||||||
59 | FERROUS ASCORBATE, FOLIC ACID SUSPENSION | EACH 5 ML CONTAINS: | SUSPENSION | DOMESTIC | ||
FERROUS ASCORBATE | I.P. | |||||
EQ TO ELEMENTAL IRON | 30 MG | |||||
FOLIC ACID | I.P. | 550 MCG | ||||
FLAVORED SYRUP BASE | Q.S | |||||
APPROVED COLOUR USED | ||||||
60 | FEXOFENADINE HYDROCHLORIDE SUSPENSION | EACH 5 ML CONTAINS: | SUSPENSION | EXPORT | ||
FEXOFENADINE HYDROCHLORIDE | U.S.P. | 30 MG | ||||
IN FLAVOURED BASE | Q.S | |||||
APPROVED COLOUR USED | ||||||
61 | IRON (III) HYDROXIDE POLYMALTOSE COMPLEX SYRUP | EACH 5 ML CONTAINS: | SYRUP | DOMESTIC | ||
IRON (III) HYDROXIDE POLYMALTOSE COMPLEX | ||||||
EQ. TO ELEMENTAL IRON | 50 MG | |||||
FLAVOURED SYRUPY BASE | Q.S | |||||
APPROVED COLOUR USED | ||||||
62 | IBUPROFEN ORAL SUSPENSION | EACH 5 ML CONTAINS: | SUSPENSION | EXPORT | ||
IBUPROFEN | B.P. | 100 MG | ||||
FLAVOURED SYRUP BASE | Q.S | |||||
APPROVED COLOUR USED | ||||||
63 | IBUPROFEN, PARACETAMOL SUSPENSION | EACH 5 ML CONTAINS: | SUSPENSION | EXPORT | ||
IBUPROFEN | B.P. | 100 MG | ||||
PARACETAMOL | B.P. | 162.50 MG | ||||
FLAVOURED SYRUP BASE | Q.S | |||||
APPROVED COLOUR USED | ||||||
64 | IVY LEAF DRY EXTRACT SOLUTION | EACH 100 ML SOLUTION CONTAINS: | SOLUTION | EXPORT | ||
IVY LEAF DRY EXTRACT | 0.70 GM | |||||
FLAVOURE SOLUTION BASE | Q.S | |||||
65 | LACTULOSE SOLUTION | EACH 5ML CONTAINS: | SOLUTION | EXPORT | ||
LACTULOSE CONCENTRATE | U.S.P. | |||||
EQ. TO LACTULOSE | 3.335 GM | |||||
FLAVOURED SYRUP BASE | Q.S | |||||
66 | LACTULOSE SOLUTION | EACH 5ML CONTAINS: | SOLUTION | DOMESTIC | ||
LACTULOSE CONCENTRATE | U.S.P. | |||||
EQ. TO LACTULOSE | 3.335 GM | |||||
FLAVOURED SYRUP BASE | Q.S | |||||
67 | LACTULOSE SOLUTION | EACH 15ML CONTAINS: | SOLUTION | DOMESTIC | ||
LACTULOSE CONCENTRATE | U.S.P. | |||||
EQ. TO LACTULOSE | 10 GM | |||||
FLAVOURED SYRUP BASE | Q.S | |||||
68 | LEVOCETIRIZINE DIHYDROCHLORIDE SYRUP | EACH 5 ML CONTAINS: | SYRUP | DOMESTIC | ||
LEVOCETIRIZINE DIHYDROCHLORIDE | I.P. | 2.5 MG | ||||
FLAVOURED SYRUPY BASE | Q.S | |||||
APPROVED COLOUR USED | ||||||
69 | LEVOCETIRIZINE DIHYDROCHLORIDE SYRUP | EACH 5 ML CONTAINS: | SYRUP | EXPORT | ||
LEVOCETIRIZINE DIHYDROCHLORIDE | U.S.P. | 2.5 MG | ||||
FLAVOURED SYRUPY BASE | Q.S | |||||
APPROVED COLOUR USED | ||||||
70 | LEVOSALBUTAMOL SULPHATE, GUAIPHENESIN, AMBROXOL HYDROCHLORIDE SYRUP | EACH 5 ML CONTAINS: | SYRUP | DOMESTIC | ||
LEVOSALBUTAMOL SULPHATE | I.P. | 0.5 MG | ||||
AMBROXOL HYDROCHLORIDE | I.P. | 15 MG | ||||
GUAIPHENESIN | I.P. | 50 MG | ||||
FLAVOURED SYRUP BASE | Q. S | |||||
APPROVED COLOUR USED | ||||||
71 | LEVOSALBUTAMOL SULPHATE, GUAIPHENESIN, AMBROXOL HYDROCHLORIDE SYRUP | EACH 5 ML CONTAINS: | SYRUP | DOMESTIC | ||
LEVOSALBUTAMOL SULPHATE | I.P. | 1 MG | ||||
AMBROXOL HYDROCHLORIDE | I.P. | 30 MG | ||||
GUAIPHENESIN | I.P. | 50 MG | ||||
FLAVOURED SYRUP BASE | Q. S | |||||
APPROVED COLOUR USED | ||||||
72 | LINEZOLID ORAL SUSPENSION | EACH 5 ML RECONSTITUTED SUSPENSION CONTAINS: | SUSPENSION | DOMESTIC | ||
LINEZOLID | I.P. | 100 MG | ||||
FLAVOURED SYRUPY BASE | Q. S | |||||
APPROVED COLOUR USED | ||||||
73 | LORATADINE SUSPENSION | EACH 5 ML CONTAINS: | SUSPENSION | EXPORT | ||
LORATADINE | U.S.P. | 5 MG | ||||
IN A FLAVOURED SUSPENSION BASE | Q.S | |||||
APPROVED COLOUR USED | ||||||
74 | LORATADINE ORAL SOLUTION | EACH 5 ML CONTAINS: | SOLUTION | EXPORT | ||
LORATADINE | U.S.P. | 5 MG | ||||
FLAVOURED SYRUP BASE | Q.S | |||||
75 | MEFENAMIC ACID, PARACETAMOL SUSPENSION | EACH 5 ML CONTAINS: | SUSPENSION | DOMESTIC | ||
MEFENAMIC ACID | I.P. | 50 MG | ||||
PARACETAMOL | I.P. | 125 MG | ||||
IN A FLAVOURED SYRUPY BASE | Q. S | |||||
APPROVED COLOUR USED | ||||||
76 | METRONIDAZOLE ORAL SUSPENSOIN | EACH 5 ML CONTAINS: | SUSPENSION | EXPORT | ||
METRONIDAZOLE BENZOATE | B.P. | |||||
EQ TO METRONIDAZOLE | 200 MG | |||||
FLAVOURED SYRUPY BASE | Q.S | |||||
APPROVED COLOUR USED | ||||||
77 | METRONIDAZOL, FURAZOLIDONE SUSPENSION | EACH 5 ML CONTAINS: | SUSPENSION | EXPORT | ||
METRONIDAZOLE BENZOATE | B.P. | |||||
EQ. TO METRONIDAZOLE | 100 MG | |||||
FURAZOLIDONE | B.P. | 30 MG | ||||
IN A SYRUPY BASE | Q.S | |||||
APPROVED COLOUR USED | ||||||
78 | MONTELUKAST, LEVOCETIRIZINE DIHYDROCHLORIDE SUSPENSION | EACH 5 ML CONTAINS: | SUSPENSION | EXPORT | ||
MONTELUKAST SODIUM | B.P. | |||||
EQ. TO MONTELUKAST | 4 MG | |||||
LEVOCETIRIZINE DIHYDROCHLORIDE | U.S.P. | 2.5 MG | ||||
FLAVOURED SYRUPY BASE | Q.S | |||||
APPROVED COLOUR USED | ||||||
79 | MULTIVITAMIN AND MINERAL DROPS | EACH ML CONTAINS: | DROPS | EXPORT | ||
CHOLICALCIFEROL (VIT. D3) | B.P. | 400 I.U (10 µg) | ||||
VITAMIN A PLAMITATE | B.P. | 350 µg | ||||
VITAMIN E | B.P. | 2 MG | ||||
ASCORBIC ACID (VITAMIN C) | B.P. | 12 MG | ||||
THIAMIN HYDROCHLORIDE (VIT. B1) | B.P. | 0.2 MG | ||||
(DL ALFA TOCOPHERYL ACETATE) | ||||||
RIBOFLAVIN SODIUM PHOSPHATE (VIT. B2) | B.P. | 0.25 MG | ||||
NICOTINAMIDE (VIT. B3) | B.P. | 3 MG | ||||
PYRIDOXINE HCL (VIT.B6) | B.P. | 0.25 MG | ||||
FOLIC ACID | B.P. | 50 µg | ||||
CYANOCOBALAMIN(VITAMIN B12) | B.P. | 4 µg | ||||
BIOTIN | B.P. | 8 µg | ||||
D-PANTHENOL (PANTOTHENIC ACID) | B.P. | 0.9 MG | ||||
FERRIC AMONIUM CITRATE | B.P. | |||||
EQ TO IRON | 2.2 MG | |||||
ZINC SULPHATE | B.P. | |||||
EQ TO ZINC | 1.5 MG | |||||
L-LYSINE MONOCHLORIDE | B.P. | 10 MG | ||||
MALT EXTRACT | 150 MG | |||||
FLAVOURED SYRUPY ASE | Q.S | |||||
APPROVED COLOUR USED | ||||||
79 | NALIDIXIC ACID ORAL SUSPENSOIN | EACH 5 ML CONTAINS: | SUSPENSION | EXPORT | ||
NALIDIXIC ACID | B.P. | 300 MG | ||||
IN SYRUP BASE | Q.S | |||||
APPROVED COLOUR USED | ||||||
80 | NAPHTHYZIN NASAL DROPS | COMPOSITION: | DROPS | EXPORT | ||
NAPHTHYZIN | B.P. | 1.00%W/V | ||||
IN NON AQUEOUS BASE | Q.S | |||||
81 | NIMESULIDE SUSPENSION | EACH 5 ML CONTAINS: | SUSPENSION | EXPORT | ||
NIMESULIDE | B.P. | 50 MG | ||||
IN FLAVOURED SYRUPY BASE | Q.S | |||||
APPROVED COLOUR USED | ||||||
82 | OFLOXACIN, METRONIDAZOLE BENZOATE SUSPENSION | EACH 5 ML CONTAINS: | SUSPENSION | DOMESTIC | ||
OFLOXACIN | I.P. | 50 MG | ||||
METRONIDAZOLE BENZOATE | I.P. | |||||
EQ. TO METRONIDAZOLE | 100 MG | |||||
IN A FLAVOURED SYRUPY BASE | Q. S | |||||
APPROVED COLOUR USED | ||||||
83 | OFLOXACIN, ORNIDAZOLE SUSPENSION | EACH 5 ML CONTAINS: | SUSPENSION | EXPORT | ||
OFLOXACIN | B.P. | 50 MG | ||||
ORNIDAZOLE | B.P. | 125 MG | ||||
FLAVOURED SYRUP BASE | Q.S | |||||
APPROVED COLOUR USED | ||||||
84 | ONDANSETRON HYDROCHLORIDE SYRUP | EACH 5 ML CONTAINS: | SYRUP | DOMESTIC | ||
ONDANSETRON HYDROCHLORIDE | I.P. | |||||
EQ.TO ONDANSETRON | 2 MG | |||||
IN A FLAVOURED SYRUP BASE | Q. S | |||||
APPROVED COLOUR USED | ||||||
85 | OXYMETAZOLINE HYDROCHLORIDE NASAL SOLUTION | COMPOSITION: | SOLUTION | EXPORT | ||
OXYMETAZOLINE HYDROCHLORIDE | U.S.P. | 0.01%W/V | ||||
PRESERVATIVE | ||||||
BENZALKONIUM CHLORIDE SOLUTION | B.P. | 0.01%W/V | ||||
IN A BUFFERED AQUEOUS SOLUTION | Q.S | |||||
86 | OXYMETAZOLINE HYDROCHLORIDE NASAL SOLUTION | COMPOSITION: | SOLUTION | EXPORT | ||
OXYMETAZOLINE HYDROCHLORIDE | U.S.P. | 0.025%W/V | ||||
PRESERVATIVE | ||||||
BENZALKONIUM CHLORIDE SOLUTION | B.P. | 0.01%W/V | ||||
IN A BUFFERED AQUEOUS SOLUTION | ||||||
87 | OXYMETAZOLINE HYDROCHLORIDE NASAL SOLUTION | COMPOSITION: | SOLUTION | EXPORT | ||
OXYMETAZOLINE HYDROCHLORIDE | U.S.P. | 0.050%W/V | ||||
PRESERVATIVE | ||||||
BENZALKONIUM CHLORIDE SOLUTION | B.P. | 0.01%W/V | ||||
IN A BUFFERED AQUEOUS SOLUTION | ||||||
88 | OXYMETAZOLINE HYDROCHLORIDE NASAL SOLUTION | COMPOSITION: | SOLUTION | EXPORT | ||
OXYMETAZOLINE HYDROCHLORIDE | U.S.P. | 0.10%W/V | ||||
PRESERVATIVE | ||||||
BENZALKONIUM CHLORIDE SOLUTION | B.P. | 0.01%W/V | ||||
IN A BUFFERED AQUEOUS SOLUTION | ||||||
89 | OXYMETAZOLINE HYDROCHLORIDE NASAL SOLUTION | COMPOSITION: | SOLUTION | DOMESTIC | ||
OXYMETAZOLINE HYDROCHLORIDE | I.P. | 0.05%W/V | ||||
PRESERVATIVE | ||||||
BENZALKONIUM CHLORIDE SOLUTION | I.P. | 0.01%W/V | ||||
IN A BUFFERED AQUEOUS SOLUTION | Q. S | |||||
90 | PARACETAMOL PAEDIATRIC ORAL SUSPENSION | EACH ML CONTAINS: | SUSPENSION | EXPORT | ||
PARACETAMOL | B.P. | 100 MG | ||||
FLAVOURED SUSPENSION BASE | Q.S | |||||
APPROVED COLOUR USED | ||||||
91 | PARACETAMOL PAEDIATRIC ORAL SUSPENSION | EACH ML CONTAINS: | SUSPENSION | DOMESTIC | ||
PARACETAMOL | I.P. | 100 MG | ||||
FLAVOURED SUSPENSION BASE | Q.S | |||||
APPROVED COLOUR USED | ||||||
92 | PARACETAMOL PAEDIATRIC ORAL SUSPENSION | EACH 5ML CONTAINS: | SUSPENSION | EXPORT | ||
PARACETAMOL | B.P. | 125 MG | ||||
IN FLAVOURED SYRUPY BASE | Q.S | |||||
APPROVED COLOUR USED | ||||||
93 | PARACETAMOL PAEDIATRIC ORAL SUSPENSION | EACH 5ML CONTAINS: | SUSPENSION | DOMESTIC | ||
PARACETAMOL | I.P. | 125 MG | ||||
IN FLAVOURED SYRUPY BASE | Q.S | |||||
APPROVED COLOUR USED | ||||||
94 | PARACETAMOL PAEDIATRIC ORAL SUSPENSION | EACH 5 ML CONATAINS: | SUSPENSION | EXPORT | ||
PARACETAMOL | B.P. | 250 MG | ||||
FLAVOURED SYRUPY BASE | Q. S | |||||
APPROVED COLOUR USED | ||||||
95 | PARACETAMOL PAEDIATRIC ORAL SUSPENSION | EACH 5 ML CONATAINS: | SUSPENSION | DOMESTIC | ||
PARACETAMOL | I.P. | 250 MG | ||||
FLAVOURED SYRUPY BASE | Q. S | |||||
APPROVED COLOUR USED | ||||||
96 | PARACETAMOL DROPS | EACH ML CONTAINS: | DROPS | DOMESTIC | ||
PARACETAMOL | I.P. | 150 MG | ||||
FLAVOURED SYRUPY BASE | Q. S | |||||
APPROVED COLOUR USED | ||||||
97 | PARACETAMOL, PHENYLEPHRINE HYDROCHLORIDE, BROMHEXINE HYDROCHLORIDE SYRUP | EACH 5 ML CONTAINS: | SYRUP | EXPORT | ||
PARACETAMOL | B.P. | 125 MG | ||||
PHENYLEPHRINE HYDROCHLORIDE | B.P. | 2.5 MG | ||||
BROMHEXINE HYDROCHLORIDE | B.P. | 2 MG | ||||
IN A FLAVOURED SYRUP BASE | Q. S | |||||
APPROVED COLOUR USED | ||||||
98 | PARACETAMOL, PHENYLEPHRINE HYDROCHLORIDE, BROMHEXINE HYDROCHLORIDE SYRUP | EACH 5 ML CONTAINS: | SYRUP | DOMESTIC | ||
PARACETAMOL | I.P. | 125 MG | ||||
PHENYLEPHRINE HYDROCHLORIDE | I.P. | 2.5 MG | ||||
BROMHEXINE HYDROCHLORIDE | I.P. | 2 MG | ||||
IN A FLAVOURED SYRUP BASE | Q. S | |||||
APPROVED COLOUR USED | ||||||
99 | PARACETAMOL, PHENYLEPHRINE HYDROCHLORIDE, CHLORPHENAMINE MALEATE SYRUP | EACH 5 ML CONTAINS: | SYRUP | EXPORT | ||
PARACETAMOL | B.P. | 125 MG | ||||
PHENYLEPHRINE HYDROCHLORIDE | B.P. | 5 MG | ||||
CHLORPHENAMINE MALEATE | B.P. | 1 MG | ||||
FLAVOURED SYRUPY BASE | Q.S | |||||
100 | PARACETAMOL, PHENYLEPHRINE HYDROCHLORIDE, CETIRIZINE DI-HYDROCHLORIDE SYRUP | EACH 5 ML CONTAINS: | SYRUP | DOMESTIC | ||
PARACETAMOL | I.P. | 325 MG | ||||
PHENYLEPHRINE HYDROCHLORIDE | I.P. | 10 MG | ||||
CETIRIZINE DIHYDROCHLORIDE | I.P. | 2.5 MG | ||||
FLAVOURED SYRUPY BASE | Q. S | |||||
APPROVED COLOUR USED | ||||||
101 | PHENYLEPHRINE HYDROCHLORIDE, CHLORPHENIRAMINE MALEATE SYRUP | EACH 5 ML CONTAINS: | SYRUP | DOMESTIC | ||
PHENYLEPHRINE HYDROCHLORIDE | I.P. | 5 MG | ||||
CHLORPHENIRAMINE MALEATE | I.P. | 2 MG | ||||
IN FLAVOURED SYRUPY BASE | Q.S | |||||
APPROVED COLOUR | ||||||
102 | PHENYLEPHRINE HYDROCHLORIDE, PARACETAMOL, CHLORPHENIRAMINE MALEATE SYRUP | EACH 5 ML CONTAINS: | SYRUP | DOMESTIC | ||
PHENYLEPHRINE HYDROCHLORIDE | I.P. | 2.5 MG | ||||
PARACETAMOL | I.P. | 125 MG | ||||
CHLORPHENIRAMINE MALEATE | I.P. | 1 MG | ||||
IN A FLAVOURED SYRUPY BASE | Q.S | |||||
APPROVED COLOUR USED | ||||||
103 | PHENYLEPHRINE HYDROCHLORIDE, PARACETAMOL, CHLORPHENIRAMINE MALEATE SYRUP | EACH 5 ML CONTAINS: | SYRUP | DOMESTIC | ||
PHENYLEPHRINE HYDROCHLORIDE | I.P. | 5 MG | ||||
PARACETAMOL | I.P. | 125 MG | ||||
CHLORPHENIRAMINE MALEATE | I.P. | 1 MG | ||||
IN A FLAVOURED SYRUPY BASE | Q.S | |||||
APPROVED COLOUR USED | ||||||
104 | PHENYLEPHRINE HYDROCHLORIDE, PARACETAMOL, CHLORPHENIRAMINE MALEATE SUSPENTION | EACH 5 ML CONTAINS: | SUSPENSION | DOMESTIC | ||
PHENYLEPHRINE HYDROCHLORIDE | I.P. | 5 MG | ||||
PARACETAMOL | I.P. | 125 MG | ||||
CHLORPHENIRAMINE MALEATE | I.P. | 2 MG | ||||
IN A FLAVOURED SYRUPY BASE | Q.S | |||||
APPROVED COLOUR USED | ||||||
105 | PHENYLEPHRINE HYDROCHLORIDE, PARACETAMOL, CHLORPHENIRAMINE MALEATE DROP | EACH ML CONTAINS: | DROPS | DOMESTIC | ||
PHENYLEPHRINE HYDROCHLORIDE | I.P. | 2.5 MG | ||||
PARACETAMOL | I.P. | 125 MG | ||||
CHLORPHENIRAMINE MALEATE | I.P. | 1 MG | ||||
IN A FLAVOURED SYRUPY BASE | Q. S | |||||
APPROVED COLOUR USED | ||||||
106 | PHENYLEPHRINE HYDROCHLORIDE, PARACETAMOL, CHLORPHENIRAMINE MALEATE SUSPENSION | EACH 5 ML CONTAINS: | SUSPENSION | DOMESTIC | ||
PHENYLEPHRINE HYDROCHLORIDE | I.P. | 2.5 MG | ||||
PARACETAMOL | I.P. | 250 MG | ||||
CHLORPHENIRAMINE MALEATE | I.P. | 1 MG | ||||
IN A FLAOUR SYRUPY BASE | Q. S | |||||
APPROVED COLOUR USED | ||||||
107 | PHENYLEPHRINE HYDROCHLORIDE, PARACETAMOL, CHLORPHENIRAMINE MALEATE SUSPENSION | EACH 5 ML CONTAINS: | SUSPENSION | DOMESTIC | ||
PHENYLEPHRINE HYDROCHLORIDE | I.P. | 5 MG | ||||
PARACETAMOL | I.P. | 250 MG | ||||
CHLORPHENIRAMINE MALEATE | I.P. | 2 MG | ||||
IN A FLAOUR SYRUPY BASE | Q. S | |||||
APPROVED COLOUR USED | ||||||
108 | POTASSIUM CITRATE MONOHYDRATE, CITRIC ACID MONOHYDRATE SOLUTION | EACH 5 ML CONTAINS: | SOLUTION | DOMESTIC | ||
POTASSIUM CITRATE MONOHYDRATE | I.P. | 1100 MG | ||||
CITRIC ACID MONOHYDRATE | I.P. | 334 MG | ||||
FLAVOURED BASE | Q. S | |||||
APPROVED COLOUR USED | ||||||
109 | POTASSIUM NITRATE, SODIUM MONOFLUOROPHOSPHATE, TRICLOSAN TOOTHPASTE | COMPOSITION: | TOOTHPASTE | EXPORT | ||
POTASSIUM NITRATE | B.P. | 5.0%W/W | ||||
SODIUM MONOFLUOROPHOSPHATE | U.S.P. | 0.70%W/W | ||||
TRICLOSAN | U.S.P. | 0.30%W/W | ||||
IN A PLEASENTLY BASE | Q.S | |||||
AVAILABLE FLUORIDE CONTENT 917 PPM WHEN PACKED APPROVED COLOUR USED | ||||||
110 | PROMETHAZINE ORAL SOLUTION | EACH 10 ML (SPOONFUL) CONTAINS: | SOLUTION | EXPORT | ||
PROMETHAZINE HYDROCHLORIDE | B.P. | 10 MG | ||||
FLAVOURED BASE | Q. S | |||||
APPROVED COLOUR USED | ||||||
111 | SALBUTAMOL SULPHATE SUSPENSION | EACH 5 ML CONTAINS: | SUSPENSION | EXPORT | ||
SALBUTAMOL SULPHATE | B.P. | |||||
EQ. TO SALBUTAMOL | 2 MG | |||||
FLAVOURED SUSPENSION BASE | Q.S | |||||
APPROVED COLOUR USED | ||||||
112 | SILYMARIN SUSPENSION | EACH 5 ML CONTAINS: | SUSPENSION | DOMESTIC | ||
SILYMARIN (AS SILYBIN) | I.P. | 35 MG | ||||
FLAVOURED SYRUP BASE | Q. S | |||||
APPROVED COLOUR USED | ||||||
113 | SIMETHICONE, DIL OIL, FENNEL OIL DROPS | EACH ML CONTAINS: | DROPS | EXPORT | ||
SIMETHICONE EMULSION | U.S.P. | |||||
EQ TO SIMETHICONE | 40 MG | |||||
DIL OIL | B.P. | 0.005 ML | ||||
FENNEL OIL | U.S.P. | 0.0007 ML | ||||
FLAVOURED SYRUPY BASE | Q.S | |||||
114 | SODIUM CHLORIDE NASAL DROPS | COMPOSITION: | DROPS | DOMESTIC | ||
SODIUM CHLORIDE | I.P. | 0.65%W/V | ||||
(IN PURIFIED WATER MADE ISOTONIC AND BUFFERED) | ||||||
BENZALKONIUM CHLORIDE SOLUTION | I.P. | |||||
EQ. TO. BENZALKONIUM CHLORIDE | 0.01%W/V | |||||
(AS PRESERVATIVE) | Q.S | |||||
115 | TRICHOLINE CITRATE SYRUP | EACH 10 ML CONTAINS: | SYRUP | DOMESTIC | ||
TRICHOLINE CITRATE (65%) | I.P. | 550 MG | ||||
FLAVOURED NON SYRUP BASE | Q. S | |||||
APPROVED COLOUR USED | ||||||
116 | THEOPHYLLINE ORAL SOLUTION | EACH 5 ML CONTAINS: | SOLUTION | EXPORT | ||
THEOPHYLLINE (ANHYDROUS) | U.S.P. | 26.667 MG | ||||
PRESERVATIVES: | ||||||
METHYL PARABEN | U.S.P. | 0.1%W/V | ||||
PROPYL PARABEN | U.S.P. | 0.015%W/V | ||||
ALCOHOL | U.S.P. | 0.5%V/V | ||||
IN A FLAOUR SYRUPY BASE | Q. S | |||||
APPROVED COLOUR USED | ||||||
117 | TRICHOLINE CITRATE, SORBITOL SOLUTION | EACH 5 ML CONTAINS: | SOLUTION | DOMESTIC | ||
TRICHOLINE CITRATE (65%) | I.P. | 275 MG | ||||
SORBITOL SOLUTION (70%) | I.P. | 3.5 MG | ||||
FLAVOURED SYRUP BASE | Q. S | |||||
APPROVED COLOUR USED | ||||||
118 | TRIMETHOPRIM, SULFAMETHOXAZOLE SUSPENSION | EACH 5 ML CONTAINS: | SUSPENSION | EXPORT | ||
TRIMETHOPRIM | B.P. | 40 MG | ||||
SULFAMETHOXAZOLE | B.P. | 200 MG | ||||
FLAVOURED SYRUPY BASE | Q.S | |||||
119 | URSODESOXYCHOLIC ACID ORAL SUSPENSION | EACH 5 ML CONATINS: | SUSPENSION | DOMESTIC | ||
URSODIOL (URSODEOXYCHOLIC ACID) | I.P. | 125 MG | ||||
IN FLAVOURED BASE | Q. S | |||||
APPROVED COLUR USED |
COMPOSITION | FORM | THERAPEUTIC SEGMENTS |
ALPHA AMYLASE, PAPAIN, DIL OIL, ANISE OIL, CARAWAY OIL | DROPS | DIGESTIVE ENZYMES |
ALPHA AMYLASE, PEPSIN | SYRUP | DIGESTIVE ENZYMES |
DOMPERIDONE | SUSPENSION | DOPAMINE ANTAGONISTS |
DOMPERIDONE, SIMETHICONE | SUSPENSION | DOPAMINE ANTAGONISTS |
DRIED ALUMINIUM HYDROXIDE, MAGNESIUM HYDROXIDE, ACTIVATED DIMETHICONE | SUSPENSION | ANTACIDS |
LACTULOSE | SOLUTION | LAXATIVES |
SIMETHICONE, DIL OIL, FENNEL OIL | DROPS | ANTACIDS, ANTIREFLUX AGENTS & ANTIULCERANTS |
LOPERAMIDE HYDOCHLORIDE, DICYCLOVERINE HYDROCHLORIDE, LACTIC ACID BACILLUS | CAPSULE | ANTI-DIARRHEAL AGENT |
LOPERAMIDE HYDROCHLORIDE | CAPSULE | ANTI-DIARRHEAL AGENT |
DICYCLOMINE HYDROCHLORIDE, SIMETHICONE | SUSPENSION | ANTICHOLINERGICS / ANTISPASMODICS |
OMEPRAZOLE | CAPSULE | GASTROESOPHAGEAL |
OMEPRAZOLE, DOMPERIDONE | CAPSULE | GASTROESOPHAGEAL |
PANTOPRAZOLE (ENTERIC COATED), DOMPERIDONE (SUSTAINED RELEASE) | CAPSULE | GASTROESOPHAGEAL |
PANTOPRAZOLE SODIUM DELAYED-RELEASE | CAPSULE | GASTROESOPHAGEAL |
PANTOPRAZOLE SODIUM, LEVOSULPIRIDE SUSTAINED RELEASE | CAPSULE | GASTROESOPHAGEAL |
RABEPRAZOLE SODIUM (ENTERIC COATED) | CAPSULE | GASTROESOPHAGEAL |
RABEPRAZOLE SODIUM (ENTERIC COATED), DOMPERIDONE (SUSTAINED RELEASE) | CAPSULE | GASTROESOPHAGEAL |
ILAPRAZOLE, DOMPERIDONE | CAPSULE | GASTROESOPHAGEAL |
RABEPRAZOLE (ENTERIC COATED), LEVOSULPIRIDE SUSTAINED RELEASE | CAPSULE | GASTROESOPHAGEAL |
ESOMEPRAZOLE (ENTERIC COATED), DOMPERIDONE SUSTAINED RELEASE | CAPSULE | GASTROESOPHAGEAL |
LOPERAMIDE HYDROCHLORIDE | TABLET | ANTI-DIARRHEAL AGENT |
DICYCLOMINE HYDROCHLORIDE, PARACETAMOL | TABLET | ANTISPASMODICS |
DROTAVERINE HYDROCHLORIDE | TABLET | ANTISPASMODICS |
DROTAVERINE HYDROCHLORIDE, MEFENAMIC ACID | TABLET | ANTISPASMODICS |
DROTAVERINE HYDROCHLORIDE, PARACETAMOL | TABLET | ANTISPASMODICS |
FAMOTIDINE | TABLET | H2-BLOCKERS |
ESOMEPRAZOLE GASTRO RESISTANCE | TABLET | PROTON-PUMP INHIBITORS |
ESOMEPRAZOLE MAGNESIUM | TABLET | PROTON-PUMP INHIBITORS |
PANTOPRAZOLE | TABLET | PROTON-PUMP INHIBITORS |
PANTOPRAZOLE SODIUM, DOMPERIDONE | TABLET | PROTON-PUMP INHIBITORS |
RABEPRAZOLE SODIUM | TABLET | PROTON-PUMP INHIBITORS |
RABEPRAZOLE SODIUM, DOMPERIDONE | TABLET | PROTON-PUMP INHIBITORS |
BISACODYL | TABLET | STIMULANT LAXATIVES |
BISACODYL DELAY RELEASE | TABLET | STIMULANT LAXATIVES |
OMEPRAZOLE MAGNESIUM, DOMPERIDONE | TABLET | PROTON-PUMP INHIBITORS TREATMENT OF FUNCTIONAL GASTROINTESTINAL DISORDERS |
COMPOSITION | FORM | THERAPEUTIC SEGMENTS |
BENZOYL PEROXIDE | GEL | ANTIBIOTICS |
CLARITHROMYCIN | CREAM | ANTIBIOTICS |
CLINDAMYCIN PHOSPHATE | GEL | ANTIBIOTICS |
CLINDAMYCIN PHOSPHATE, NICOTINAMIDE | GEL | ANTIBIOTICS |
FUSIDIC ACID | CREAM/OINTMENT | ANTIBIOTICS |
MUPIROCIN | OINTMENT | ANTIBIOTICS |
NADIFLOXACIN | CREAM | ANTIBIOTICS |
NEOMYCIN SULPHATE, CLOBETASOL PROPIONATE, MICONAZOLE | CREAM | ANTIBIOTICS |
NEOMYCIN SULPHATE, FLUOCINOLONE ACETONIDE | OINTMENT | ANTIBIOTICS |
SILVER SULFADIAZINE, CHLORHEXADINE GLUCONATE | CREAM/OINTMENT | ANTIBIOTICS |
SILVER SULFADIAZINE, LIGNOCAINE HYDROCHLORIDE, CHLORHEXIDINE GLUCONATE | CREAM | ANTIBIOTICS |
SODIUM FUSIDATE | OINTMENT | ANTIBIOTICS |
SUCRALFATE, METRONIDAZOLE, POVIDONE IODINE | OINTMENT | ANTIBIOTICS |
BECLOMETHASONE DIPROPIONATE, CLOTRIMAZOLE | LOTION | ANTIBIOTICS AND STEROIDS |
BECLOMETHASONE DIPROPIONATE, FUSIDIC ACID | CREAM | ANTIBIOTICS AND STEROIDS |
BETAMETHASONE DIPROPIONATE, GENTAMICIN SULPHATE ,TOLNAFTATE, IODOCHLORHYDROXYQUINOLINE | CREAM | ANTIBIOTICS AND STEROIDS |
BETAMETHASONE DIPROPIONATE, CLOTRIMAZOLE, GENTAMICIN | CREAM/OINTMENT | ANTIBIOTICS AND STEROIDS |
BETAMETHASONE DIPROPIONATE, GENTAMYCIN | CREAM | ANTIBIOTICS AND STEROIDS |
BETAMETHASONE VALERATE, GENTAMICIN | CREAM | ANTIBIOTICS AND STEROIDS |
CLOBETASOL PROPIONATE AND FUSIDIC ACID | CREAM | ANTIBIOTICS AND STEROIDS |
CLOBETASOL PROPIONATE | CREAM/ OINTMENT | ANTIBIOTICS AND STEROIDS |
CLOBETASOL PROPIONATE, GENTAMICIN, TOLNAFTATE, IODOCHLORHYDROXYQUINOLINE, CLOTRIMAZOLE | CREAM | ANTIBIOTICS AND STEROIDS |
CLOBETASOL PROPIONATE, NEOMYCIN SULPHATE | CREAM | ANTIBIOTICS AND STEROIDS |
CLOBETASOL PROPIONATE, NEOMYCIN SULPHATE, CLOTRIMAZOLE | CREAM | ANTIBIOTICS AND STEROIDS |
CLOBETASOL PROPIONATE, NEOMYCIN SULPHATE, MICONAZOLE | CREAM | ANTIBIOTICS AND STEROIDS |
CLOBETASOL PROPIONATE, SALICYLIC ACID | OINTMENT | ANTIBIOTICS AND STEROIDS |
CLOBETASONE 17-BUTYRATE, GENTAMICIN SULPHATE | CREAM | ANTIBIOTICS AND STEROIDS |
DEXAMETHASONE SODIUM PHOSPHATE, NEOMYCIN SULPHATE | CREAM/OINTMENT | ANTIBIOTICS AND STEROIDS |
DEXAMETHASONE, NEOMYCIN SULPHATE | OINTMENT | ANTIBIOTICS AND STEROIDS |
FLUOCINOLONE ACETONIDE, MICONAZOLE NITRATE | CREAM | ANTIBIOTICS AND STEROIDS |
FLUTICASONE PROPIONATE | CREAM | ANTIBIOTICS AND STEROIDS |
HALOBETASOLE PROPIONATE | CREAM | ANTIBIOTICS AND STEROIDS |
HALOBETASOLE PROPIONATE, CLOTRIMAZOLE | CREAM | ANTIBIOTICS AND STEROIDS |
HALOBETASOLE PROPIONATE, SALICYLIC ACID | OINTMENT | ANTIBIOTICS AND STEROIDS |
HYDROCORTISONE | CREAM | ANTIBIOTICS AND STEROIDS |
HYDROQUINONE, TRETINOIN, MOMETASONE FUROATE | CREAM | ANTIBIOTICS AND STEROIDS |
MOMETASONE FUROATE | CREAM | ANTIBIOTICS AND STEROIDS |
MOMETASONE FUROATE, FUSIDIC ACID | CREAM | ANTIBIOTICS AND STEROIDS |
MOMETASONE FUROATE, SALICYLIC ACID | CREAM | ANTIBIOTICS AND STEROIDS |
MOMETASONE FUROATE, TERBINAFINE HYDROCHLORIDE | CREAM | ANTIBIOTICS AND STEROIDS |
OFLOXACIN, ORNIDAZOLE, TERBINAFINE HYDROCHLORIDE, CLOBETASOL PROPIONATE | CREAM | ANTIBIOTICS AND STEROIDS |
TRIAMCINOLONE ACETONIDE | CREAM | ANTIBIOTICS AND STEROIDS |
ORNIDAZOLE, POVIDONE IODINE | OINTMENT | ANTISEPTIC |
POVIDONE IODINE | OINTMENT | ANTISEPTIC |
POVIDONE IODINE, SUCRALFATE | OINTMENT | ANTISEPTIC |
BECLOMETHASONE DIPROPIONATE, CLOTRIMAZOLE, NEOMYCIN | CREAM | ANTIBIOTICS AND STEROIDS |
BECLOMETHASONE DIPROPIONATE, NEOMYCIN, CLOTRIMAZOLE | CREAM | ANTIBIOTICS AND STEROIDS |
BETAMETHASONE VALERATE, NEOMYCIN SULPHATE, TOLNAFTATE, IODOCHLORHYDROXQUINOLINE | CREAM | ANTIBIOTICS AND STEROIDS |
CHLORHEXIDINE GLUCONATE, METRONIDAZOLE | GEL | ANTISEPTIC |
METRONIDAZOL, FURAZOLIDONE | SUSPENSION | MISCELLANEOUS ANTIBIOTICS |
METRONIDAZOLE SUSPENSOIN | SUSPENSION | AMEBICIDES, MISCELLANEOUS ANTIBIOTICS |
OFLOXACIN, METRONIDAZOLE BENZOATE | SUSPENSION | ANTIBIOTICS |
OFLOXACIN, ORNIDAZOLE | SUSPENSION | ANTIBIOTICS |
AZITHROMYCIN | SUSPENSION | ANTIBIOTICS |
BECLOMETHASONE, CLOTRIMAZOLE, LIGNOCAINE, NEOMYCIN | DROPS | ANTIBIOTICS AND STEROIDS |
CHLORHEXIDINE GLUCONATE, METRONIDAZOLE | SOLUTION | ANTISEPTIC AND GERMICIDES, MOUTH AND THROAT PRODUCTS |
CIPROFLOXACIN | SUSPENSION | QUINOLONES AND FLUOROQUINOLONES |
CIPROFLOXACIN, TINIDAZOLE | SUSPENSION | FLUOROQUINOLONES |
ERYTHROMYCIN | SUSPENSION | ANTIBIOTICS |
LINEZOLID | SUSPENSION | OXAZOLIDINONE-CLASS |
NALIDIXIC ACID SUSPENSOIN | SUSPENSION | QUINOLONES AND FLUOROQUINOLONES (URINARY ANTI-INFECTIVES) |
AZITHROMYCIN | CAPSULE | ANTIBIOTICS |
CLINDAMYCIN | CAPSULE | ANTIBIOTICS |
DOXYCYCLINE HYDROCHLORIDE | CAPSULE | ANTIBIOTICS |
LINEZOLID | TABLET | ANTIBACTERIALS |
CHLORAMPHENICOL | TABLET | ANTIBIOTICS |
CIPROFLOXACIN HYDROCHLORIDE | TABLET | ANTIBIOTICS |
CIPROFLOXACIN HYDROCHLORIDE, ORNIDAZOLE | TABLET | ANTIBIOTICS |
CIPROFLOXACIN HYDROCHLORIDE, TINIDAZOLE | TABLET | ANTIBIOTICS |
CLARITHROMYCIN | TABLET | ANTIBIOTICS |
ORNIDAZOLE | TABLET | ANTIBIOTICS |
TINIDAZOLE | TABLET | ANTIBACTERIALS |
OFLOXACIN | TABLET | FLUOROQUINOLONE ANTIBIOTICS |
OFLOXACIN, ORNIDAZOLE | TABLET | FLUOROQUINOLONE ANTIBIOTICS |
OFLOXACIN, TINIDAZOLE | TABLET | FLUOROQUINOLONE ANTIBIOTICS |
LEVOFLOXACIN | TABLET | FLUOROQUINOLONE DRUG BACTERICIDAL ANTIBIOTIC |
SPARFLOXACIN | TABLET | FLUOROQUINOLONES (TREAT VARIOUS TYPES OF BACTERIAL INFECTIONS) |
NITROXOLINE | TABLET | HYDROXYQUINOLINE DERIVATIVE URINARY ANTIBACTERIAL AGENT |
ROXITHROMYCIN | TABLET | MACROLIDE ANTIBIOTICS |
AZITHROMYCIN | TABLET | MACROLIDE ANTIBIOTICS |
ERYTHROMYCIN | TABLET | MACROLIDE ANTIBIOTICS |
METRONIDAZOLE | TABLET | NITROIMIDAZOLE CLASS ANTIBIOTIC |
METRONIDAZOLE, FURAZOLIDINE | TABLET | NITROIMIDAZOLE CLASS ANTIBIOTIC |
NALIDIXIC ACID | TABLET | QUINOLONE ANTIBIOTICS |
NORFLOXACIN | TABLET | QUINOLONE ANTIBIOTICS |
NORFLOXACIN, TINIDAZOLE | TABLET | QUINOLONE ANTIBIOTICS |
TRIMETHOPRIM, SULFAMETHOXAZOLE | TABLET | SULFONAMIDE ANTIBIOTICS |
MINOCYCLINE | TABLET | TETRACYCLINE ANTIBIOTICS |
COMPOSITION | FORM | THERAPEUTIC SEGMENTS |
AMOROLFINE HYDROCHLORIDE | CREAM | ANTIFUNGALS |
CIPROFLOXACIN HYDROCHLORIDE, FLUOCINOLONE ACETONIDE, CLOTRIMAZOLE | CREAM | ANTIFUNGALS |
CLOTRIMAZOLE | CREAM/ LOTION | ANTIFUNGALS |
CLOTRIMAZOLE VAGINAL | GEL | ANTIFUNGALS |
CLOTRIMAZOLE, BECLOMETHASONE | CREAM | ANTIFUNGALS |
CLOTRIMAZOLE, BECLOMETHASONE DIPROPIONATE, GENTAMYCIN SULPHATE | OINTMENT | ANTIFUNGALS |
EBERCONAZOLE NITRATE | CREAM | ANTIFUNGALS |
FLUCONAZOLE | CREAM | ANTIFUNGALS |
FLUOCINOLONE ACETONIDE | OINTMENT | ANTIFUNGALS |
ITRACONAZOLE | GEL | ANTIFUNGALS |
ITRACONAZOLE, OFLOXACIN, ORNIDAZOLE, CLOBETASOL PROPIONATE | CREAM | ANTIFUNGALS |
KETOCONAZOLE | CREAM/SHAMPOO | ANTIFUNGALS |
KETOCONAZOLE, BECLOMETHASONE DIPROPIONATE | CREAM | ANTIFUNGALS |
KETOCONAZOLE, CLOBETASOLE PROPIONATE, NEOMYCIN | CREAM | ANTIFUNGALS |
KETOCONAZOLE, IODOCHLORHYDROXYQUINOLINE, TOLNAFTATE, NEOMYCIN SULPHATE, CLOBETASOL PROPIONATE | CREAM | ANTIFUNGALS |
KETOCONAZOLE, ZINC PYRITHIONE | SHAMPOO | ANTIFUNGALS |
LULICONAZOLE | LOTION/CREAM | ANTIFUNGALS |
LULICONAZOLE, CLOBETASOLE PROPIONATE | CREAM | ANTIFUNGALS |
OFLOXACIN, TERBINAFINE HYDROCHLORIDE, ORNIDAZOLE, BECLOMETHASONE DIPROPIONATE | CREAM | ANTIFUNGALS |
TERBINAFINE HYDROCHLORIDE | CREAM | ANTIFUNGALS |
TERBINAFINE HYDROCHLORIDE, CHLORHEXIDINE GLUCONATE, SALICYLIC ACID | LOTION | ANTIFUNGALS |
SERTACONAZOLE NITRATE | CREAM | ANTIFUNGALS |
TRIMETHOPRIM, SULFAMETHOXAZOLE | SUSPENSION | SULFONAMIDES |
FLUCONAZOLE | CAPSULE | ANTIFUNGALS |
ITRACONAZOLE | CAPSULE | ANTIFUNGALS |
CLOTRIMAZOLE VAGINAL | TABLET | ANTIFUNGALS |
FLUCONAZOLE | TABLET | ANTIFUNGALS |
KETOCONAZOLE | TABLET | ANTIFUNGALS |
NYSTATIN | TABLET | ANTIFUNGALS |
TERBINAFINE HYDROCHLORIDE | TABLET | ANTIFUNGALS |
COMPOSITION | FORM | THERAPEUTIC SEGMENTS |
ONDANSETRON HYDROCHLORIDE | SYRUP | ANTIEMATIC |
DOMPERIDONE | TABLET | ANTIEMETIC |
ONDANSETRON HYDROCHLORIDE ORALLY DISINTEGRATING |
TABLET | ANTIEMETIC |
DIURETIC | TABLET | DOPAMINE ANTAGONIST (TREAT NAUSEA AND VOMITING) |
COMPOSITION | FORM | THERAPEUTIC SEGMENTS |
ARTEMETHER, LUMEFENTRINE | SUSPENSION | ANTI-MALARIAL |
ARTEMETHER, LUMEFENTRINE | TABLET | ANTI-MALARIAL |
HYDROXYCHLOROQUINE SULPHATE | TABLET | ANTI-MALARIAL |
PRIMAQUINE PHOSPHATE | TABLET | ANTI-MALARIAL |
COMPOSITION | FORM | THERAPEUTIC SEGMENTS |
CITICOLINE SODIUM | SYRUP | PSYCHOSTIMULANTS |
PREGABALIN | CAPSULE | ANTICONVULSANTS |
PREGABALIN, METHYLCOBALAMIN | CAPSULE | ANTICONVULSANTS |
FLUOXETINE HYDROCHLORIDE | CAPSULE | ANTIDEPRESSANT |
PROPRANOLOL HYDROCHLORIDE (SUSTAINED RELEASE), FLUNARIZINE DIHYDROCHLORIDE | CAPSULE | ANTI-MIGRAINE |
PIRACETAM | CAPSULE | NOOTROPIC DRUG |
DIETHYLCARBAMAZINE CITRATE, CHLORPHENIRAMINE MALEATE | TABLET | ANTICONVULSANTS |
DIPHENOXYLATE HYDROCHLORIDE, ATROPINE SULPHATE | TABLET | ANTICHOLINERGICS |
CARBAMAZEPINE | TABLET | ANTICONVULSANTS |
LAMOTRIGINE DISPERSIBLE | TABLET | ANTICONVULSANTS |
LEVETIRACETAM TABLES | TABLET | ANTICONVULSANTS |
SODIUM VALPROATE GASTRO-RESISTANT | TABLET | ANTICONVULSANTS |
SODIUM VALPROATE, VALPROIC ACID CONTROLLED RELEASE | TABLET | ANTICONVULSANTS |
VENLAFAXINE HYDROCHLORIDE | TABLET | ANTIDEPRESSANT/ ANTIPSYCHOTIC |
ALPRAZOLAM, FLUOXETINE HYDROCHLORIDE | TABLET | ANTIDEPRESSANTS |
DESVENLAFAXINE EXTENDED RELEASE | TABLET | ANTIDEPRESSANTS |
DIAZEPAM | TABLET | ANTIDEPRESSANTS |
DULOXETINE HYDROCHLORIDE | TABLET | ANTIDEPRESSANTS |
ESCITALOPRAM OXALATE | TABLET | ANTIDEPRESSANTS |
ESCITALOPRAM OXALATE, CLONAZEPAM | TABLET | ANTIDEPRESSANTS |
FLUOXETINE HYDROCHLORIDE | TABLET | ANTIDEPRESSANTS |
NORTRIPTYLINE | TABLET | ANTIDEPRESSANTS |
PAROXETINE HYDROCHLORIDE | TABLET | ANTIDEPRESSANTS |
SERTRALINE HYDROCHLORIDE | TABLET | ANTIDEPRESSANTS |
TRAZODONE HYDROCHLORIDE | TABLET | ANTIDEPRESSANTS |
DIVALPROEX SODIUM EXTENDED RELEASE | TABLET | ANTI-EPILEPTICS |
TOPIRAMATE | TABLET | ANTI-EPILEPTICS |
PRAMIPEXOLE | TABLET | ANTI-PARKINSONIAN |
AMISULPRIDE | TABLET | ANTIPSYCHOTICS |
ETIZOLAM | TABLET | ANTIPSYCHOTICS |
HALOPERIDOL | TABLET | ANTIPSYCHOTICS |
OLANZAPINE MOUTH DISSOLVING | TABLET | ANTIPSYCHOTICS |
PROCHLORPERAZINE MALEATE | TABLET | ANTIPSYCHOTICS |
PROMETHAZINE HYDROCHLORIDE | TABLET | ANTIPSYCHOTICS |
QUETIAPINE | TABLET | ANTIPSYCHOTICS |
RISPERIDONE | TABLET | ANTIPSYCHOTICS |
RISPERIDONE, TRIHEXYPHENIDYL HYDROCHLORIDE | TABLET | ANTIPSYCHOTICS |
NITRAZEPAM | TABLET | BENZODIAZEPINE CLASS (TREATMENT OF ANXIETY) |
LORAZEPAM | TABLET | BENZODIAZEPINES (TREAT ANXIETY) |
ACETAZOLAMIDE | TABLET | CARBONIC ANHYDRASE INHIBITORS DIURETIC |
ALPRAZOLAM | TABLET | CENTRAL NERVOUS SYSTEM (CNS) DEPRESSANTS |
CINNARIZINE, PIRACETAM | TABLET | NOOTROPICS |
PIRACETAM | TABLET | NOOTROPICS |
CHLORDIAZEPOXIDE | TABLET | PSYCHOTROPIC AGENT |
CHLORDIAZEPOXIDE, TRIFLUOPERAZINE | TABLET | PSYCHOTROPIC AGENT |
CLOBAZAM | TABLET | PSYCHOTROPIC AGENT |
CLOMIPHENE CITRATE | TABLET | PSYCHOTROPIC AGENT |
CLOMIPRAMINE HYDROCHLORIDE | TABLET | PSYCHOTROPIC AGENT |
CLONAZEPAM | TABLET | PSYCHOTROPIC AGENT |
CLONAZEPAM, PAROXETINE (CONTROLLED RELEASED) | TABLET | PSYCHOTROPIC AGENT |
CLONAZEPAM, PROPRANOLOL HYDROCHLORIDE | TABLET | PSYCHOTROPIC AGENT |
CLONIDINE HYDROCHLORIDE | TABLET | PSYCHOTROPIC AGENT |
CLOZAPINE | TABLET | PSYCHOTROPIC AGENT |
IMIPRAMINE HYDROCHLORIDE | TABLET | RICYCLIC ANTIDEPRESSANTS |
ZOPICLONE | TABLET | SEDATIVES/HYPNOTICS |
MIRTAZAPINE | TABLET | TETRACYCLIC ANTIDEPRESSANTS |
AMITRIPTYLINE HYDROCHLORIDE | TABLET | TRICYCLIC ANTIDEPRESSANTS (TCA) |
AMITRIPTYLINE HYDROCHLORIDE, CHLORDIAZEPOXIDE | TABLET | TRICYCLIC ANTIDEPRESSANTS (TCA) |
AMITRIPTYLINE HYDROCHLORIDE, CLONAZEPAM | TABLET | TRICYCLIC ANTIDEPRESSANTS (TCA) |
DOXEPIN HYDROCHLORIDE | TABLET | TRICYCLIC ANTIDEPRESSANTS (TCA) |
DULOXETINE GASTRO-RESISTANT | TABLET | ANTIDEPRESSANTS/ANTISPASMODICS |
COMPOSITION | FORM | THERAPEUTIC SEGMENTS |
DI-SODIUM HYDROGEN CITRATE | SYRUP | KIDENY STONE |
POTASSIUM CITRATE MONOHYDRATE, CITRIC ACID MONOHYDRATE | SOLUTION | URINARY ALKALINIZERS |
POTASSIUM NITRATE, SODIUM MONOFLUOROPHOSPHATE, TRICLOSAN | TOOTHPASTE | DENTAL PRODUCTS |
SILYMARIN | SUSPENSION | HEPATOPROTECTIVE MEDICINES |
SODIUM CHLORIDE NASAL | DROPS | DECONGESTANT INTRANASAL |
TRICHOLINE CITRATE | SYRUP | BILE ACID BINDING AGENT |
TRICHOLINE CITRATE, SORBITOL | SOLUTION | CHOLESTEROL-LOWERING AGENTS |
URSODESOXYCHOLIC ACID | SUSPENSION | GASTROINTESTINAL DRUG |
TAMSULOSIN HYDROCHLORIDE PROLONGED RELEASE AND DUTASTERIDE | CAPSULE | PROSTATIC HYPERPLASIA |
TRIHEXYPHENIDYL HYDROCHLORIDE | TABLET | ANTICHOLINERGIC |
TRIHEXYPHENIDYL HYDROCHLORIDE, TRIFLUOPERAZINE | TABLET | ANTICHOLINERGIC |
LEFLUNOMIDE | TABLET | ANTIRHEUMATIC DRUGS |
ACETAZOLAMIDE | TABLET | CARBONIC ANHYDRASE INHIBITORS DIURETIC |
BETAMETHASONE | TABLET | CORTICOSTEROIDS |
DEFLAZACORT | TABLET | CORTICOSTEROIDS |
DEXAMETHASONE | TABLET | CORTICOSTEROIDS |
PREDNISOLONE | TABLET | CORTICOSTEROIDS |
POTASSIUM OROTATE | TABLET | DIURETIC |
URSODIOL (URSODESOXYCHOLIC ACID) | TABLET | GALLSTONE DISSOLUTION AGENTS |
TADALAFIL TABETS | TABLET | ERECTILE DYSFUNCTION |
SILDENAFIL CITRATE | TABLET | ERECTILE DYSFUNCTION |
LACTIC ACID BACILLUS | TABLET | PROBIOTICS ANTIDIARRHOEA |
TRIOXSALEN | TABLET | PSORIASIS |
FLUVOXAMINE MALEATE | TABLET | SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIS) |
CARISOPRODOL | TABLET | SKELETAL MUSCLE RELAXANTS |
SILYMARIN | TABLET | TREAT CHRONIC (LONG-STANDING) LIVER DISEASES |
METHYLPREDNISOLONE | TABLET | SYSTEMIC CORTICOSTEROIDS |
COMPOSITION | FORM | THERAPEUTIC SEGMENTS |
FERRIC AMMONIUM CITRATE, FOLIC ACID, CYANOCOBALAMIN | SYRUP | NUTRITIONAL SUPPLEMENTS |
FERRIC AMMONIUM CITRATE, IRON WITH VITAMIN B12, B- COMPLEX | SYRUP | NUTRITIONAL SUPPLEMENTS |
FERRIC AMMONIUM CITRATE, VITAMIN B12, FOLIC ACID | SYRUP | NUTRITIONAL SUPPLEMENTS |
FERROUS ASCORBATE, FOLIC ACID | SUSPENSION | IRON PRODUCTS, VITAMIN AND MINERALS COMBINATIONS |
IRON (III) HYDROXIDE POLYMALTOSE COMPLEX | SYRUP | MINERAL SUPLIMENTS |
IVY LEAF DRY EXTRACT | SOLUTION | HERBAL MEDICATIONS |
MULTIVITAMIN AND MINERAL | DROPS | VITAMINS (FOOD SUPIMENTS) |
DRIED FERROUS SULFATE, VITAMIN C, THIAMINE MONONITRATE, PYRIDOXINE HYDROCHLORIDE, RIBOFLAVIN NICOTINAMIDE, CALCIUM PANTOTHENATE, FOLIC ACID, ZINC SULFATE MONOHYDRATE | CAPSULE | ANEMIA |
FERROUS FUMARATE, CYANOCOBALAMIN, FOLIC ACID, ZINC | CAPSULE | ANEMIA |
FERROUS FUMARATE, FOLIC ACID, CYANOCOBALAMIN, ASCORBIC ACID, ZINC | CAPSULE | ANEMIA |
FOLIC ACID | TABLET | VITAMINS (FOOD SUPIMENTS) |
ZINC SULPHATE DISPERSIBLE | TABLET | MINERAL SUPLIMENTS |
FERROUS ASCORBATE, FOLIC ACID | TABLET | HAEMATINICS |
FERROUS ASCORBATE, ZINC, FOLIC ACID | TABLET | HAEMATINICS |
FERROUS FUMARATE, CYANOCOBALAMIN, ZINC, FOLIC ACID | TABLET | HAEMATINICS |
CALCIUM GLUCONATE | TABLET | HYPOCALCEMIA |
MAGNESIUM LACTATE DIHYDRATE, PYRIDOXINE HYDROCHLORIDE | TABLET | MINERAL SUPPLEMENT |
CALCIUM, CHOLECALCIFEROL | TABLET | MULTI-MINERALS |
CALCIUM, MAGNESIUM, ZINC, VITAMIN D3 | TABLET | MULTI-MINERALS |
CALCIUM, VITAMIN D3 | TABLET | MULTI-MINERALS |
DOXYLAMINE SUCCINATE, PYRIDOXINE HYDROCHLORIDE, FOLIC ACID |
TABLET | VITAMINS |
DOXYLAMINE SUCCINATE, PYRIDOXINE HYDROCHLORIDE |
TABLET | VITAMINS |
METHYLCOBALAMIN | TABLET | VITAMINS |
METHYLCOBALAMIN, PYRIDOXINE HYDROCHLORIDE, FOLIC ACID | TABLET | VITAMINS |
MULTIVITAMIN, MINERALS | TABLET | VITAMINS |
SODIUM FEREDETATE, FOLIC ACID, VITAMIN B12 | TABLET | VITAMINS |
PYRIDOXINE HYDROCHLORIDE | TABLET | VITAMINS |
THIAMINE HYDROCHLORIDE, PYRIDOXINE HYDROCHLORIDE, CYNOCOBALAMIN | TABLET | VITAMINS |
THIAMINE MONONITRATE, PYRIDOXINE HYDROCHLORIDE, CYANOCOBALAMIN | TABLET | VITAMINS |
COMPOSITION | FORM | THERAPEUTIC SEGMENTS |
CETIRIZINE HYDROCHLORIDE | SUSPENSION/SOLUTION | ANTIHISTAMINES (BCS CLASS III) |
CYPROHEPTADINE HYDROCHLORIDE | SYRUP | ANTIHISTAMINES |
CYPROHEPTADINE HYDROCHLORIDE, TRICHOLINE CITRATE | DROPS/SYRUP | ANTIHISTAMINES |
FEXOFENADINE HYDROCHLORIDE | SUSPENSION | ANTIHISTAMINES |
LEVOCETIRIZINE DIHYDROCHLORIDE | SYRUP | ANTIHISTAMINES |
LORATADINE | SUSPENSION/SOLUTION | ANTIHISTAMINES |
MONTELUKAST, LEVOCETIRIZINE DIHYDROCHLORIDE | SUSPENSION | ANTIALLERGIC (SKIN) |
OXYMETAZOLINE HYDROCHLORIDE NASAL | SOLUTION | NASAL DECONGESTANTS |
PROMETHAZINE | SOLUTION | PHENOTHIAZINES |
BUDESONIDE | CAPSULE | CORTICOSTEROID |
CINNARIZINE, DOMPERIDONE | TABLET | ANTI-HISTAMINE/ANTI-EMETIC |
CETIRIZINE DI-HYDROCHLORIDE | TABLET | ANTIHISTAMINES |
CETIRIZINE HYDROCHLORIDE | TABLET | ANTIHISTAMINES |
CHLORPHENIRAMINE MALEATE | TABLET | ANTIHISTAMINES |
CHLORPROMAZINE HDROCHLORIDE | TABLET | ANTIHISTAMINES |
CINNARIZINE | TABLET | ANTIHISTAMINES |
CYPROHEPTADINE HYDROCHLORIDE | TABLET | ANTIHISTAMINES |
DESLORATADINE | TABLET | ANTIHISTAMINES |
DIPHENHYDRAMINE HYDROCHLORIDE | TABLET | ANTIHISTAMINES |
FEXOFENADINE HYDROCHLORIDE | TABLET | ANTIHISTAMINES |
FEXOFENADINE HYDROCHLORIDE DISPERSIBLE | TABLET | ANTIHISTAMINES |
FEXOFENADINE HYDROCHLORIDE, MONTELUKAST | TABLET | ANTIHISTAMINES |
HYDROXYZINE HYDROCHLORIDE | TABLET | ANTIHISTAMINES |
KETOTIFEN FUMARATE | TABLET | ANTIHISTAMINES |
LEVOCETIRIZINE DIHYDROCHLORIDE | TABLET | ANTIHISTAMINES |
LEVOCETIRIZINE DIHYDROCHLORIDE, MONTELUKAST | TABLET | ANTIHISTAMINES |
LEVOCETIRIZINE HYDROCHLORIDE, AMBROXOL HYDROCHLORIDE | TABLET | ANTIHISTAMINES |
LEVOCETIRIZINE HYDROCHLORIDE, PHENYLEPHRINE HYDROCHLORIDE | TABLET | ANTIHISTAMINES |
LORATADINE | TABLET | ANTIHISTAMINES |
MEBHYDROLINE NAPADISYLATE | TABLET | ANTIHISTAMINES |
FLUNARIZINE | TABLET | ANTIHISTAMINES |
COMPOSITION | FORM | THERAPEUTIC SEGMENTS |
IVERMECTIN | CREAM/SHAMPOO | ANTHELMINTIC |
ALBENDAZOLE | SUSPENSION | ANTHELMINTIC (ANTI-WORM MEDICATION) |
ALBENDAZOLE, IVERMECTIN | SUSPENSION | ANTI PARASITE MEDICATION |
IVERMECTIN | TABLET | ANTHELMINTICS |
LEVAMISOLE | TABLET | ANTHELMINTICS |
MEBENDAZOLE | TABLET | ANTHELMINTICS |
PRAZIQUANTEL | TABLET | ANTHELMINTICS |
ALBENDAZOLE | TABLET | ANTHELMINTICS |
ALBENDAZOLE, IVERMECTIN | TABLET | ANTHELMINTICS |
BENDAZOLE | TABLET | ANTHELMINTICS |
NICLOSAMIDE (ANHYDROUS) | TABLET | ANTHELMINTICS |
COMPOSITION | FORM | THERAPEUTIC SEGMENTS |
GAMMABENZENE HEXACHLORIDE | LOTION | ANTISCABIES |
GAMMABENZENE HEXACHLORIDE, CETRIMIDE | LOTION | ANTISCABIES |
PERMETHRIN | CREAM/LOTION | PEDICULICIDE |
COMPOSITION | FORM | THERAPEUTIC SEGMENTS |
DEXPANTHENOL | OINTMENT | DERMALS |
SALICYLIC ACID | FACE WASH/OINTMENT | CLEANING AGENT |
TACROLIMUS | OINTMENT | MISCELLENIOUS TOPICAL AGENT (TREAT MODERATE TO SEVERE ECZEMA) |
TRETINOIN | CREAM | RETINOIDS |
ISOTRETINOIN | CAPSULE | DERMALS |
COMPOSITION | FORM | THERAPEUTIC SEGMENTS |
AMBROXOL HYDROCHLORIDE, GUAIPHENESIN, TERBUTALINE SULPHATE, MENTHOL | SYRUP | EXPECTORANTS |
AMBROXOL HYDROCHLORIDE, GUAIPHENESIN, PHENYLEPHRINE HYDROCHLORIDE | SYRUP | EXPECTORANTS |
AMBROXOL HYDROCHLORIDE, GUAIPHENESIN, TERBUTALINE SULPHATE, MENTHOL | SYRUP | EXPECTORANTS |
DIPHENHYDRAMINE HYDROCHLORIDE, AMMONIUM CHLORIDE, SODIUM CITRATE, MENTHOL | SYRUP | EXPECTORANTS |
PARACETAMOL, PHENYLEPHRINE HYDROCHLORIDE, BROMHEXINE HYDROCHLORIDE | SYRUP | EXPECTORANTS |
PARACETAMOL, PHENYLEPHRINE HYDROCHLORIDE, CETIRIZINE DI-HYDROCHLORIDE | SYRUP | EXPECTORANTS |
PARACETAMOL, PHENYLEPHRINE HYDROCHLORIDE, CHLORPHENAMINE MALEATE | SYRUP | EXPECTORANTS |
AMBROXOL HYDROCHLORIDE | SYRUP | MUCOLYTIC AGENTS |
AMBROXOL HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE | SYRUP | MUCOLYTIC AGENTS |
AMBROXOL HYDROCHLORIDE, LEVOCETIRIZINE HYDROCHLORIDE | SUSPENSION | MUCOLYTIC AGENTS |
AMBROXOL HYDROCHLORIDE, TERBUTALINE SULPHATE, GUAIFENESIN | SYRUP | MUCOLYTIC AGENTS (COUGH AND MUCUS) |
BROMHEXINE HYDROCHLORIDE | SYRUP | MUCOLYTIC AGENTS |
BROMHEXINE HYDROCHLORIDE, GUAIPHENESIN, TERBUTALINE SULPHATE | SYRUP | MUCOLYTIC AGENTS (COUGH AND MUCUS) |
BROMHEXINE HYDROCHLORIDE, TERBUTALINE, GUAIPHENESIN, MENTHOL | SYRUP | MUCOLYTIC AGENTS |
LEVOSALBUTAMOL SULPHATE, GUAIPHENESIN, AMBROXOL HYDROCHLORIDE | SYRUP | MUCOLYTIC AGENTS (COUGH AND MUCUS) |
CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HYDROCHLORIDE | SYRUP | UPPER RESPIRATORY COMBINATION |
DEXTROMETHORPHAN HYDROBROMIDE, CHLORPHENIRAMINE MALEATE | SYRUP | UPPER RESPIRATORY COMBINATION |
DEXTROMETHORPHAN, CHLORPHENIRAMINE MALEATE, HYDROBROMIDE, PHENYLEPHRINE HYDROCHLORIDE | SYRUP | UPPER RESPIRATORY COMBINATION |
PHENYLEPHRINE HYDROCHLORIDE, CHLORPHENIRAMINE MALEATE | SYRUP | UPPER RESPIRATORY COMBINATION |
BROMHEXINE HYDROCHLORIDE, SLABUTAMOL SULPHATE, GUAIPHENESIN, MENTHOL | SYRUP | EXPECTORANTS |
DEXTROMETHORPHAN HYDROBROMIDE, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HYDROCHLORIDE | SYRUP | COUGH AND NASAL CONGESTION |
PHENYLEPHRINE HYDROCHLORIDE, PARACETAMOL, CHLORPHENIRAMINE MALEATE | SUSPENSION/DROPS/SYRUP | COUGH AND COLD |
SALBUTAMOL SULPHATE | SUSPENSION | BRONCHODILATOR |
THEOPHYLLINE | SOLUTION | ANTIASMTTMATIC |
PHENYLEPHRINE HYDROCHLORIDE, CHLORPHENAMINE MALEATE, PARACETAMOL, ASCORBIC ACID, CAFFEINE | CAPSULE | ANTICOLD |
DEXTROMETHORPHAN | TABLET | ANTITUSSIVES |
SALBUTAMOL SULPHATE | TABLET | BRONCHODILATOR |
SALBUTAMOL, ETOFYLLINE, BROMHEXINE HYDROCHLORIDE | TABLET | BRONCHODILATOR |
SALBUTAMOL, THEOPHYLLINE | TABLET | BRONCHODILATOR |
PARACETAMOL, CAFFEINE, PHENYLEPHRINE HYDROCHLORIDE, CHLORPHENIRAMINE MALEATE | TABLET | COUGH AND COLD MEDICATIONS |
PARACETAMOL, CAFFEINE, PHENYLEPHRINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE | TABLET | COUGH AND COLD MEDICATIONS |
PARACETAMOL, PHENYLEPHRINE HYDROCHLORIDE LEVOCETIRIZINE HYDROCHLORIDE | TABLET | COUGH AND COLD MEDICATIONS |
PARACETAMOL, PHENYLEPHRINE HYDROCHLORIDE, CETIRIZINE DI-HYDROCHLORIDE | TABLET | COUGH AND COLD MEDICATIONS |
PARACETAMOL, PHENYLEPHRINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE | TABLET | COUGH AND COLD MEDICATIONS |
BROMHEXINE HYDROCHLORIDE, TERBUTALINE SULPHATE, GUAIPHENESIN | TABLET | EXPECTORANT |
AMBROXOL HYDROCHLORIDE | TABLET | MUCOLYTIC |
PARACETAMOL, PHENYLEPHRINE HCL, CAFFEINE, CETIRIZINE HYDROCHLORIDE | TABLET | COUGH AND COLD MEDICATIONS |
AMBROXOL HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE | TABLET | NON-SEDATIVE ANTIHISTAMINES |
COMPOSITION | FORM | THERAPEUTIC SEGMENTS |
GLIMEPIRIDE, METFORMIN HYDROCHLORIDE | TABLET | ANTI-DIABETIC DRUGS |
METFORMIN HYDROCHLORIDE | TABLET | ANTI-DIABETIC DRUGS |
METFORMIN HYDROCHLORIDE SUSTAINED RELEASE | TABLET | ANTI-DIABETIC DRUGS |
SITAGLIPTIN PHOSPHATE | TABLET | ANTI-DIABETIC DRUGS |
SITAGLIPTIN PHOSPHATE, METFORMIN HYDROCHLORIDE | TABLET | ANTI-DIABETIC DRUGS |
GLIBENCLAMIDE | TABLET | ANTI-DIABETIC DRUGS |
GLIMEPIRIDE | TABLET | ANTI-DIABETIC DRUGS |
COMPOSITION | FORM | THERAPEUTIC SEGMENTS |
DICLOFENAC DIETHYLAMINE, BENZYL ALCOHOL | GEL | NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS) |
DICLOFENAC DIETHYLAMINE, LINSEED OIL, MENTHOL, METHYL SALICYLATE, BENZYL ALCOHOL | GEL | NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS) |
DICLOFENAC DIETHYLAMINE, LINSEED OIL, MENTHOL, METHYL SALICYLATE | GEL | NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS) |
DICLOFENAC DIETHYLAMINE, LINSEED OIL,MENTHOL , METHYL SALICYLATE, CAPSAICIN | GEL | NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS) |
DICLOFENAC DIETHYLAMINE, MENTHOL, METHYL SALICYLATE | GEL | NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS) |
DICLOFENAC DIETHYLAMINE, OLIUM LINI,MENTHOL , METHYL SALICYLATE, BENZYL ALCOHOL | GEL | NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS) |
DICLOFENAC | GEL | NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS) |
KETOPROFEN | GEL | NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS) |
LIGNOCAINE HYDROCHLORIDE | GEL | ANESTHETICS |
RACEMIC MENTHOL, PROCAINE HYDROCHLORIDE, BENZOCAINE | OINTMENT | ANESTHETICS |
IBUPROFEN, MENTHOL, METHYL SALICYLATE, MEPHENESIN | GEL | NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS) |
NIFEDIPINE, LIDOCAINE HYDROCHLORIDE | CREAM | ANTIHEMORROIDAL |
SUCRALFATE, METRONIDAZOLE, LIGNOCAINE HYDROCHORIDE | CREAM | ANORECTAL PREPARATIONS (BEDSORE, PILES AND ANAL FISSURES) |
THYMOL, MENTHOL, ICHTHAMMOL, LIGNOCAINE HCl | OINTMENT | ANORECTAL PREPARATIONS |
TROXERUTIN | GEL | ANTIHEMORROIDAL |
UREA, LACTIC ACID, PROPYLENE GLYCOL, LIQUID PARAFFIN | CREAM | FOOT CREAM (TO TREAT DRY SKIN) |
WHITE PETROLIUM JELLY, LIGHT LIQUID PARAFFIN | OINTMENT/CREAM | TOPICAL AGENT (TREAT ECZEMA AND RELATED DRY SKIN CONDITIONS) |
IBUPROFEN | SUSPENSION | NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS) |
IBUPROFEN, PARACETAMOL | SUSPENSION | NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS) |
MEFENAMIC ACID, PARACETAMOL | SUSPENSION | NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS) |
LIGNOCAINE HYDROCHLORIDE | GEL | ANESTHETICS |
RACEMIC MENTHOL, PROCAINE HYDROCHLORIDE, BENZOCAINE | OINTMENT | ANESTHETICS |
CHOLINE SALICYLATE, LIGNOCAINE HYDROCHLORIDE, BENZALKONIUM CHLORIDE | GEL | ANALGESICS |
ACECLOFENAC, PARACETAMOL | SUSPENSION | ANALGESIC /ANTIPYRETIC DRUG |
ACETAMINOPHEN | SYRUP/SUSPENSION | MISCELLANEOUS ANALGESICS |
CHLORBUTOL, BENZOCAINE, PARADICHLOROBENZENE | DROPS | OTIC AGENTS |
DEFLAZACORT | SUSPENSION | GLUCOCORTICOIDS |
NIMESULIDE | SUSPENSION | ANTI INFLAMATORY DRUG |
PARACETAMOL | DROPS | ANTIPYRETICS |
PARACETAMOL PAEDIATRIC | SUSPENSION | ANALGESIC /ANTIPYRETIC DRUG |
DICYCLOMINE HYDROCHLORIDE, TRAMADOL HYDROCHLORIDE, ACETAMINOPHEN | CAPSULE | ANALGESICS / ANALGESIC /ANTIPYRETIC DRUG |
RABEPRAZOLE (ENTERIC COATED), DICLOFENAC SODIUM (SUSTAINED RELEASE) | CAPSULE | ANTI INFLAMATORY DRUG |
TRAMADOL HYDROCHLORIDE | CAPSULE | OPIOID ANALGESICS |
ACECLOFENAC | TABLET | ANALGESIC |
ACECLOFENAC, DROTAVERINE HYDROCHLORIDE | TABLET | ANALGESIC AND ANTIPYRETIC |
ACECLOFENAC, PARACETAMOL | TABLET | ANALGESIC AND ANTIPYRETIC |
PARACETAMOL | TABLET | ANALGESIC AND ANTIPYRETIC |
PARACETAMOL DISPERSIBLE | TABLET | ANALGESIC AND ANTIPYRETIC |
PARACETAMOL, CAFFEINE | TABLET | ANALGESIC AND ANTIPYRETIC |
PARACETAMOL, CAFFEINE, ACETYLSALICYLIC ACID | TABLET | ANALGESIC AND ANTIPYRETIC |
PARACETAMOL, ETODOLAC | TABLET | ANALGESIC AND ANTIPYRETIC |
SULFASALZINE DELAYED RELEASE | TABLET | ANTI-RHEUMATIC DRUG |
ARIPIPRAZOLE | TABLET | ATYPICAL ANTIPSYCHOTICS |
ACECLOFENAC, PARACETAMOL, CHLORZOXAZONE | TABLET | NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS) |
ACECLOFENAC, PARACETAMOL, SERRATIOPEPTIDASE | TABLET | NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS) |
ACECLOFENAC, THIOCOLCHICOSIDE | TABLET | NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS) |
ACETYLSALICYLIC ACID | TABLET | NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS) |
DICLOFENAC POTASSIUM | TABLET | NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS) |
DICLOFENAC POTASSIUM, PARACETAMOL | TABLET | NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS) |
DICLOFENAC POTASSIUM, PARACETAMOL, SERRATIOPEPTIDASE | TABLET | NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS) |
DICLOFENAC SODIUM | TABLET | NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS) |
DICLOFENAC SODIUM, PARACETAMOL | TABLET | NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS) |
DICLOFENAC SODIUM, PARACETAMOL, CHLORPHENAMINE MALEATE, MAGNESIUM TRISILICATE | TABLET | NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS) |
DICLOFENAC SODIUM, PARACETAMOL, CHLORZOXAZONE | TABLET | NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS) |
ETORICOXIB | TABLET | NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS) |
ETORICOXIB, THIOCOLCHICOSIDE | TABLET | NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS) |
IBUPROFEN | TABLET | NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS) |
IBUPROFEN, PARACETAMOL | TABLET | NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS) |
IBUPROFEN, PARACETAMOL | TABLET | NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS) |
INDOMETHACIN | TABLET | NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS) |
KETOROLAC TROMETHAMINE | TABLET | NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS) |
MEFENAMIC ACID, DICYCLOMINE HYDROCHLORIDE | TABLET | NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS) |
MELOXICAM | TABLET | NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS) |
METAMIZOLE SODIUM | TABLET | NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS) |
METAMIZOLE SODIUM, PITOFENONE HYDROCHLORIDE, FENPIVERINIUM BROMIDE | TABLET | NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS) |
NIMESULIDE | TABLET | NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS) |
NIMESULIDE, PARACETAMOL | TABLET | NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS) |
SERRATIOPEPTIDASE | TABLET | NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS) |
TRAMADOL HYDROCHLORIDE | TABLET | OPIOID ANALGESICS |
TRAMADOL HYDROCHLORIDE SUSTAINED RELEASE | TABLET | OPIOID ANALGESICS |
TRAMADOL HYDROCHLORIDE, PARACETAMOL | TABLET | OPIOID ANALGESICS |
COMPOSITION | FORM | THERAPEUTIC SEGMENTS |
ACYCLOVIR | OINTMENT | ANTIVIRAL |
UMIFENOVIR HYDROCHLORIDE | CAPSULE | ANTIVIRAL |
VALACYCLOVIR | TABLET | ANTIVIRAL |
ACICLOVIR | TABLET | ANTIVIRAL |
ACICLOVIR DISPERSIBLE | TABLET | ANTIVIRAL |
COMPOSITION | FORM | THERAPEUTIC SEGMENTS |
ISOXSUPRINE HYDROCHLORIDE | CAPSULES | VASODILATORS |
LISINOPRIL DIHYDRATE | TABLET | ACE INHIBITORS |
LOSARTAN POTASSIUM | TABLET | ANGIOTENSIN RECEPTOR BLOCKERS (ARBS) (TREAT HIGH BLOOD PRESSURE) |
LOSARTAN POTASSIUM, HYDROCHLORTHIAZIDE | TABLET | ANGIOTENSIN RECEPTOR BLOCKERS (ARBS) (TREAT HIGH BLOOD PRESSURE) |
TELMISARTAN | TABLET | ANGIOTENSIN RECEPTOR BLOCKERS (ARBS) (TREAT HIGH BLOOD PRESSURE) |
TELMISARTAN, CHLORTHALIDONE | TABLET | ANGIOTENSIN RECEPTOR BLOCKERS (ARBS) (TREAT HIGH BLOOD PRESSURE) |
TELMISARTAN, HYDROCHLORTHIAZIDE | TABLET | ANGIOTENSIN RECEPTOR BLOCKERS (ARBS) (TREAT HIGH BLOOD PRESSURE) |
TRANEXAMIC ACID | TABLET | ANTIFIBRINOLYTICS (TREAT HEAVY BLEEDING) |
TRANEXAMIC ACID, ETAMSYLATE | TABLET | ANTIFIBRINOLYTICS (TREAT HEAVY BLEEDING) |
TRANEXAMIC ACID, MEFENAMIC ACID | TABLET | ANTIFIBRINOLYTICS (TREAT HEAVY BLEEDING) |
ETAMSYLATE, MEFENAMIC ACID, TRANEXAMIC ACID |
TABLET | ANTIHEMORRHAGIC |
AMLODIPINE, LISINOPRIL | TABLET | ANTI-HYPERTENSIVE DRUGS |
AMLODIPINE, LOSARTAN POTASSIUM | TABLET | ANTI-HYPERTENSIVE DRUGS |
ATENOLOL | TABLET | BETA BLOCKERS |
BISOPROLOL FUMARATE | TABLET | BETA BLOCKERS |
METOPROLOL TARTRATE | TABLET | BETA BLOCKERS |
PROPRANOLOL HYDROCHLORIDE | TABLET | BETA BLOCKERS |
PROPRANOLOL HYDROCHLORIDE, FLUNARIZINE DIHYDROCHLORIDE | TABLET | BETA BLOCKERS |
AMLODIPINE | TABLET | CALCIUM CHANNEL BLOCKERS |
AMLODIPINE, ATENOLOL | TABLET | CALCIUM CHANNEL BLOCKERS |
AMLODIPINE, TELMISARTAN | TABLET | CALCIUM CHANNEL BLOCKERS |
DILUTED ISOSORBIDE MONONITRATE | TABLET | CORONARY HEART DISEASE |
ETHAMSYLATE | TABLET | HEMOSTATIC AGENT |
ATORVASTATIN | TABLET | HMG-COA REDUCTASE INHIBITORS |
ROSUVASTATIN CALCIUM | TABLET | HMG-COA REDUCTASE INHIBITORS |
DIPYRIDAMOLE | TABLET | PLATELET INHIBITOR PREVENT BLOOD CLOTS |
ISOXSUPRINE HYDROCHLORIDE | TABLET | VASODILATORS |
DIGOXIN | TABLET | CARDIAC GLYCOSIDE |
CAPTOPRIL | TABLET | ACE INHIBITORS (HYPERTENSION) |